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Abstract
ABSTRACT
Protein kinases (PKs) are ubiquitous enzymes which utilise phosphorylation, a reversible 
post-translational modification, to regulate protein activity. Protein phosphorylation is 
widespread, affecting nearly all aspects of growth and homeostasis in eukaryotic cells. 
However, over twenty years ago certain viral transforming genes were found to possess 
PK activity, bringing protein phosphorylation to the attention of virologists.
Sequence analysis of the herpes simplex virus type 1 (HSV-1) genome identified two 
genes, US3 and UL13, whose products exhibit PK-specific amino acid sequence motifs. 
The US3 PK has been purified, the enzyme activity characterised and a number of targets 
for phosphorylation identified. The UL13 PK has not yet been purified, but its enzymatic 
characteristics and potential target proteins have been investigated. It localises in the 
nuclei of infected cells, utilises ATP or GTP to phosphorylate acidic but not basic 
substrates, and is a minor component of the virion tegument. The UL13 PK activity is 
stimulated by high salt concentration and is insensitive to inhibition by heparin. Several 
proteins have been identified as targets for the UL13 PK, one being the abundant viral 
tegument protein encoded by HSV-1 gene UL49.
The aims of this project were to confirm that the UL13 PK targets the UL49 protein for 
phosphorylation, to characterise further the UL13 PK activity, and to map 
phosphorylated residues within the UL13 and UL49 proteins.
From an analysis of three independent UL13 mutants, each with a lesion in a different 
region of the UL13 gene, it was confirmed using an in vitro assay that phosphorylation of 
the UL49 protein was dramatically reduced in the absence of a functional UL13 protein. 
In radiolabelled nuclear extracts of wt HSV-1 infected cells or membrane-stripped wt 
virions, the UL13 protein was detected as a highly radiolabelled 57 kDa phosphoprotein. 
Phosphorylation of this protein was stimulated by increasing salt concentrations. Thus, 
HSV-1 UL13 PK differs significantly from the previously characterised HSV-2 UL13 
PK in both its salt sensitivity and optimum pH.
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Radiolabelling of the UL13 PK maybe attributed to autophosphorylation. However, at 
least two hyperphosphorylated forms of the UL13 protein were detected in radiolabelled 
nuclear extracts incubated with excess unlabelled ATP or GTP. The level of 
hyperphosphorylation differed between cell lines, and hyperphosphorylated UL13 
protein was not detected in radiolabelled m em brane-stripped virions. 
Hyperphosphorylation was insensitive to heparin, but was completely abolished in the 
presence of a potent inhibitor of cellular casein kinase II.
The most obvious target for the UL13 PK identified during this study was a 38 kDa 
virion protein, which was confirmed by mass spectrometry and by use of a mutant virus 
expressing a C-terminally truncated form of the UL49 protein to be encoded by HSV-1 
gene UL49. The UL49 protein was still phosphorylated, albeit to a greatly reduced level, 
in nuclear extracts prepared from UL13 mutant-infected cells. The additional PK or PKs 
targeting the UL49 were inhibited by heparin and sensitive to increasing salt 
concentrations. This suggests that a cellular PK targets the UL49 protein. However, an 
inhibitor of casein kinase II had little effect on phosphorylation of the UL49 protein.
Initially, the UL49 protein was found to cycle phosphate, and did not appear to be 
hyperphosphorylated beyond a basal level. However, under altered buffer conditions, it 
was hyperphosphorylated and also possibly nucleotidylylated, these modifications 
seeming to require sequences near the C-terminus of the UL49 protein.
Phosphopeptide mapping experiments performed on the UL49 protein phosphorylated at 
low salt concentrations led to detection of a 2 kDa tryptic phosphopeptide by SDS- 
PAGE, and mass spectrometric analysis identified a phosphorylated 1703.91 Da tryptic 
peptide which was phosphorylated at high salt concentrations. It is likely that these two 
peptides represent cellular and viral PK target sites. Mapping of the UL13 protein 
suggested that phosphopeptide fragments are located in the serine-rich, N-terminal 100 
residues of the protein, a region which lies outside the established catalytic domain of the 
UL13 PK.
As well as providing data in support of UL13 encoding a PK which targets the UL49 
protein for phosphorylation, the data presented in this thesis represents a further
Abstract
characterisation of the UL13 PK activity and provides new insights into phosphorylation 
of the UL49 and UL13 proteins.
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Introduction Chapter 1
INTRODUCTION
This thesis examines phosphorylation of the HSV-1 UL13 protein kinase and its target 
proteins. The introduction will cover three main subjects: protein phosphorylation and 
protein kinase function, herpesviruses and herpesviral protein kinases. It begins with a 
general introduction to protein kinases using cyclic AMP-dependent protein kinase, one 
of the best studied protein kinases, as the basis for a description of protein kinase 
structure and function. This is followed by a brief introduction to herpesviruses leading 
to a summary of herpesviral protein kinases, and culminates in a review of the current 
status of research on the HSV-1 UL13 protein kinase, its homologues in other 
herpesviruses, and their target proteins.
1.1 Protein phosphorylation
Since the discovery of its role in enzyme control by Krebs & Fischer (1956), 
phosphorylation has been regarded as a ubiquitous mechanism for regulating biochemical 
pathways. Protein phosphorylation requires covalent modification of specific serine 
(Ser), threonine (Thr) or tyrosine (Tyr) residues by attachment of the y-phosphate derived 
from a nucleoside triphosphate. The nucleoside triphosphate is generally ATP, although 
in a few cases both ATP and GTP can act as phosphate donors (Hathaway & Traugh, 
1982). These modifications can be reversed by hydrolysis of the phosphate ester linkage.
Metabolic pathways, cell division, ion transport and hormone responses are among the 
processes controlled by protein phosphorylation. In each case, the function of key 
proteins participating in these processes is modulated by phosphorylation state. 
Phosphate moieties on proteins can dramatically affect the catalytic activity of an enzyme 
by allosteric means or by altering the ability of a protein to interact with ligands or other 
proteins.
The family of proteins responsible for intracellular phosphorylation is the protein kinases 
(PKs). These proteins can be divided into two main groups based upon their ability to 
phosphorylate either Ser/Thr or Tyr residues. PKs and protein phosphatases are often 
themselves targets for regulation by protein phosphorylation as part of the cascades 
involved in signal transduction pathways (Lin et al., 1992). Protein kinases also play a
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key role in signal transduction pathways in prokaryotic cells, as well as prokaryotic cell 
growth, division and differentiation (Wu et al., 1999; Motley & Lory, 1999).
1.1.1 Protein kinases
1.1.1.1 Protein kinase catalytic domains
Amino acid sequences are considered to represent PKs if they include certain key 
residues found by Hanks et al. (1988) to be highly conserved in the catalytic core of 
known PKs. To identify these residues, Hanks et al. (1988) aligned sequences of the 
catalytic domains of 65 members of the PK family. The analysis was subdivided into two 
main groups based upon ability to phosphorylate either Ser/Thr or Tyr residues, and 
included known and putative PKs. In total, 38 Ser/Thr and 27 Tyr PKs were analysed.
Subdomain Residues Consensus sequence
I 48-58 xnGxGxx(GAS)xVx
n 69-75 xAnKxnx
m 90-92 xEx
IV 102-104 xnx
V 125-128 x(GVS)(DES)x
VI Ser/Thr 
VI Tyr
152-173
152-173
x(GAT)xxanxxxxxx(HY)RDnK(PLS)cNnx
x(GA)(MC)x(YF)nxxxxxxHRDL(RA)A(RA)N(IVC)x
VII 181-188 xnxDFGnx
VIII Ser/Thr 
VIE Tyr
200-209
200-209
x(TS)xxax(APS)PEx
xPnx(KR)(TM)(APS)(PL)Ex
IX 219-227 xDxW(SA)xGnx
X 257-259 xn/sx
XI 268-281 xnxxxxxxxxxxRx
Table 1.1 Conserved sequences indicative of the subdomains found within the 
catalytic core of PKs (derived from Hanks et al., 1988; Hanks & Quinn, 1991).
Key: x = any residue; R = amino acid sidechain, n = nonpolar chain R group (M, L, I or 
V); a = aromatic or ring-containing R group (F, Y, W or H); s = small R  group with near 
neutral polarity (A, G, S, T or P); c = acidic or uncharged polar R group (D, E, N or Q); b 
= basic polar R group (K, R or H). Residues shown in red are invariant. Residues shown 
in blue were conserved in 62 or more of the 65 PK sequences analysed. Residues 
enclosed within brackets signify alternatives for that position. Residue numbers refers to 
the position within the cAMP-dependent protein kinase (cAPK) sequence.
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Hanks et al. (1988) found that the catalytic domain, which ranged in size from 250 to 
300 residues, could be divided into 11 conserved subdomains (I-XI). However, the 
relative spacing of these subdomains varied from one PK to another. Consensus 
sequences were identified for each subdomain (see Table 1.1), with 9 invariant and 6 
highly conserved residues scattered throughout the PK core. Residues outside the 
subdomains were also conserved, but to a lesser extent.
The conserved residues within the subdomains were considered to be important for 
catalytic function, either directly as components of the active site or indirectly by 
contributing to the formation of the active site through constraints imposed on secondary 
structure. Non-conserved regions are likely to occur in loop structures folded to allow the 
essential conserved regions to be positioned correctly. Conserved subdomains VI and 
VIII contain residues specifically conserved in either the Ser/Thr or the Tyr PKs. This 
substrate-specific sequence variation is likely to play a role in recognising the correct 
hydroxyamino acid.
Understanding PK function requires not only the identification of conserved regions but 
also a knowledge of how they are arranged spatially in the active enzyme. This was
|
facilitated by determination of the crystal structure of a PK.
I
il
| 1.1.1.2 Protein kinase structure
This section will focus on one of the better-studied and simplest members of the PK 
family, the cAMP-dependent protein kinase (cAPK), also known as protein kinase A and 
formerly called phosphorylase kinase kinase (Walsh et a l, 1968). Like most non- 
oncogenic PKs, cAPK is maintained in an inactive state in the absence of the appropriate 
signal, in this case cAMP. The inactive tetrameric holoenzyme consists of two regulatory 
(R) and two catalytic (C) subunits. Binding of cAMP causes the complex to dissociate as 
follows:
R2C2 + 4cAMP -> R2(cAMP)4 + 2C 
The free catalytic C-subunits can then phosphorylate substrate proteins containing the 
relevant target sequence.
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After phosphorylase kinase (Krebs et al., 1959), cAPK was the second PK to be purified 
and the first PK for which the three-dimensional structure was solved (Knighton et al., 
1991a). The relative simplicity of cAPK aided elucidation of its 3-D structure. While in 
many PKs the regulatory and catalytic components are functional elements of one large 
protein, in cAPK they are separate, with activation involving subunit dissociation. This 
allowed the catalytic protein to be studied in the absence of its regulatory subunit. 
Nonetheless, cAPK has been shown to serve as a good general structural template for the 
entire PK family.
To date, three structures for cAPK have been reported. All were visualised complexed 
with a high-affinity 20-amino acid pseudosubstrate inhibitor peptide, PKI(5-24), derived 
from the N-terminal region of the heat stable PK inhibitor protein. Knighton et al. 
(1991a, b) analysed the binary complex, which comprised the recombinant mouse C- 
subunit bound to PKI (5-24) (Knighton et al., 1991a). The ternary complex contains both 
MgATP and PKI(5-24) (Zheng et al., 1993). Bossemeyer et al. (1993) solved the 
structure of the porcine heart C-subunit in a ternary complex with the MgATP analogue 
MnAMP-PNP.
1.1.1.3 cAPK structure
The C-subunit consists of two lobes, one somewhat larger than the other (Fig. 1.1). The 
smaller lobe is derived primarily from the N-terminal region, while the core of the larger 
lobe corresponds to the C-terminal region. A deep cleft is situated between the two lobes. 
In the binary complex the cleft is filled by a portion of the bound inhibitor, and in the 
ternary complex MgATP is located at the base of the cleft (Knighton et al., 1991a).
Fig. 1.1 shows the general features of the C-subunit. The N-terminus begins with an 
amphipathic a-helix that lies primarily along the surface of the large lobe. Within the 
small lobe the dominant secondary structure is an antiparallel p-sheet comprising five 
strands. Residues 120-126 link the two lobes and are important for anchoring the adenine 
moiety. The large lobe is dominated by helices, with a small p-sheet near the cleft that is 
essential for catalysis, and the 50 residues at the C-terminus wrap around the surface of 
both lobes (Knighton et al., 1991a).
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terminal lobe
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y  Large, C- 
terminal lobe
Figure 1.1 A schematic representation of the cAPK C-subunit topology.
The blue arrows represent (3-strands (size in residues shown in brackets); (31(9), p2(8), 
(33(8), P4(6), P5(7), P6(2), P7(3), P8(3) and p9(2). The red boxes represent a-helices, 
aA, aB(6), aC(13), aD(8), aE(19), aF(4), aG(16), aH(10), al(10) and aJ(2). Derived 
from Knighton et al. (1991a).
Subdomain /
Figure 1.2 A linear alignment of the structural subdomains in residues 43 to 290 of 
cAPK and corresponding conserved regions.
The yellow boxes represent the positions of the conserved sequences, the blue blocks 
represent P-strands, and red blocks represent a-helices. Derived from Singh (1994) and 
Hanks et al. (1988)
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Residues 40 to 280 constitute the conserved PK catalytic core. Fig. 1.2 shows a 
schematic representation in which the subdomains are aligned with the conserved 
sequences.
1.1.1.4 Conservation and function of cAPK residues
Singh (1994) performed a multiple sequence alignment of 53 Ser/Thr and 33 Tyr PKs, 
mapping the results onto the 3-D structure of cAPK and calculating the degree of 
conservation of the residues within the catalytic core of cAPK. Each residue in the 
catalytic domain was grouped into one of five major (1 to 5) and three minor ( 6  to 8 ) 
groups (see Table 1.2), depending upon its conservation. A variety of other factors were 
also considered, such as whether residues were buried within the protein structure or 
exposed at the surface.
Group Conserved within 
Ser/Thr PKs
Conserved within 
Tyr PKs
Conserved within 
Ser/Thr and Tyr PKs
1 Conserved Conserved Conserved
2 Conserved Conserved Varied
3 Conserved Varied Varied
4 Varied Conserved Varied
5 Varied Varied Varied
6 Conserved Varied Conserved
7 Varied Conserved Conserved
8 Varied Varied Conserved
Table 1.2 Designation of residue conservation groups in the catalytic domain of PKs
(derived from Singh (1994)).
Group 5 has the greatest number of members. Residues in this group vary throughout the 
PK family and account for 101 (41%) of the 248 residues in the cAPK catalytic domain. 
The majority (69%) of these residues are located on the surface of the protein, suggesting 
that group 5 residues represent the exposed surface of the protein. In contrast, 8 6 % of the 
residues in group 1 are buried within the protein. These represent the inner core of the 
enzyme, with the strict conservation of these hydrophobic residues underlining their 
importance. The majority of the residues in groups 2, 3 and 4 are also buried within the 
enzyme. However, unlike group 1 residues, they lie outside the enzyme’s inner catalytic 
core. It is likely that group 3 and 4 residues include those involved in distinguishing
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between Ser/Thr and Tyr substrates. The majority of the group 2 to 4 residues occur in 
the large C-terminal domain.
4- I - ► 4— I I ------- >
cAPK seq. 49 L G T G S F G R V 69 Y A M K I L 82 L K Q
ConS. 1 1 5 1 3 1 1 5 1 2 1 1 1 5 1 5 5 5
Sub. S S S S S S S
Nuc. N R R P P C N N P
Access B B B B B B B B B B B
4 - l V >  <---------------------------V
cAPK seq. 90 N E K 103 L V K 120 M E Y V 127 E M F s H
ConS. 5 1 4 1 7 5 3 1 1 4 3 1 5 5 4
Sub. S S S
Nuc. N N N N R
Access B B B B B B B B B B
>  <---------- V I -------------► <
cA P K  seq. 132 L R 136 G 165 R D L K P E N L L 182 V T D
C onS. 1 4 5 1 1 1 2 4 2 1 2 I 1 4 1
Sub. S S S S S S
N uc. P P R P N N M
A ccess B B B B B B B B B B
-VII— ► 4 ----------------VIII------------- ► <
cAPK seq. 185 F G F A 198 L c G T P E Y L A P E 220 D W
ConS. 1 1 1 1 4 5 2 2 4 4 1 4 1 1 1 1 4
Sub. S S S S S S S S S
Nuc.
Access B B B B B B B B B B B B B
IX  ► <
cAPK seq. 222 W A L G V L I 230 E M A A G Y P P 239 F A
ConS. 1 1 1 1 1 1 1 1 1 3 4 1 5 5 1 5 5
Sub. S S S S S S S
Nuc.
Access B B B B B B B B B B B B B
X -----------------------------► 4
cAPK seq. 241 D Q P I Q 256 I Y E K I  V S 269 L R N L
ConS. 3 5 5 5 5 3 3 5 5 6 5 5 1 5 5 2
Sub. S S S S S
Nuc.
Access B B B B
- X I  ------------------- ►
cAPK seq. 273 L Q V D L T K R
ConS. 2 5 5 2 1 5  5 1
Sub.
Nuc.
Access B B B
Table 1.3 Sequence and the functional properties of regions of cAPK subdomains.
Residue number refers to the position within cAPK. The conservation group is indicated 
by ConS. Substrate binding sites are shown as Sub and marked by an S, while nucleotide 
binding sites are shown as Nuc and are denoted by identifiers N, R, M, P and C 
depending upon whether the residue contacts the nucleotide, ribose, metal atoms, 
phosphate or a non-specific group. The buried residues of cAPK are shown in Access 
and are denoted by B. Derived from Singh (1994).
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Figure 1.3 3-D structure of the catalytic core of the C-subunit of cAPK complexed 
with PKI(5-24) and MnATP.
This represents the ternary complex of cAPK solved by Zheng et al. (1993). The small 
lobe, corresponding to the nucleotide binding fold (residues 40 to 126) can be seen as 
dominantly p-strands, shown here as orange arrows. The large lobe (residues 127 to 280) 
can be seen as dominantly a-helices, shown here as green barrels. The catalytic cleft can 
be seen between the two lobes.
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Singh (1994) assigned functions to 50 residues in the cAPK catalytic domain. Nucleotide 
binding activity was attributed to 21 residues and substrate binding activity to 37 
residues, and 8  residues were identified as interacting with both MgATP and substrate. 
These data are summarised in Table 1.3.
In most cases the regions implicated in nucleotide or substrate interactions correlate with 
the consensus sequences identified by Hanks et a l (1988). In some cases, the residues 
identified as interacting with substrate are distinct from the PK consensus sequences. For 
example, in subdomain VIII the APE consensus sequence is conserved, but it is the 8  
residues immediately N-terminal which are implicated in substrate interaction. Some 
subdomains (e.g. subdomain XI) show conservation of buried residues but lack 
functional interactions. This implies that they are of conformational importance.
Table 1.3 shows that 13 of the 21 (62%) residues involved in nucleoside triphosphate 
binding are conserved in all PKs analysed, whereas only 8  of the 37 (22%) substrate 
binding residues are conserved. This may reflect the fact that PKs have maintained a
|
I narrow nucleoside specificity but have developed a broad substrate specificity.
I
1.1.2 Subdomain conformations
I
Fig. 1.3 shows the 3-D ternary structure of cAPK complexed with PKI(5-24) (Fig. 1.5) 
and MnATP. The N- and C-terminal lobes can be clearly seen, as can the catalytic cleft.
!
This section will discuss the important features of each of the lobes, and the linker region 
connecting them together.
1.1.2.1 N-terminal lobe 
Glycine-rich loop
Non-PK mononucleotide triphosphate binding proteins share a characteristic consensus 
sequence Gly-X-X-Gly-X-Gly-Lys (Wierenga & Hoi, 1983). This conserved nucleotide 
binding sequence forms part of a structure called the Rossmann fold, comprising a sheet 
of mostly parallel (3-strands with helices above and below the plane of the sheet. The 
motif begins with a p-strand followed by a sharp turn and an a-helix. The glycine-rich 
loop is typically located at this first turn, and is the only region within the Rossmann fold 
motif that shows sequence conservation.
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While comparable to the Rossmann fold motif, the nucleotide binding motif within PK 
subdomain I does exhibit significant differences. The PK consensus sequence, Gly-X- 
Gly-X-X-Gly-X-Val, was shown by Bossemeyer et al. (1993) to form part of a P-strand, 
turn, p-strand structure. The p-strands are stabilised by backbone hydrogen bonds 
between Gly50 and Val57, both invariant residues, and between the invariant Gly52 and 
highly conserved Gly55 (Hanks & Quinn, 1991). One of the most important motifs in the 
conserved catalytic core, the glycine-rich loop lies parallel to and embraces the entire 
nucleotide moiety. It is very mobile, demonstrating sufficient conformational flexibility 
to anchor the phosphoryl group and avoid steric clash with ATP (Bossemeyer et a l,
1993). It is also exquisitely sensitive to what occupies the active site cleft (Aimes et al., 
2000). Of the three conserved Gly residues, Gly52 is the most important for catalysis 
because it allows the backbone amide of Ser53 at the tip of the loop to hydrogen bond to 
the y-phosphate of ATP (Grant et al., 1998).
The glycine-rich loop in the small lobe is the first of two essential conserved loops, the 
second being the catalytic loop within subdomain VI (Fig. 1.6). Both loops lie on the 
surface that lines the cleft between the two lobes. Seven of the invariant residues are 
located either in the loops themselves or connected directly with loop residues, providing 
a finely tuned scaffold for communication at the active site (Knighton et al., 1991a).
Invariant lysine residue
The lysine residue in subdomain II (Table 1.3), Lys72, appears to be functionally 
irreplaceable (Chen et al., 1987) and invariant in all PKs. Situated within p-strand 3 (Fig.
1.2), Lys72 is thought to be directly involved in the phosphotransfer reaction (Kamps & 
Sefton, 1986). The position of Lys72 is fixed by its ionic interaction with the invariant 
glutamic acid (Glu91) (Fig. 1.4) in subdomain III. Subdomain III is the final subdomain 
situated in the small lobe of the PK catalytic subunit.
1.1.2.2 Linker region
The two lobes of the PK are joined by an extended coil, composed of two strands (Fig. 
1.1). One of these strands is derived from the N-terminal region and one from the C- 
terminal region. Residues 120-127, from subdomain V (Table 1.3), form one strand of
9
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the linker region. The subdomains following subdomain V are considered to lie in the C- 
terminal lobe. A stretch of amino acids within the last 70 residues of the C-terminal lobe 
also lie in the linker region. These C-terminal residues lie outside the conserved catalytic 
core (Knighton et al., 1991a).
1.1.2.3 C-terminal lobe
The central core of the catalytic domain consists of subdomains VI and VII (Fig. 1.2). 
These catalytically important, conserved sequence motifs (Table 1.3) lie in two loops that 
connect (3-strands at the surface of the cleft. Their importance is underlined by their 
conservation in PKs of prokaryotes and eukaryotes.
Catalytic loop
A highly conserved loop extends from Arg165 through Asn171 and is termed the “catalytic 
loop” (Fig. 1.6). The loop, Arg165-Asp166-LeuI67-Lys168-Pro169-Glu170-Asn171, contains two 
invariant residues (Asp166 and Asn171) and two highly conserved residues (Arg165 and 
Leu167), and is a hub for communicating with different parts of the molecule. Arg165 
precedes the loop and interacts with Thr197, the autophosphorylation site (Fig. 1.6). The 
loop is stabilised by Asn171 hydrogen bonding with the backbone carbonyl of Asp166 
(Taylor et al., 1993). In the ternary complex, Asp166 is oriented towards the pseudo­
phosphorylation site in PKI(5-24) (Fig. 1.5), leading to the suggestion that Asp166 acts as 
the catalytic base, abstracting the proton from the attacking hydroxyl group (Bossemeyer 
et al., 1993).
Subdomain VII contains the most conserved short stretch in the catalytic domain (Table
1.3). It is flanked for two positions on either side by hydrophobic or near-neutral 
residues. This motif forms a tight loop between P-strands 8  and 9 (Taylor et al., 1993). 
Very large inserts, in excess of 60 residues, can occur between subdomains VII and VIII.
The remaining conserved sequence motifs appear to confer structural stability and do not 
interact directly with substrates at the active site. The Glu in subdomain VIII (Glu203) and 
the arginine in subdomain XI (Arg280) form an ionic pair, while the highly conserved 
aspartic acid in subdomain IX (Asp223) hydrogen bonds with the two backbone amides 
that precede the catalytic loop.
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1.1.3 Protein kinase function
PK function will be explained through the interactions occurring between the PK, 
MnATP/MgATP and substrate. This is a highly complex situation, with many 
interactions involving residues from different subdomains meeting in the active 
conformation of the enzyme.
1.1.3.1 MnATP/MgATP binding
Binding of MgATP can be divided into four parts: the purine base, the ribose, the 
triphosphate group and the metal ions. The interactions can be illustrated as shown in 
Fig. 1.4, where MgATP has been substituted by the analogue MnAMP-PNP 
(Bossemeyer et al., 1993)
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Figure 1.4 Schematic diagram of the interactions between the MgATP substitute 
MnAMP-PNP and the cAPK catalytic subunit.
Dashed lines correspond to hydrogen bonds (<3.5 A) and thin solid lines indicate metal- 
ligand bonds (reproduced from Bossemeyer et al., 1993).
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1.1.3.2 Purine binding
Fig. 1.4 shows the hydrogen bonds between the adenine base and three residues in the 
enzyme. Two hydrogen bonds exist between N6  and the backbone carbonyl of Glu121, 
and N1 and backbone amide of Val123. Both Glu121 and Val123 lie within PK subdomain V 
(Table 1.3). The third hydrogen bond is between N7 and the hydroxyl group of Thr183 in 
subdomain VII (Bossemeyer et al., 1993). Singh (1994) identified Val123 and Thr183, but 
not Glu121, as nucleotide binding residues (Table 1.3), and whereas Glu121 is conserved 
across the PK family, Val123 and Thr183 are conserved only in Tyr PKs. Although not 
shown in Fig. 1.4, non-polar interactions with one side of the purine ring occur with the 
highly conserved Leu49 and invariant Val57, while further non-polar interactions from the 
opposite direction come from Leu173 in subdomain VI.
1.1.3.3 Ribose binding
The sidechain of Glu127 and the carbonyl group of Glu170 are hydrogen bonded to the 
ribose hydroxyl groups (Fig. 1.4). A third hydrogen bond occurs between the 3’OH and 
the sidechain of the inhibitor peptide substrate residue Arg 1-14 (Fig. 1.5).
1.1.3.4 Triphosphate binding
Binding of the triphosphate group is complex, involving a large number of hydrogen 
bonds. Fig. 1.4 shows the stabilising hydrogen bonds formed to the phosphate oxygen 
atoms by the mainchain amides of Ser53, Phe54 and Gly55 (subdomain I), the sidechains of 
Lys72 (subdomain II) and Lys168 (subdomain VII) and the backbone amide of Ala 1-17 
(Fig. 1.5). The invariant residues within the highly conserved phosphate-binding flap 
(Gly50, Gly52 and Val57) lie parallel to the nucleotide but do not interact directly with any 
of the phosphoryl groups (Bossemeyer et al., 1993).
Both Lys72 (subdomain II) and Asp184 (subdomain VII) are invariant (Table 1.3) and are 
considered to be essential residues, since mutating either residue completely abolishes 
PK activity (Taylor et al., 1993; Gibbs et al., 1992). Buechler & Taylor (1989) 
demonstrated the close proximity of these two residues by crosslinking experiments. 
Bossemeyer et al. (1993) showed that Lys72 ion-pairs with the non-transferable a- and p- 
phosphates of MgATP (Fig. 1.4) and forms a salt bridge to the carboxyl group of the 
invariant Glu91. However, Lys72 is too far away from the catalytic site to participate in the
12
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immediate catalytic act. Asp184 chelates the activating metal ion, shown in Fig. 1.4 as 
Mn2+2, which in turn binds the p and y-phosphate group oxygens. When P- and y- 
phosphates are present, divalent metals are required for positioning of these phosphates. 
Heberg et al. (1999) showed that complexes containing two metal ions are the most 
stable.
Invariant residue Asn171 interacts indirectly with phosphoryl oxygens via Mn2+1 (Fig.
1.4). In addition, Asn171 forms a hydrogen bond with the backbone carbonyl of Asp166, 
stabilising the catalytic loop. The hydroxyl of the substrate phosphotransfer site, or P- 
site, serine is 2.7 A from the carbonyl oxygen of Asp166, an ideal position for a concerted 
phosphotransferase reaction.
1.1.4 Protein kinase-substrate interactions
The crystal structure of cAPK revealed at least three factors which are important for 
substrate recognition. Firstly, recognition of the substrate to be phosphorylated. 
Secondly, recognition of positively charged residues N-terminal to the residue to be 
| phosphorylated. Finally, the presence of a hydrophobic pocket responsible for substrate-
| specific variations.
|
ii
| 1.1.4.1 cAPK substrate consensus sequence
!
The position of the peptide consensus sequence is firmly fixed and precisely oriented in 
relation to the enzyme by a combination of ion pairs, hydrogen bonds and hydrophobic 
interactions. Fig. 1.5 shows the cAPK substrate recognition sequence as described by 
Knighton et al. (1991b). It represents the 20-amino acid peptide inhibitor, PKI (5-24), 
used in derivation of the crystal structure of cAPK.
5 10 15 + + 20  24
i i i i i
PKI(5-24) T T Y A D F I A S G R T G R R N A I H D  
Consensus * 16 £ - 10 £ - 5  £  £ + 3
Nomenclature
Figure 1.5 Sequence of PKI (5-24), an inhibitor peptide of cAPK derived from the 
N-terminal region of a naturally occurring heat stable PK inhibitor protein.
| Residues important for peptide recognition are shown in blue; +, indicates the positions
| of the basic residues integral to the consensus sequence (derived from Knighton et al.,
| 1991b).
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The substrate recognition sequence of cAPK is characterised by two basic residues, 
usually arginines, followed by one intervening small residue preceding the site of 
phosphotransfer. The phosphate acceptor site, either Ser or Thr, is followed immediately 
by a large hydrophobic residue. In the case of PKI(5-24) the Ser has been replaced with 
an Ala to create an inhibitor peptide with poorer affinity (Knighton et al., 1991b).
1.1.4.2 Substrate binding
The substrate-binding residues are widely dispersed both in the linear sequence and on 
the surface of the enzyme. The portion of the substrate which contains the consensus 
recognition sequence lies within the large lobe, along the surface of the cleft.
1.1.4.3 Ion pairs
The cAPK residues Glu127, Glu170 and Glu230 are important in substrate binding. Singh
(1994) showed that Glu127 is conserved in Ser/Thr PKs, residue Glu170 is conserved as an 
acidic and uncharged polar residue (Asp, Glu, Asn or Gin) in Ser/Thr PKs or as Ala or 
Arg in Tyr PKs, and Glu230 is conserved in all PKs. Both Glu170 and Glu230 are situated in 
the large lobe of the PK, and Glu127 is situated in the coil connecting the two lobes. These 
residues characteristically recognise basic substrate residues. In the structure of the 
binary (Knighton et a l , 1991a) and the ternary complexes (Bossemeyer et al., 1993), 
substrate residue ArgI-15 makes ion pairs with Glu230 and Glu170. A second substrate 
residue, ArgI-14, forms ion pairs with Glu127. Knighton et al. (1991a) identified a further 
ion pair of ArgI-14-Glu331, but neither Bossemeyer et al. (1993) nor Singh (1994) 
registered this interaction.
1.1.4.4 Hydrogen bonds and hydrophobic interactions
As well as the interactions seen in the binary complex, the ternary complex shows that 
the sidechain of ArgI-14 forms a hydrogen bond to the 3’-hydroxyl group of the ribose 
and also to Thr51 in the glycine-rich flap. The substrate analogue therefore interacts 
directly with the small lobe of the PK as well as with the large lobe and connecting coil 
structure. In addition to these interactions, the sidechain of IleI-18 lies in a hydrophobic 
pocket provided by Pro202, Leu205 and Leu198, and the backbone amide of IleI-18 forms a 
hydrogen bond with the backbone carbonyl of Gly200. The helical segment of the peptide
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is amphipathic, with its hydrophobic face lying in a hydrophobic pocket on the surface of 
the large lobe (Knighton et al., 1991a).
1.1.5 Protein kinase substrate specificity
The discovery of the Tyr PKs (Eckhart et al., 1979) raised the issue of how amino acid 
substrate specificity is achieved. Despite a few dual-specificity protein kinases, such as 
the MAP kinase kinase that can phosphorylate both Ser/Thr and Tyr substrates, most PKs 
thus far characterised are either Ser/Thr- or Tyr-specific. Although both Ser/Thr and Tyr 
PKs have very similar catalytic domain structures, a number of residues within the 
catalytic domain are highly conserved within each type of PK, creating Ser/Thr or Tyr 
PK specific signature motifs (Hanks et al., 1988).
1.1.5.1 Substrate specific sequence variations
Hanks et al. (1988) identified subdomains VI and VIII as containing residues specifically 
conserved in either the Ser/Thr or Tyr PKs. The sequences are shown in Table 1.4.
Su ^domain VI
Ser/Thr PK D L K P E N
Tyr PK (for vertebrate members of the Src family) D L R A A N
Tyr PK (for all others) D L A A R N
Subdomain VUI
Ser/Thr PK G T/S X X Y/F X A P E
Tyr PK X P I/V K/R W T/M A P E
Table 1.4 Comparison of the Ser/Thr and Tyr PK sequences in two PK subdomains.
Subdomain sequences as defined by Hanks et al. (1988). Variable residues are shown in 
blue.
The most striking indicator of amino acid specificity is found in subdomain VI. In cAPK 
this lies between Asp166 and Asn171, both residues that are implicated in ATP binding. The 
second region in subdomain VIII lies immediately on the N-terminal side of the APE 
consensus. This region is highly conserved among Tyr PKs, with less conservation 
among Ser/Thr PKs (Hanks et al., 1988). Singh (1994) also showed that cAPK residues 
168 and 204 demonstrate substrate specific variation, and attributed substrate binding 
functions to Tyr204 and phosphate binding functions to Lys168.
15
Introduction Chapter 1
The majority of differences between Ser/Thr PK and Tyr PK sequences occurred in the 
large C-terminal lobe, with less than a quarter of them occurring in the N-terminal lobe 
(Singh, 1994). This seems reasonable, since the N-terminal lobe is primarily involved in 
nucleotide binding. However, there are substrate-specific residue variations in the N- 
terminal lobe and linker region. For example, p4 and part of aC, corresponding to 
subdomains III and IV, are tightly conserved in Tyr PKs but not in Ser/Thr PKs.
Attempts to alter the substrate specificity of the PK by switching the motifs from a 
Ser/Thr to a Tyr PK simply inactivated the enzyme (Hanks et al., 1988). Purified Tyr 
PKs show an exquisite selectivity for tyrosine and do not phosphorylate serine or 
threonine even when they are substituted for tyrosine in a known acceptor sequence 
(Weinmaster & Pawson, 1986). Conversely, most Ser/Thr PKs do not phosphorylate 
tyrosine.
1.1.5.2 Discrimination between Ser/Thr and Tyr protein kinases
The structure of the catalytic subunit of cAPK bound to ATP and an inhibitor peptide 
gave an idea of the structural restrictions imposed upon substrate binding. The 
substrate:ADP complex of cAPK showed that the hydroxyl of the Ser at the 
phosphotransfer site (P-site) is 2.7 A from the carboxyl oxygen of the proposed catalytic 
base (Asp166). This is an ideal position to undergo a concerted phosphotransferase 
reaction. Because the serine and threonine hydroxyls are both linked to the p-carbon 
atom, they are equivalent in terms of catalysis. The only difference is that the extra 
methyl group has to be accommodated in the active site without interfering with 
phosphate transfer if threonine is to be phosphorylated. From the structure it became 
clear that if the substrate peptide backbone was maintained in the same position, the 
tyrosine side chain would not fit correctly into the active site so that the 0 4-hydroxyl 
group could be positioned to receive the phosphate group.
When the structure of the epidermal growth factor (EGF) receptor protein-tyrosine kinase 
was modelled on the known cAPK structure (Knighton et al., 1993) the predicted general 
folding of the EGF receptor catalytic domain was similar to that of cAPK. However, the 
backbone of the substrate peptide must be positioned differently at the active site in order
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to accommodate the tyrosine and prevent its hydroxyl group from protruding into the 
ATP-binding site. Conversely, if the catalytic cleft of the protein-tyrosine kinase is 
configured to allow the hydroxyl group of tyrosine to accept phosphate this will preclude 
phosphorylation of serine and threonine, since their hydroxyls would not penetrate deep 
enough to act as acceptors. This raises interesting questions concerning the dual­
specificity PKs, such as MAP kinase kinase.
The 3-D structure of the unphosphorylated, inactive insulin receptor protein-tyrosine 
kinase catalytic domain helped reveal why this enzyme is specific for Tyr (Hubbard et 
al., 1994). As predicted from sequence similarities (Hanks et al., 1988) the overall 
folding of the polypeptide chain is the same. With the exception of inserts, such as a 
large one between a4 and a5, the general secondary structure is conserved. With one 
exception, invariant residues in the catalytic core are located in the same position in all 
known PK structures. However, as expected, there are some differences in the small lobe 
and in the orientation of the two lobes relative to each other. The major differences 
between the enzymes are in the activation loop in the large lobe near the cleft interface.
1.1.6 Protein kinase mechanism
As mentioned above, non-PK nucleotide binding proteins possess a conserved Lys in 
their glycine-rich loop structure. This is almost analogous to the invariant Lys72 in PK 
subdomain III, but does demonstrate some functional differences. In adenylate kinase the 
Lys residue forms hydrogen bonds with both the (3- and y-phosphoryl groups, and is 
proposed to follow the y-phosphoryl group during transfer (Schulz et al., 1992). 
However, as shown in Fig. 1.4, in PKs the conserved active site lysine (Lys72) is bonded 
to a  and P-phosphoryl oxygens (Bossemeyer et al., 1993). Lys72 is situated in the third 
anti-parallel p-strand (Fig. 1.2), and contacting the y-phosphoryl group would require 
large structural movements of the p- strand. Bossemeyer et al. (1993) suggested that a 
better candidate for stabilising the transition state of the y-phosphoryl is Lys168. Although 
this residue is conserved in Ser/Thr PKs but is present as an Arg in Tyr PKs, both are 
capable of neutralising the negative charge of the y-phosphoryl group during transfer, 
thus lowering the free energy of the transition state.
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A catalytic base is absolutely required to abstract a proton from the attacking hydroxyl 
group during PK catalysis (Yoon & Cook, 1987). It has been suggested that Asp166 exerts 
this function (Fig. 1.6). Asp166 is an invariant amino acid found not only in all PKs but 
also in phosphotransferases, and is well positioned to hydrogen bond to the hydroxyl 
group of a Ser modelled into the position of Ala 1-17 (Fig. 1.5).
1.1.6.1 The phosphotransferase reaction
The transfer of the y-phosphoryl group to the hydroxyl group of an amino acid on a 
substrate has been the subject of a great deal of research. The structure of the cAPK 
ternary complex (Knighton et al., 1991a) set the stage for understanding the catalytic 
reaction. There is a short distance between the y-phosphate and A lai-17 (3.7A), 
indicating that this could be the position of the substrate residue to be phosphorylated. 
Substituting the Alai-17 with a serine gives an effective model of the situation within the 
active site, and essentially changes the PK-inhibitor structure obtained by Knighton et al. 
(1991b) to an effective model of PK-substrate interaction (Bossemeyer et al., 1993). This 
gives a distance between the oxygen of the seryl group (seryl Oy) and the y-phosphorus 
atom as 2.7A. As stated above, a catalytic base is required for proton abstraction from 
Seri-17 Oy. It was initially thought that this may be the carboxylate group of Asp166 at a 
distance of 2.8 A, as this structure is clearly poised towards a Py transition state 
(Bossemeyer et al., 1993). However, more recent research found that Asp166 does not 
accept a proton at any of the reaction steps. Asp166 is less important in the phosphoryl 
transfer than it is in maintaining the configuration of the active site. In fact the side chain 
of Lys168 is necessary to stabilise the intermediate reaction states (Hutter & Helms, 1999).
1.1.6.2 Autophosphorylation
If cellular life is to function in an orderly manner, the switching on and off of PKs and 
phosphatases is as crucial for their function as their catalytic activity. Multiple sequence 
alignments indicate that all PKs are likely to have similar structures, with conserved 
features identified in the subdomains of all PKs (Hanks et al., 1988). However, there is a 
wide degree of variability in other parts of the PK domain, and different PKs may contain 
additional domains or subunits. As a result, several different mechanisms for PK control 
are evident.
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A variety of control mechanisms have been identified. These can involve regulation by 
additional, non-catalytic subunits or domains, or control by phosphorylation and 
dephosphorylation of the PK itself, a process referred to as autophosphorylation. 
Autophosphorylation is a feature common to many PKs, but its physiological 
significance was questioned since it was considered that regulation of an autocatalytic 
event would be excessively complex (Hallenbeck & Walsh, 1983). Indeed, there are 
multisubunit PKs which undergo interpeptide autophosphorylation. However, it has been 
shown that a number of PKs, for example protein kinase C (PKC), are capable of 
intrapeptide autophosphorylation, in which a single polypeptide chain phosphorylates 
itself.
A key aspect of regulation demonstrated by many, but not all PKs, is activation by 
phosphorylation of residues within a segment located between subdomains VII and VIII 
of the catalytic domain. Two areas have been identified, both lying in the same region. 
The activation segment, which spans the conserved DFG (subdomain VII) and APE 
(subdomain VIII) sequences, corresponding to residues 184-208 in cAPK. The activation 
loop (Johnson et al., 1996) is located between 5 and 10 residues N-terminal to the 
conserved APE motif, corresponding to residues 196-201 in cAPK (Romano et al., 
1998). The conformation of the activation segment, controlled by phosphorylation, plays 
a key role in the transformation of an inactive to an active PK. Conformational changes 
in the protein are stimulated, leading to the correct disposition of substrate binding and 
catalytic groups and relief of steric blocking to allow access of substrates to the catalytic 
site.
Steinburg et al. (1993) showed definitively that phosphorylation in cAPK is promoted by 
an autocatalytic event which is crucial for activation. Previously, Knighton et al. (1991a) 
demonstrated the structural importance of Thr197, which forms hydrogen bonds with the 
charged sidechains of Arg165 and Lys189, and the possible roles of phosphorylation in 
promotion of activation. Bossemeyer et al. (1993) showed that the ternary complex of 
porcine cAPK was phosphorylated on one residue, Thr197. The activation segment of 
cAPK was shown to contain the sequence RTWT*L, with T* the phosphorylated Thr197. 
This sequence is consistent with the consensus recognition sequence for cAPK, 
RXXT*/S*Hy, where X denotes any residue and Hy denotes a hydrophobic residue
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(Hardie & Hanks, 1995). However, this is not the case with all PKs. For example, neither 
CDK2 nor MAPK exhibit conservation between activation segment and recognition 
sequences, indicating that phosphorylation by other PKs is required for activation of 
these enzymes (Taylor et al., 1995).
Figure 1.6 A schematic representation of ATP and some of the key residues at the 
catalytic site and activation segment of cAPK. Reproduced from Johnson et al. (1996).
The structure and functional interactions of cAPK have been described above. However, 
since PK activation by autophosphorylation is intrinsically linked to PK function, the 
relevant interactions are summarised in Fig 1.6. In addition, the relative position of the 
activation segment is shown. As detailed earlier, the adenine is positioned in a 
hydrophobic pocket and the ribose is stabilised by hydrogen bonds. The phosphates are 
aligned for catalysis by interactions with the main chain nitrogens of the glycine-rich 
loop, Lys72 and interactions with Mg2+ ions, notably the activatory Mg2+, which binds to
Glu91
NH3+
Ser-substrateAdenosine
Activating
Mg++
A sp184
A sp166
Arg 165
Catalytic loop
Lys189
Thr197
Activation segm ent
O
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the (3- and y-phosphate groups of ATP and to Asp184. The catalytic aspartate (Asp166), 
located within the catalytic loop, is presumed to act as a base to remove a proton from the 
protein substrate hydroxyl group, and the resulting ion is then positioned to attack the y- 
phosphate of ATP. The activation segment, beginning with Asp184, consists of a (3-strand 
((39), followed by a loop containing the autophosphorylation site, Thr197. The final 
residue of the activation segment is Glu208, a highly conserved residue of the APE motif, 
and is hydrogen bonded to Arg280. The position of the activation segment appears to be 
important in aligning the catalytic residues.
It is known that the phosphothreonine (Thr197-P) contacts His87, Arg165, Lys189 and Thr195, 
the phosphate compensating for the cluster of positively charged residues (Taylor & 
Radzio-Andzelm, 1994). The contact of the phosphothreonine of the activation segment 
to Arg165, adjacent to the catalytic base (Asp166), appears especially important, providing a 
direct link between the phosphorylated, charged residue and the catalytic site. Adams et 
al. (1995) showed that mutating Thr197 in cAPK resulted in reduced catalytic efficiency.
I The reduced activity was specifically due to lower ATP affinity and reduced rates of
phosphoryl transfer, not to peptide substrate binding affinity.
iI
| The importance of Thr197-P in PK activation is apparent, but its role remains ambiguous.
|
| It is clear that Thr197-P stabilises the positively charged cluster Arg165, Lys189 and His87.
I
j  The interaction with Arg165 may facilitate the orientation of Asp166, the catalytic base,
while interactions between Thr197-P and Lys189 may help orientate Asp184, which contacts 
the activatory Mg2+. Contact between Thr197-P and His87, which is situated in the N- 
terminal domain, may promote correct domain-domain interactions, critical for ATP 
binding.
In addition to autophosphorylation within the activation loop, multiple 
autophosphorylation can occur on specific residues located in the N- or C-terminal 
portions of the polypeptide chain, as in PKC (Fig. 1.7). However, an individual molecule 
of PKC does not have every site modified.
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Figure 1.7 Illustration of PKC with the six autophosphorylation sites located close 
to the catalytic site.
Individual phosphorylation sites are marked. Reproduced from Flint et al., 1990.
As already outlined, intramolecular autophosphorylation, especially at multiple sites of a 
single polypeptide chain, would require significant protein flexibility. Alternatively, 
phosphorylation could be intermolecular. The first step in the activation of the dimeric 
insulin receptor upon insulin binding is an intermolecular autophosphorylation event that 
occurs between two catalytic domains. As many as seven tyrosines can be 
autophosphorylated, but kinetically the first three to be phosphorylated lie within the 
activation loop.
An autophosphorylation event may produce a variety of effects. Bronstein et al. (1986) 
showed that autophosphorylation of purified calmodulin kinase II (Calm-k II) 
dramatically inhibited PK activity and enhanced substrate selectivity. It was hypothesised 
that autophosphorylation of Calm-k II may be a mechanism for limiting phosphorylation 
to physiological substrates. For example, when incubated with several substrates, Calm-k 
II phosphorylated glycogen synthase, then itself, in the process dramatically reducing its 
ability to phosphorylate histones. This type of mechanism could enhance substrate 
specificity in vivo and limit phosphorylation to selected proteins.
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1.2 The Herpesviruses
1.2.1 General properties of herpesviruses
The Herpesviridae are a large family of eukaryotic viruses comprising at least 112 
members, divided into three sub-families, the Alpha-, Beta- and Gammaherpesvirinae. 
They infect a wide range of vertebrates, including fish, amphibians, reptiles, birds, 
marsupials and mammals, including humans (Roizman & Sears, 1993) and at least one 
invertebrate, the oyster (Comps & Cochennec, 1993). Herpesviruses exhibit a high 
degree of host specificity, usually being limited to a single species in natural infections. 
However, single animal species can be host to several herpesviruses. The eight 
herpesviruses associated with humans form the focus of the following introduction to 
herpesviruses.
1.2.2 Human herpesviruses
1.2.2.1 Biological properties
The eight herpesviruses known to infect humans are shown in Table 1.5. Most are 
widespread in both the developed and the underdeveloped world (Whitely & Schlitt, 
1991), and humans remain the sole known reservoir for transmission, which occurs via 
person to person contact. Symptoms, which are summarised in Table 1.6, cover a broad 
spectrum of clinical manifestations, from minor lesions to severe and life-threatening 
encephalopathies.
Virus ICTV
designation
Subfamily Genus Review
HSV-1 HHV-1 Alphaherpesvirinae Simplexvirus Subak-Sharpe & 
Dargan (1998)
HSV-2 HHV-2 Alphaherpesvirinae Simplexvirus Levine (1992)
vzv HHV-3 A Iphaherpesvirinae Varicello virus Gelb (1990)
EBV HHV-4 Gammaherpesvirinae Lymphocryptovirus Miller (1990)
HCMV HHV-5 Betaherpesvirinae Cytomegalovirus Britt (1996)
HHV-6 HHV-6 Betaherpesvirinae Roseolovirus Levy (1997)
HHV-7 HHV-7 Betaherpesvirinae Roseolovirus Levy (1997)
KSHV HHV-8 Gammaherpesvirinae Rhadinovirus Levy(1997)
Table 1.5 The eight herpesviruses known to infect humans and their corresponding 
designations by the International Committee on Taxonomy of Viruses (ICTY).
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Virus Associated illness
HSV-1 80-95% of oral lesions, or “cold sores,” and 30-50% of genital lesions are caused by 
HSV-1. Primary infection and reactivation give similar symptoms. In rare cases it 
causes conjunctivitis, herpetic whitlow, keratitis and encephalitis. Neonatal infections 
are often life threatening.
HSV-2 5-20% of oral lesions and 50-70% of genital lesions are caused by HSV-2. Primary 
in fec tion  and reac tiva t ion  g ive  s im ila r  sym ptom s.  In rare  cases  it causes  
conjunctivitis, herpetic whitlow, kerititis and encephalitis . Neonatal infections are 
often life threatening.
vzv Prim ary infection: chicken pox- a rash which appears 14-15 days post-infection, 
accom panied by a fever. Reactivated infection, “shingles,” appears at the relevant 
dermatome often accompanied by extreme pain.
HCM V Primary infection: en largem ent and fusion of  m acrophages often occurs, Usually 
asym ptom atic  but can be fatal. Reactivation can occur. Infection is problematic in 
immunocompromised individuals. Symptoms include gastro-enteritis and retinitis.
HHV-6 Infant rash exanthem subitum
HHV-7 Febrile illness
EBV Primary infection is often asymptomatic in young children, but occurs as infectious 
mononucleosis in older children and adults. Associated with B urkitt’s lymphoma and 
nasopharyngeal carcinoma.
KSHV Associated with Kaposi’s sarcoma, a vasculated nodular skin lesion
Table 1.6 Summary of the clinical manifestations of the eight herpesviruses known 
to infect humans.
1.2.3 HSV-1 viral architecture
The HSV virion is composed of four morphologically distinct structures (Fig. 1.8), the 
DNA core, the icosahedral nucleocapsid, the amorphous tegument and the outer lipid 
envelope from which the glycoprotein spikes protrude (Dargan, 1986; Beers et al., 1994).
Tegument
Capsid, containing 
the DNA core
Envelope
Glycoprotein spikes
Figure 1.8 Schematic representation of a herpesvirus particle.
The core contains the viral genome in a tightly packed structure (Booy et a l,  1991). The 
capsid is approximately 125 nm in diameter, and is composed of 162 capsomeres, of 
which 150 are hexameric (hexons) and 12 pentameric (pentons), and 320 triplexes that
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provide intercapsomeric connections (Wildy et al., 1960; Schrag et al., 1989; Zhou et al., 
1994). The hexons and pentons are composed of VP5 (coded by gene UL19) with VP26 
(UL35) located at the tips of the hexons, while the intercapsomeric triplex is composed 
of one copy of VP19C (UL38) and two copies of VP23 (UL18). VP24 (UL26, 5’ portion) 
is a protease involved in capsid formation, and VP21 (UL26, 3’ portion) and VP22a 
(UL26.5) are the major and minor scaffolding proteins, respectively.
The tegument is an amorphous proteinaceous layer (Zhou et al., 1999) which lies 
between the nucleocapsid and envelope (Wildy et al., 1960). It consists of at least 18 
proteins, the functions of many of which have not been fully elucidated. Certain 
functions related to morphogenesis, uncoating and regulation of gene expression have 
been assigned to its component proteins.
The virion is enclosed by a lipid envelope (Wildy et al., 1960) containing protruding 
glycoprotein spikes (Wildy e ta l., 1960; Stannard et al., 1987) which vary in size from 8- 
24 nm (Stannard et al., 1987). Thus far eleven glycoproteins have been identified 
(reviewed by Spear, 1993; Haarr & Skulstad, 1994) gB, gC, gD, gE, gG, gH, gl, gJ, gK, 
gL and gM encoded by the genes UL27, UL44, US6, US8, US4, UL22, US7, US5, 
UL53, UL1 and UL10, respectively. Of these, gB, gD, gH and gL are essential for 
infectivity in cell culture (Cai et al., 1988; Ligas & Johnson, 1988; Desai et al., 1988; 
Hutchinson eta l., 1992).
A species of membrane-enclosed particles termed Light particles (L particles)were 
identified by Szilagyi & Cunningham (1991). The L particles resembled HSV virions in 
appearance, but lacked the viral nucleocapsid and were not infectious. However, 
differences in the phosphoprotein content suggested that L particles were genuine 
products of the HSV-1 infectious process and not merely virions which formed without 
the inclusion of a nucleocapsid or lose their nucleocapsid during preparative handling.
1.2.4 Classification and evolution
Historically, herpesviruses were subdivided into three subfamilies, A lpha-, Beta- and 
Gammaherpesvirinae, according to biological properties (Roizman et al., 1981). Genetic 
content is now the chief tool for classifying herpesviruses.
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While herpesviruses are highly divergent, conservation of a subset of core genes across 
the three subfamilies suggests a common evolutionary origin. It is believed that 
herpesviruses evolved with their hosts, allowing McGeoch & Cook (1994) and McGeoch 
et al. (1995) to propose an evolutionary timescale (Fig. 1.9). Herpesvirus evolution is 
thought to have proceeded through mutational and recombinational processes, including 
large scale genomic rearrangements, gene capture and gene duplications (McGeoch, 
1989; McGeoch & Cook, 1994).
_____________________ | C
 | t = =
;  , -
•—  ■ 1  — « ■ « »
240 200 160 120 80 40 0
Myears BP
Figure 1.9 A phylogenetic tree for the herpesviruses.
Derived from herpesvirus sequence comparisons, the time scale (millions of years before 
present) is based on the hypothesis that the viruses have co-speciated with their hosts. 
Broken lines indicate regions of lower confidence. Reproduced from McGeoch et al.
(1995).
1.2.5 Genetic properties of herpesviruses
1.2.5.1 Genome features
Herpesvirus genomes vary in size from 125 to 250 kbp and contain from 70 to 200 genes 
(Roizman & Sears, 1990, 1993). All genomes investigated contain direct or inverted 
repeat sequences located internally or at the genome termini.
1.2.5.2 HSV-1 genome
The genome of HSV-1 (Fig. 1.10) is a 152 kbp linear molecule of double-stranded DNA 
(McGeoch et al., 1985, 1986, 1988), consisting of two covalently linked regions, L and
HSV-1
HSV-2
EHV-1
PRV
VZV
HCMV
HHV-6
EHV-2
HVS
EBV
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S. Each region comprises a unique region (UL, 107.9 kbp and US, 13 kbp) flanked by 
inverted repeats, RL (9 kbp) and RS (6.5 kbp) (McGeoch et al., 1988). The sequences of 
RL and RS are unrelated, with the exception of a direct repeat (the a sequence) of 
approximately 400 bp located at the genome termini. One copy of the a sequence is 
present at the S terminus, but the L terminus sometimes contains more. The a sequence is 
also present at the L-S joint as an inverted copy (Wagner & Summers, 1978).
L .  .  S
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Figure 1.10 Schematic representation of the HSV-1 genome.
Showing the 2 covalently linked components, L and S (double headed arrows) which 
contain unique elements UL and US (solid lines) flanked by inverted repeats (red and 
yellow rectangles). The a sequence is represented by the unshaded box and is present at 
each end of the genome and in an inverted orientation at the L-S junction. The L and S 
region can invert relative to each other to produce four isomers (single headed arrows).
Recombination between the repeat sequences results in inversion of UL and US 
(Sheldrick & Berthelot, 1974). Four equimolar populations, differing with respect to the 
relative orientations of the two unique regions, exist in virion DNA (Hayward et al., 
1975).
The complete sequence of the HSV-1 strain 17+ contains 152,260 residues and encodes at 
least 77 genes. The UL region encodes 59 genes, and the US region encodes 13. The 
inverted repeats encode four genes in duplicate. The genome contains three origins of 
DNA replication, one in UL (oriL) and one in RS (ons; two copies).
1.2.6 The infectious cycle of HSV-1
Infection begins with binding of viral glycoproteins to the cell surface, followed by 
fusion with the plasma membrane and release of the tegument and capsid into the 
cytoplasm. A variety of targets appear to be employed in viral attachment. gC binds to 
heparin sulphate proteoglycan, and gD interacts with a human TNF receptor-like
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molecule designated herpesvirus entry mediator (HveA) (Montgomery et a l, 1996). 
HSV-1 was also found to interact with a poliovirus receptor-related protein, designated 
HveC (Geraghty et al., 1998) whose cellular distribution suggests it may be a prime 
mediator for HSV-1 infection of mucosal surfaces and spread to the nervous system.
It is thought that capsids then use the microtubule network to traverse the cytoplasm to 
the nuclear pores (Penfold et a l, 1994). Sodeik et al. (1997) showed that the capsid, 
having shed the tegument proteins, binds dynein, a cytoplasmic component responsible 
for direction of chromosomes and membrane organelles along microtubules (Mitchison, 
1988). Once at the nucleus, the capsid probably releases its viral DNA through the 
nuclear pores by an unknown mechanism.
Certain tegument proteins also migrate to the nucleus. These include the UL41 and UL48 
proteins. The UL41 protein possesses host shut-off activity, and is thus designated virion 
host shut-off protein (vhs) (Kwong et al., 1988). Vhs, which displays limited amino acid 
sequence homology to the fen-1 nuclease family, accelerates mRNA degradation during 
the early stages of HSV infection through endoribonucleolytic cleavage (Elgadi & 
Smiley, 1999). VP16, encoded by UL48, serves multiple functions, including 
transcriptional activation of viral IE genes, a role in virus assembly and maturation and 
downregulation of vhs.
All HSV-1 genes are transcribed in the nucleus (Wagner & Roizman, 1969) by the 
cellular RNA polymerase II (Costanzo et al., 1977). They are expressed in an ordered 
cascade. The first genes transcribed are the immediate early (IE) or a  genes, followed by 
the early (E) or p genes and finally the late (L) or y genes (Swanstrom & Wagner, 1974; 
Honess & Roizman, 1974).
Transcription of the IE genes is stimulated by VP 16 (Batterson & Roizman, 1983; 
Campbell et al., 1984). Four of the five IE proteins ICP27, ICP22 and in particular ICPO 
(Everett, 1984) and ICP4 (Preston, 1979), have a regulatory role in initiating E gene 
expression (reviewed by Hayward, 1993; Subak-Sharpe & Dargan, 1998). The fifth IE 
protein, ICP47, plays a role in inhibiting antigen presentation by infected cells (Jugovic 
et al., 1998). E gene transcription is not stimulated in the absence of IE proteins.
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Expression of E genes signals the onset of viral DNA synthesis and expression of L 
genes. These encode mainly the viral structural proteins. Their transcription levels are 
enhanced during DNA replication and peak 8-10 h pi, persisting for the remainder of the 
lytic cycle (Honess & Roizman, 1974; Harris-Hamilton & Bachenheimer, 1985).
Gene Status Protein function
UL2 NE Uracil-DNA glycosylase
UL5 E Component of DNA helicase-primase complex; possesses helicase motifs
UL12 NE Deoxyribonuclease; role in maturation/packaging of DNA
UL13 NE Protein kinase
UL23 NE Thymidine kinase
UL26 E Protease; acts in virion maturation
UL30 E Catalytic subunit of replicative DNA polymerase
UL39 NE Ribonucleotide reductase large subunit (ICP6, Vmwl36, Rl)
UL40 NE Ribonucleotide reductase small subunit (Vmw38. R2)
UL50 NE Deoxyuridine triphosphatase
US3 NE Protein kinase
Table 1.7 Enzymes encoded by HSV-1
Enzymes shown in blue are directly involved in DNA replication, those shown in red are 
indirectly involved in DNA replication. E indicates that the function is absolutely 
required for viral growth in cell culture, and NE that it is not.
HSV-1 encodes a number of enzymes (Table 1.7), the majority of which are involved, 
directly or indirectly, in viral DNA replication. DNA replication (reviewed by Challberg, 
1991; Boehmer & Lehman, 1997) appears to initiate at distinct virus specific structures 
in the nucleus, designated replication compartments (Quinlan et al., 1984), with the 
entire nucleus becoming involved as infection proceeds (Roizman & Sears, 1996). It is 
proposed that the DNA circularises in the nucleus (Jacob & Roizman, 1977) by ligation 
of the terminal a sequences (Davison & Wilkie, 1983), and is replicated by a rolling 
circle mechanism (Roizman, 1979).
Seven HSV-1 genes are essential for viral DNA replication, two of which are shown in 
Table 1.7. UL5, UL8 and UL52 primarily form the helicase/primase complex. UL30 and
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UL42 represent the catalytic and accessory subunit of a heterodimeric DNA polymerase. 
UL29 encodes a single stranded DNA-binding protein, and the UL9 protein acts as an 
origin-binding protein with helicase activity.
DNA replication produces “endless” molecules which must be cleaved for packaging 
into preformed capsids. The signal for cleavage has been determined as the a sequence.
1.2.7 Virus assembly and release
The mechanism by which tegument proteins assemble around the capsid is unknown, and 
may occur in the nucleus or cytoplasm. The envelope consists of altered host cell 
membranes containing viral glycoproteins, probably derived from a Golgi component. 
The virion is released from the cell by exocytosis (Rixon, 1993).
1.2.8 Latency
Following primary infection and replication, HSV-1 can be transported to the trigeminal 
ganglia by retrograde transport through the axons (Cook & Steven, 1973; Kristensson et 
al., 1986), where it establishes latency. The genome is not integrated into the host 
genome (Mellerick & Fraser, 1987), and the number of viral genome copies within 
individual latently infected neurons is extremely variable (Sawtell et al., 1998).
The only expression known to occur during HSV latency occurs from a 10.4 kb fragment 
within RL/RS (Stevens et al., 1987; Deatly et al., 1987; Stevens et al., 1988). The 
latency-associated transcripts (LATs) accumulate during latent infection (Spivack & 
Fraser, 1988). LAT-negative mutants retain their ability to become latent, but their ability 
to reactivate is hindered (Javier et al., 1988; Ho & Mocarski, 1989; Hill et a l, 1990; 
Trousdale et al, 1991). Despite much research, the molecular mechanisms of latency 
remain elusive (reviewed by Preston, 2000; Millhouse & Wigdahl, 2000).
1.3 Herpesviral protein kinases
Phosphorylation of viral and cellular proteins occurs during the lytic infection of cells by 
herpesviruses (Pereira et a l, 1977; Marsden et a l, 1978; Wilcox et a l, 1980; Kennedy et 
a l, 1981). It is possible that some of these proteins are phosphorylated by virally 
encoded PKs. It is difficult to distinguish virally encoded PK activities from those of the
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host cell on a biochemical basis (Stevely et al., 1985). Therefore, the number, origin and 
substrate specificity of herpesviral PKs was elucidated when DNA sequence data became 
available.
Searches for amino acid sequence motifs diagnostic of conserved regions within PK 
catalytic domains identified three potential PKs in herpesviruses: the HSV-1 US3 and 
UL13 gene products (Table 1.7) and the large subunit of ribonucleotide reductase (RR; 
encoded by gene UL39).
1.3.1 Ribonucleotide Reductase (UL39)
1.3.1.1 Ribonucleotide reductase function
Ribonucleotide reductase (RR) catalyses the conversion of ribonucleotides to the 
corresponding deoxyribonucleotides, essential for de novo synthesis of DNA (Reichard,
1993). Many herpesviruses encode an active RR, the active enzyme consisting of 
homodimeric large (Rl) and small (R2) subunits in an a 2p2 configuration (Conner et al.,
1994).
The HSV-1 Rl (1R1) and HSV-2 Rl (2R1) subunits are 1137 and 1142 amino acid 
residues in size respectively, and possess an additional N-terminal domain in comparison 
to eukaryotic, prokaryotic and other viral counterparts (Nikas et al., 1986). Proteolytic 
degradation studies located RR activity to the C-terminal two-thirds of 1R1, leading to 
the suggestion that the unique N-terminal domain of the HSV protein may be 
functionally distinct (Clements et al., 1977). Potential bifunctionality of R l was 
reinforced when it was found that R l mRNA demonstrated IE kinetics, whereas R2 
mRNA was not expressed until early times postinfection (Clements et al., 1977).
1.3.1.2 Ribonucleotide reductase protein kinase activity
Sequence analysis of 2R1 identified regions corresponding to eight of the eleven PK 
domains clustered within the N-terminal 411 residues. Eight of the nine conserved 
residues indicative of these PK subdomains were present in 2R1. Sequence analysis of 
1R1 also identified PK subdomains, but only six of the nine conserved residues were 
present (Chung et al., 1989; Ali et al., 1992). Fig. 1.11 shows the relevant sequence 
details.
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Subdomain I II III IV
cAPK 50 G T G S F G R V 70 A M K 91 E 103 L
2RI 105 G D G R T A V V 174 A E K 209 E 244 V
IRI 134 S D G G T A V V 196 E G D 225 E 260 V
cAPK 
2R I 
1RI
115 n [ T ]  y m v m e y v p g  
261 R P G D S P G N P G L  
270 P [T ]  D V C P G T P G P
VI VII
E M F S H L F S E P H A
A G T G P G S A T D P R
A D A G G P S A V D P H
VIII
cAPK 166 D L K P E N 184 D F G 204 Y L A P E
2R1 324 E L T P E N 378 D F G 407 Y H L R E
IRI 335 E L T P E N 389 D F G 418 Y Y L R E
Figure 1.11 Amino acid sequence alignment of 2R1 (from HSV-2 strain 333) and 
1R1 (from HSV-1 strain 17) with cAPK.
Subdomain numbering is in line with Hanks et al. (1988), with boxed residues 
representing conserved regions. Blue characters represent highly conserved or invariant 
residues in known PKs.
Both 1R1 and 2R1 show relatively poor conservation of residues within the PK 
subdomains. For example, the conserved Lys in subdomain II, essential for activity and 
invariant in eukaryotic PKs, is absent from 1R1. However, there is conservation of the 
DFG motif in subdomain VII and the invariant Glu in the APE motif. The DFG motif is 
regarded as the most highly conserved short stretch in the PK domains, and the APE 
motif is a key catalytic domain indicator (Table 1.1).
Because it was believed that RR might be bifunctional and PK motifs had been identified 
within 2R1, it was suspected that 2R1 might possess PK activity. To test this hypothesis, 
PK assays were performed on 2R1 immunocomplexes. It was found that the 2R1 subunit 
was phosphorylated on Ser and Thr residues. Despite the lack of homology between the 
2R1 and 1R1 N-terminus in regions that are conserved in known PK sequences, Chung et 
al. (1989) attributed PK activity to the N-terminal portion of the 2R1 subunit. Indeed, a 
series of insertion or deletion mutants identified the PK catalytic core of 1R1 as 
comprising residues 1 to 292.
Cooper et al. (1995) purified 1R1 and 2R1 from an Escherichia coli expression system, 
and demonstrated that purified 1R1 was capable of autophosphorylation, but that neither 
protein was capable of transphosphorylating histones or calmodulin. In contrast, several
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groups found 1R1 capable of transphosphorylating histone and calmodulin, attributing 
the inability of other groups to reproduce these results as due to HSV-1 strain variations. 
Ali (1995) performed a study of Rl PK activity across a broad variety of HSV-1 and 
HSV-2 strains, finding that the R l subunit was consistently capable of 
autophosphorylation but not transphosphorylation.
It was perhaps no surprise when 1R1 was eventually found to be a target for 
phosphorylation by cellular casein kinase II (CKII), with multiple phosphorylation sites 
mapping to the N-terminal domain (Langelier et al,, 1998; Conner, 1999). Residual 
amounts of CKII were shown to contaminate immunoprecipitated 1R1, explaining the 
apparent autophosphorylation-positive but transphosphorylation-negative nature of the 
Rl PK. In proving that the N-terminal domain of 1R1 does not possess intrinsic PK 
activity, these data strongly suggest that all previous results were due to contaminating 
cellular PKs, principally CKII (Conner, 1999). In this respect, this train of events 
provides a signal lesson in the pitfall of research in protein kinases.
1.3.2 HSV-1 US3
1.3.2.1 Identification of the US3 ORF
McGeoch et al. (1985) identified the US3 gene within the HSV-1 genome (Fig. 1.12). 
Mapping experiments detected the 5’-termini of two mRNA species in this region, both 
specifying a 481 residue protein with an Mw of 52,831 (McGeoch et al., 1985).
McGeoch & Davison (1986) compared the sequences of the predicted products of HSV-1 
US3 and its homologue VZV ORF66 with available PK sequences. Both proteins 
demonstrated strongest homology to CDC28, a PK involved in yeast cell division. The 
best conserved region resides in an 80 amino acid region of US3 (residues 295-376) and 
contains PK subdomains VI to IX which include the DFG and APE consensus sequences. 
A careful search of EBV ORFs failed to identify a US3 homologue (McGeoch & 
Davison, 1986). HSV-1 US3 is now known to have homologues only among the 
Alphaherpesvirinae (Table 1.8).
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US3
US2 US4
Figure 1.12 Genomic location and organisation of the US3 gene.
The upper part of the figure shows a schematic representation of the HSV-1 genome, 
with unique regions shown as lines and major repeat elements as open boxes. The lower 
part of the figure shows a 3 kb section of the short unique (Us) region containing the US3 
gene. The positions and orientations of mRNAs for genes US2, US3 and US4 are shown 
by arrows. Filled circles indicate 5’ termini of mRNAs (two for gene US3) and open 
boxes the locations of predicted protein coding regions (adapted from Rixon & 
McGeoch, 1984; McGeoch & Davison, 1986).
Virus Gene Size of protein 
(amino acid residues)
Mw of 
protein
HSV-1 US3 481 52 831
HSV-2 US3 481 52 674
VZV ORF66 393 43 677
PRV US3 334 36 879
EHV-1 ORF69 382 42 541
HVT US3 358 41 200
MDV US3 402 44 700
ILTV ORF2 471 53 800
Table 1.8 Homologues of the HSV-1 gene US3, showing the size of each encoded 
protein and the predicted Mr.
Derived from McGeoch et al. (1985); McGeoch et al. (1987); Daikoku et al. (1993); 
Davison, (1982); Davison & Scott (1986); Zhang et al. (1990); Katan et al. (1985); 
Telford et al. (1992); Zelnik et al. (1993); Brunovskis & Velicer (1995) and Kongsuwan 
et al. (1995).
A fuller analysis of the HSV-1 US3 protein was performed by Hanks et al. (1988). The 
predicted catalytic domain was aligned with 64 known or putative PKs. Conserved PK 
subdomains and consensus sequences were identified as shown in Fig. 1.13.
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Subdomain I
cAPK 49 L G T G S F G R V
US3 197 L T P G S E G C
ORF66 99 F T P G A E G F A
II
70 A M
218 I V
120 V I
K
K
K
III IV
91 E 103 L
230 E 242 I
132 E 144 V
VI VII VIII
cAPK 164 Y R D L K P E N L 184 D F G 201 T P E Y L A P E
US 3 303 H R D I K T E N I 323 D F G 345 T I D T N A P E
ORF66 204 H R D I K S E N I 224 D F G 245 T I A T N S P E
cAPK 220
US3 364
ORF66 264
D
D
D
W
I
I
W
W
W
IX
A L 
S A 
S A
G
G
G
V L 269 L R N L
L V 455 V C K A
I V  355 I C K M
L
L
L
XI
Q v
T F 
S F
D
D
D
L T K 
G A L  
A R H
R
R
R
F
P
P
Figure 1.13 Amino acid sequence alignment of HSV-1 US3 and VZV ORF66 with 
cAPK.
Subdomain numbering is in line with Hanks et al. (1988). Boxed residues are conserved 
between cAPK and the putative PKs. Blue residues are highly conserved or invariant in 
known PKs. Numbers refer to the first residue in the relevant sequence.
Both HSV US3 and VZV ORF66 deviate from the classic PK consensus sequence in the 
nucleotide binding domain. The established PK consensus sequences of subdomains I 
and II are GxGxxGxV followed 11 to 28 residues later by AxL. In the predicted US3 
gene product the corresponding sequences are TxGxxGxV followed 13 residues later by 
IxL. Sequence alignment of 65 PKs showed the HSV US3 PK was the only to vary at 
Glu50 and only two others vary at Ala70 (Hanks et al., 1988).
1.3.2.2 US3 protein kinase activity
Blue & Stobbs (1981) and Purves et al. (1986) detected a novel PK activity in the 
cytoplasm of HSV-1- and PRV-infected cells. The enzyme was expressed with E 
kinetics. Induction of the enzyme did not occur in cells treated with cycloheximide or 
cells infected with UV-inactivated virus, and was dependent on IE gene expression. 
These data indicated that expression of the viral genome was required for induction of 
the novel PK, and further suggested that the PK may be virally encoded.
In a later study, the novel PK activity was not detected in the cytoplasm of cells infected 
with HSV-1 US3 mutants (Purves et al., 1987). Immunoblotting with an antibody raised 
against the C-terminal eight amino acid residues of the US3 protein specifically
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recognised a polypeptide with a Mr of 68,000, and a 68 kDa protein was detected when 
immunoblots were performed on extensively purified preparations of the novel PK. 
Incubating the purified PK in vitro with [y-32P]ATP stimulated phosphorylation of a 68 
kDa protein. All these data are consistent with the US3 protein encoding a 68 kDa PK 
located in the cytoplasm of HSV-1-infected cells.
1.3.2.3 Growth characteristics of US3 mutant virus
Nishiyama et al. (1992) characterised the in vitro and in vivo phenotype of an HSV-2 
US3-lacZ mutant. As with HSV-1, the HSV-2 US3 gene was shown to be non-essential 
for virus replication in vitro, but the US3-/acZ mutant demonstrated a route-dependent 
reduction of virulence in vivo. Footpad or intraperitoneal inoculation exhibited a 10,000- 
fold decrease in virulence, while corneal or intracerebral inoculation resulted in only a 
10-fold decrease. Mutant virus replication was restricted in the liver and spleen of adult 
mice, but in new-born mice the mutant grew as well as wt virus.
1.3.2.4 Characteristics of the US3 protein kinase
Purified HSV-1 US3 PK was shown to utilise ATP but not GTP as a phosphate donor to 
phosphorylate Ser or Thr residues of basic but not acidic peptides (Katan et al., 1985). 
Using synthetic oligopeptides, it was shown that the major feature of the US3 PK 
phosphorylation site is a string of Arg residues on the N-terminal side of the target Ser or 
Thr, giving a consensus sequence of (R)nX(S/T)YY, where n > 3, with X preferentially 
being Arg, Ala, Val, Pro or Ser and Y preferentially being Arg, Ala, Val, or Ser with 
Ser/Thr as the target residue (Frame et al., 1987; Leader et al., 1991). In addition, the 
US3 PK was found to be active at 1 M KC1, which clearly distiguishes it from the 
considerably more salt sensitive cellular PKs (Frame et al., 1987).
1.3.2.5 US3 protein kinase targets
A variety of proteins have been identified as targets for phosphorylation by the US 3 PK. 
The targets and their proposed physiological significance are summarised in Table 1.9, 
and the evidence is described below.
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Target Function Reference
US9 tegument protein. Daikoku et al. (1994)
UL12 deoxyribonuclease Daikoku et al. (1995)
UL34 Nonglycosylated membrane protein Purves et al. (1991)
US1 (ICP22) IE protein Purves & Roizman (1992)
Table 1.9 Proteins identified as targets for phosphorylation by the US3 PK.
US9
To determine the targets of the US3 PK, Daikoku et al. (1994) performed a series of in 
vitro phosphorylation experiments with an HSV-2 US3 lacZ insertion mutant (L1BR1). 
Compared to cytoplasmic extracts from wt HSV-2 infected cells, L1BR1 extracts showed 
reduced phosphorylation of a number of proteins ranging from 14 to 22 kDa. The PK 
activity was detected at NaCl concentrations above 500 mM and phosphorylation of the 
14 to 22 kDa proteins was inhibited by 50 mM quercetin, a potent inhibitor of HSV-2 
US3 PK (Daikoku et al., 1993). These data indicated that US3 is involved, directly or 
indirectly, in the phosphorylation of these proteins.
While the identity of the 14 to 22 kDa proteins was unknown, HSV-1 gene US9 was 
known to encode a tegument protein migrating on SDS-PAGE as 12 distinct 
phosphoproteins ranging from 12 to 20 kDa (Frame et al., 1986). Because no HSV-2 
US9 mutants existed, Daikoku et al. (1994) performed in vitro phosphorylation reactions 
on extracts of cells infected with wt HSV-1, an HSV-1 US9 mutant or L1BR1. A range 
of phosphorylated proteins from 14 to 22 kDa was detected in the cytoplasm from wt 
HSV-1 infected cells but not the US9 mutant.
Daikoku et al. (1994) repeated these experiments with membrane-stripped virions, 
obtaining similar results. This reinforced the conclusion that the 14 to 22 kDa proteins 
represent various phosphorylated species of the US9 protein which are targeted by the 
US3 PK.
UL12
Daikoku et al. (1994) also observed increased phosphorylation of a 76 kDa protein in the 
cytoplasm of L1BR1 infected cells. Further studies identified a series of strongly
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phosphorylated proteins between 75 and 80 kDa in wt HSV-2 infected cell cytoplasm 
that were absent in L1BR1 infected cells (Daikoku et al., 1995).
The 80 kDa protein was shown to be of viral origin, and its size, cellular distribution and 
kinetics of expression suggested that it was the viral alkaline nuclease encoded by gene 
UL12. Immunoprecipitations performed on in vitro phosphorylated wt and L1BR1 
infected cell extracts using an anti-alkaline nuclease monoclonal antibody precipitated an 
80 kDa phosphoprotein from wt but not L1BR1 infected cells, suggesting the UL12 
protein may be targeted for phosphorylation by the US3 PK.
Since the 76 kDa UL12 protein was phosphorylated in L1BR1 extracts, albeit to a lower 
level, it was concluded that UL12 is also targeted by PKs other than US3. Indeed, no 
significant difference was detected between the in vivo phosphorylation profile of the 
UL12 protein in wt and L1BR1 infected cells, thus calling into question the physiological 
relevance of the US3 PK in functions of the UL12 protein. Since PKC and CKII
!
; phosphorylation sites are present in the UL12 protein, it was concluded that it is
I phosphorylated by viral and cellular PKs.
j
j
UL34
Cells infected with wt or an HSV-1 US3 mutant (R7041) and radiolabelled in vivo 
i  demonstrated different phosphorylation profiles (Purves et al., 1991). A 30 kDa
j phosphoprotein in wf-infected cells was absent from R7041-infected cells, in which a
■ novel 33 kDa phosphoprotein was detected. Analysis of HSV-l/HSV-2 intertypic
recombinants identified the gene encoding the 30 kDa protein as UL34. The predicted 
UL34 gene product possessed a recognisable US3 PK target site, in this case 
RRRRTRRSRE, with both the Ser and Thr potential targets.
A UL34 mutant (R7314) was constructed with the native UL34 gene replaced by UL34 
tagged at its N-terminus with a 17-residue epitope. Extracts of cells infected with R7314 
demonstrated a novel phosphoprotein migrating more slowly than either the 30 or the 33 
kDa proteins. A monoclonal antibody, raised against the epitope tag, identified the novel 
phosphoprotein as the modified UL34 protein. When the Ser and Thr residues in the 
potential phosphorylation site within UL34 were separately mutated to Ala, both mutants
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produced a phosphoprotein indistinguishable from the 33 kDa phosphoprotein. Since 
these UL34 mutants possessed phenotypes similar to the US3' mutant, it was concluded 
that the US3 PK is necessary for post-translational processing of the UL34 protein. 
However, the 33 kDa protein was still phosphorylated in US3'-infected cells, and it 
remained unclear why UL34 appeared to migrate more slowly in its unphosphorylated 
form. Purves et al. (1991) attributed the phosphorylation-induced reduction in Mr to a 
change in charge, shape or proteolytic cleavage of the phosphoprotein.
This complex situation was resolved by Purves et al. (1992), who showed that a 
polyclonal antiserum raised against UL34 sequences did not react with the 33 kDa 
phosphoprotein, indicating it was not a product of the UL34 gene. The protein detected 
by the antiserum was actually shown not to be phosphorylated in US3 mutant-infected 
cell extracts. The unphosphorylated UL34 protein migrated faster than phosphorylated 
UL34 protein, as would be expected.
A range of at least four proteins was also found in US3'-infected cells (25-35 kDa) which 
were phosphorylated with varying degrees of efficiency and were genetically unrelated to 
UL34. The identity and functions of the 25 to 35 kDa proteins remain unclear, but they 
were detected only in lysates of cells infected with viruses incapable of phosphorylating 
UL34. They were shown to co-immunoprecipitate with UL34, suggesting they may be 
functionally related.
Anti-apoptotic activity
Viruses have developed a variety of anti-apoptotic mechanisms to maximise production 
of virus from infected cells. HSV-1 mutants lacking the major regulatory RSI gene 
(encoding ICP4) were shown to induce apoptosis, whereas wt virus did not. In fact wt 
virus protected cells from apoptosis induced by thermal shock (Leopardi & Roizman,
1996). However, when rescuants produced from the RSI" mutant failed to protect cells 
from apoptosis it became apparent that a second mutation had been introduced into US3 
(Leopardi et al., 1997a). ICP4 lacks a candidate phosphorylation site for the US3 PK, 
and Leopardi e t  al. (1997a) found no evidence to suggest that the US3 PK 
phosphorylates ICP4. These findings raised the possibility that US3 itself may be the 
principal viral protein required to block apoptosis. In a further development, Jerome et al.
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(1999) showed that US3 co-operates with US5 to inhibit apoptosis. With deletion of US3 
reducing inhibition of UV-induced apoptosis and deletion of US5 reducing protection 
from Fas-mediated apoptosis.
1.3.3 HSV-1 UL13
In work subsequent to detection of PK motifs in HSV-1 US3 and its homologues, Chee 
et al. (1989) and Smith & Smith (1989) identified a second herpesviral gene predicted to 
encode PK sequence motifs. Unlike HSV-1 US3, which has homologues only in the 
Alphaherpesvirinae, Chee et al. (1989) found PK motifs in related genes from HSV-1, 
VZV, EBV, HHV-6 and HCMV. Table 1.10 lists several of the known homologues to 
HSV-1 UL13, illustrating conservation across the A lp h a - ,  Beta- and 
Gammaherpesvirinae.
Subfamily Virus Gene Size of protein 
(amino acid residues)
Mw of 
protein
Alphaherpesvirinae HSV-1 UL13 518 57 197
Alphaherpesvirinae HSV-2 UL13 518 57 045
Alphaherpesvirinae VZV ORF47 510 57 351
Alphaherpesvirinae EHV-1 ORF49 594 65 244
Alphaherpesvirinae PRV UL13 398 41 500
Betaherpesvirinae HCMV UL97 707 78 233
Betaherpesvirinae HHV-6 15R 562 63 718
Gammaherpesvirinae EBV BGLF4 429 48 352
Gammaherpesvirinae HHV-8 ORF36 444 50 334
Gammaherpesvirinae HVS ORF36 431 48 900
Table 1.10 Homologues of the HSV-1 gene UL13, showing the size of each encoded 
protein and the predicted Mr.
Derived from McGeoch et al. (1986, 1988); Chee etal. (1989); Davison & Scott, (1986); 
Telford et al. (1992); de Wind et al. (1992); He et al. (1997); Chee et al. (1989); Russo et 
al. (1996); Albrecht et al. (1992); Lawrence et al. (1990) and Baer et al. (1984).
1.3.3.1 Sequence analysis
The sequence alignments of HSV-1 UL13 and its homologues with cAPK in Fig. 1.14 
show that the herpesvirus sequences depart from the consensus sequences at certain 
positions thought to be highly conserved. The herpesvirus homologues exhibit little 
conservation of sequences outside the PK domain, and vary extensively in the length of 
their N-terminal domains.
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Smith & Smith (1989) performed a similar sequence analysis on HSV-1 UL13 and its 
counterparts in VZV and EBV, confirming six conserved motifs corresponding to 
subdomains I, II, VI, VII, VIII and IX. In addition, Smith & Smith (1989) identified a 
Ser/Thr PK-specific pattern in the three putative herpesvirus PKs. Despite the 
autophosphorylation domain between motifs VII and IX being poorly conserved in UL13 
and its counterparts and being about 40 residues longer than in classic PKs, a Ser/Thr PK 
pattern is well conserved in the herpesviral sequences around motif VII.
n m IV
cAPK 49 L G T G S F G R V 70 A K I 91 E
UL13 157 G G S G G Y G D V 178 A V K T 91 E
VZV47 138 A G R G T Y G R V 155 A V K T 167 E
BGLF4 84 L G R G S Y G A V 100 T V K L 113 E
15R 201 L G V G A Y G K V 216 A I K T 242 D
UL97 337 L G Q G S F G E V 353 V V K V 380 E .
VI
cAPK 153 T F E Y L H S L - d [ l ] I Y R D I K P E N L 184 D
UL13 264 A V V F L N T T C G I S H L D I K C A N I 301 D
VZV47 243 A L T F L N R T C o | l | T H L D V K C G N I 282 D
BGLF4 181 A V Y F L N R H c g | l | F H S D L S P S N I 219 D
15R 299 A V R F L N L K c R I N H F D I S P N I 335 D
UL97 442 A I K F L N H Q C R V C H F D I T P N V 481 D
119 V
148 V
178 s
122 I
249 V
392 V
VII
p  f  g | 
d  f [ s
Y S
y [ g]
Y S
Y S
vm IX
cAPK 206 A P E 220 D W W A L G
UL13 353 P P E 382 D L Y A L G
VZV47 333 P P E 362 D L Y A L G
BGLF4 279 I P D 297 D L C S L G
15R 386 L V N 428 R E A Q L Y
UL97 533 I C D 573
E
V R M G
Figure 1.14 Amino acid sequence alignment of the putative herpesviral PKs 
identified by Chee et al, (1989) with cAPK.
The alignment shows the subdomains identified as homologous to known PK catalytic 
domains. Residues shown in blue were identified by Hanks et al. (1988) as highly 
conserved in the catalytic domain. The numbers refer to the position of the first residue in 
each indicated subdomain in the relevant sequence.
There is confusion in the literature over the location of some of the PK consensus 
sequences. Chee et al. (1989) and Smith & Smith (1989) disagree over the position of the 
APE consensus sequence in subdomain VIII of EBV BGLF4. Also, Chee et al. (1989)
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and Cannon et al. (1999) identified different residues as the catalytic lysine in HCMV 
UL97. Figs. 1.15 and 1.16 show the consensus sequences identified.
While the APE motifs identified by Smith & Smith (1989) and Chee et al. (1989) lie 
within subdomain VIII, one lies 16 residues downstream of the other (Fig. 1.15). 
However, the sequence identified by Smith & Smith (1989) is closer to the recognised 
sequence of the classic APE consensus motif. Referring to Fig. 1.16, the sequence 
identified by Cannon et al. (1999) is in closer agreement with the subdomain II 
consensus sequence (AxK) determined by Hanks et al. (1988). While these examples 
represent minor differences in interpretation, they serve to highlight the problems 
encountered when trying to identify sequence motifs in PKs.
261 Y K
Figure 1.15 A section of EBV BGLF4 sequence, showing the two sites identified at 
the APE consensus motif indicative of PK subdomain VIII.
Residues shown in blue represent the motif identified in Smith & Smith (1988) and 
residues in red represent the motif identified by Chee et al. (1988). Residue numbers 
refer to the predicted EBV BGLF4 amino acid sequence.
FL C | LL S KC Y I L R G  A GH [r P D| PS  A 284
352 R V V | V A R | H  360
Figure 1.16 A section of HCMV gene UL97 sequence, showing the two identified 
sites of the invariant catalytic lysine.
Residues shown in blue represent the motif identified by Chee et al. (1989) and residues 
in red represent the motif identified by Cannon et al. (1999). In each case the predicted 
catalytic lysine is boxed. Residue numbers refer to the predicted HCMV UL97 amino 
acid sequence.
Several differences exist between the classic PKs and the UL13-related PKs. There are 
minor differences, for example the hydrophobic residue at position -7  in subdomain I 
does not appear to be conserved in UL13 and ORF47, as well as major differences. In all 
putative herpesviral PKs analysed by Chee et al. (1989), the C-terminal part of 
subdomain I and the loop between subdomains I and II are absent. Although not well 
conserved in classic PKs, these residues form part of the hydrophobic core in the small
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lobe of the catalytic subunit (Singh, 1994). In cAPK, these residues lie towards the C- 
terminus of (32, and are involved in holding the adenine ring (Taylor et al., 1993).
Residues 79 to 88 in cAPK, which comprise the C-terminal portion of aB and the N- 
terminal portion of aC, are absent from most herpesviral PK sequences, including UL13. 
Most residues in this region are poorly conserved and excluded from the enzymatic core, 
but some have been implicated in substrate binding (Singh, 1994). Although the catalytic 
Lys is conserved throughout, in herpesviruses the spacing between it and the nucleotide 
binding site is between one and three amino acids, considerably smaller than the 
minimum of 14 amino acid residues found in classic PKs.
Although subdomain VI is the region with greatest frequency of highly conserved 
residues in both herpesvirus and cellular PKs, most divergence between the herpesviral 
and the classic enzymes resides in the region from subdomain V to XI. Some herpesviral 
PK sequences contain inserts between aD  (subdomain V) and aE  (VI), and all contain 
extensive inserts between (39 (subdomain VII) and aF  (VIII). Inserts at these sites would 
not be expected to interfere with PK activity, and probably forms loops between the 
regions of secondary structure in cAPK.
The herpesviral UL13 PK sequences show dramatic differences from the established 
consensus in subdomain VIII, in which the conserved triplet Ala-Pro-Glu (see Fig. 1.14) 
is considered an important PK catalytic domain indicator. Glu208 is invariant in all 65 
Ser/Thr PKs aligned by Hanks et al. (1988), but is conserved in only two of the five 
UL13-related PKs. The region immediately N-terminal to the APE consensus in cAPK 
contains the highly conserved Thr201 which, while acting as an indicator of Ser/Thr 
specificity, diverges in most of the herpesviral PK sequences.
1.3.3.2 Gene position and orientation
In HSV-1 the UL13 gene is orientated leftwards in the prototype representation of the 
HSV-1 genome, with its ORF located between nucleotides 28502 and 26946. The gene 
partly overlaps its neighbours: the promoter, transcript start site and first 82 codons of 
UL13 lie within the coding region of UL14, while the transcribed 5’ non-coding region
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of UL12 overlaps the final 34 codons of the UL13 reading frame. Fig. 1.17, lines 1 and 2 
illustrate the position and orientation of the UL13 gene.
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Figure 1.17 Genomic location and organisation of the UL13 gene.
The upper line of the figure shows a schematic representation of the HSV-1 genome, 
with unique regions shown in lines and major repeat elements as open boxes. The 
position of the UL11-UL14 gene cluster is indicated. The lower part expands this region, 
showing the relative positions of UL11 to UL14. Filled circles represent the 5 ’ termini of 
the transcripts while arrowheads represent the transcript stop sites. The open boxes 
represent the predicted protein coding regions. Reproduced from Coulter (1993).
1.3.3.3 UL13 protein kinase activity
Cunningham et al. (1992) found that HSV-1 infected cells possess a novel nuclear PK 
activity. Nuclear PK activity increased until 5 h post infection, and remained 
approximately constant thereafter. The nuclear PK activity was stimulated by high salt 
concentrations, similar to the previously characterised US3 PK activity. However, the 
US3 PK was specifically localised in the cytoplasm of infected cells, suggesting the 
nuclear PK is a distinct enzyme. The major substrate of the nuclear PK was a 57 kDa 
protein, and initial findings suggested that the 57 kDa phosphoprotein is a 
phosphorylated form of the nuclear PK.
Nuclear extracts from HSV-2 infected cells phosphorylated in vitro demonstrated a 59 
kDa phosphoprotein, slightly larger than the 57 kDa phosphoprotein in HSV-1 infected 
cells. The use of intertypic recombinants between HSV-1 and HSV-2 located the gene 
encoding the 57 kDa HSV-1 phosphoprotein to a region containing UL9 to UL15, with 
UL13 predicted to encode a protein with Mr nearest 57 kDa. To test whether the 57 kDa
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protein was the UL13 gene product, antibodies were raised to a fusion protein of (3- 
galactosidase linked to amino acid residues 149 to 207 of the predicted UL13 protein. 
The antiserum specifically immunoprecipitated a 57 kDa phosphoprotein, confirming 
that the 57 kDa phosphoprotein is encoded by UL13. In addition, the 57 kDa 
phosphoprotein was immunoprecipitated from phosphorylated purified virions, 
indicating that the 57 kDa protein is a virion component.
Although the US3 and putative UL13 PKs demonstrate similar salt sensitivities, 
Cunningham et al. (1992) noted that the cellular distributions of the two PKs are 
different. Further characterisation of the nuclear PK established additional differences, as 
summarised in Table 1.11. The UL13 PK was found to utilise GTP but the US3 PK did 
not. In addition, the two PKs demonstrated different substrate specificities, with the US3 
PK targeting basic but not acidic substrates, and the UL13 PK targeting acidic but not 
basic substrates. The nuclear PK was also significantly less sensitive to inhibition by 
heparin. Cunningham et al. (1992) concluded that the UL13 PK in HSV-1 infected cells 
is distinct from both the US3 PK or previously characterised nuclear PK activities.
PK Cellular
location
Substrate Phosphate
donor
NaCl sensitivity
US3 Cytoplasm Basic ATP Stimulated by high salt (1.5 M)
UL13 Nucleus Acidic ATP & GTP Stimulated by high salt (1.5 M)
Table 1.11 Comparison of the HSV-l-induced PK activities. Derived from 
Cunningham et al. (1992).
1.3.3.4 Protein kinase activity in the virion
Early work showed that purified membrane-stripped HSV-1 virions incubated with [y- 
32P] ATP demonstrated radiolabelling of a number of viral proteins, indicating that virions 
contain a PK (Rubenstein et al., 1972; Lemaster & Roizman, 1980). However, it was 
unclear whether the enzymatic activity was associated with a virus or host cell encoded 
PK.
Subsequently, Overton et al. (1992) phosphorylated a purified preparation of membrane- 
stripped HSV-1 virions in vitro and subjected the products to western blot analysis using 
a UL13 antiserum prepared against a GST fusion protein (Overton et a l,  1992). The
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antiserum recognised a 55 kDa protein which comigrated with a phosphorylated virion 
component. Immunoprecipitations were also performed on radiolabelled virions using 
the antiserum. A single species, corresponding in size to the predicted UL13 gene 
product, was immunoprecipitated from the virion lysate. Similar results were found with 
HSV-2, confirming that the UL13 protein is a component of the virion.
In addition, mass spectrometric analysis identified the UL13 protein in minor amounts in 
membrane-stripped HSV-1 virions and L-particles (A. Davison, unpublished data), 
suggesting that the UL13 protein is present in the HSV-1 tegument.
1.3.3.5 Purification of the UL13 protein
Attempts were made by Cunningham et al. (1992) to purify the HSV-1 UL13 PK, but 
activity was lost after initial chromatographic steps. However, the HSV-2 UL13 protein 
was purified by Daikoku et al. (1997). Nuclear extracts were prepared from Vero cells 
infected for 20 h with HSV-2, and subjected to phosphocellulose column 
chromatography, assaying PK activity in the eluted fractions by using casein as substrate. 
The fraction with greatest PK activity was shown by western blotting with an anti-UL13 
antibody to contain a 56 kDa protein. This fraction was subjected to sequential column 
chromatography on DEAE-cellulose and hydroxy apatite. The fraction demonstrating 
peak PK activity correlated in each case with antibody detection of a 56 kDa protein. The 
final preparation of the purified protein, visualised by silver staining, consisted 
predominantly of a protein of 56 kDa which reacted with anti-UL13 antiserum. 
Purification of the HSV-2 UL13 protein allowed detailed characterisation of the putative 
UL13 PK.
1.3.3.6 Heterologous expression of UL13
Native HSV-1 UL13 has not yet been expressed successfully to high bvels in 
heterologous systems. Expression of the HSV-1 UL13 protein in a heterologous system 
was attempted using E. coli and recombinant baculovirus expression systems (CVerton et 
al., 1992). A GST-UL13 fusion protein expressed to a high level in E.coli was highly 
insoluble, but was used to prepare UL13 specific antiserum. The antiserum reccgnised a 
55 kDa protein in insect cells infected with a UL 13-expressing baculovirus, but not in wt
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Name Mutation References
UL23 (tic) US3 UL13
R7350 500 bp 
deletion
Codon 135424- 
136291 deleted
a27-tk insertion at 
27269
Purves et al. 
(1992)
R7351 500 bp 
deletion
Codon 135424- 
136291 deleted
Codon 28043- 
27267 deleted
Purves et al. 
(1992)
R7352 500 bp 
deletion
Codon 135424- 
136291 deleted
Rescue of codon 
28043-27267 
deletion
Purves et al. 
(1992)
R7354 500 bp 
deletion
- a27-tk insertion at 
27269
Purves et al. 
(1992)
R7355 500 bp 
deletion
- Codon 28043- 
27267 deleted
Purves et al. 
(1992)
R7356 - - Codon 28043- 
27267 deleted
Purves et al. 
(1993)
R7357 500 bp 
deletion
Codon 135424- 
136291 deleted
- Purves et al. 
(1992)
R7358 500 bp 
deletion
- a27-tk insertion 
mutant rescued
Purves et al. 
(1992)
R4969 a27-tk mutant 
restored with 
HCMV UL97 gene
Ng et al. (1996)
R4970 500 bp 
deletion
a27-tk mutant 
restored with 
HCMV UL97 gene
Ng etal. (1996)
UL13-/ucZ E. coli lacZ gene 
inserted at residue 
28058
Coulter et al. 
(1993)
UL13' (1) & 
(5)
Multiple stop 
codons inserted at 
codons 28043
Overton et al. 
(1994)
UL13D-4bp 4 base pair 
deletion at residue 
27587
C. Cunningham, 
(unpublished)
UL13I-16bp 16 base pair 
insertion at residue 
28177
C. Cunningham, 
(unpublished)
Table 1.12 Genotypes of UL13 mutants
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baculovirus. Degradation appeared to be minimal but low expression levels were 
indicated by the inability to detect the protein in Coomassie-stained gels.
Attempts to isolate a recombinant vaccinia virus expressing the UL13 protein by 
transcription from a powerful late promoter proved unsuccessful (Cunningham et al.,
1992). It was suggested that high levels of the UL13 protein may be lethal to growth of 
vaccinia virus.
1.3.3.7 UL13 mutants
Several studies have been performed using HSV-1 mutants with insertions or deletions in 
the UL13 gene. Table 1.12 summarises the properties of these mutants.
1.3.3.8 Effect of UL13 mutations on HSV-1 growth
Using a panel of UL13 mutants (Table 1.12), Purves & Roizman (1992), Coulter et al. 
(1993), Purves et al. (1993) and Overton et al. (1994) showed that the UL13 protein, like 
the US3 PK, is not essential for HSV-1 replication in cell culture. The growth properties 
of UL13 mutants are summarised in Table 1.13.
Virus Cell type tested m.o.i. Growth characteristics
UL13-/acZ BHK-21, HFL, 
Vero
0.001 In BHK-21 cells UL13-lacZ plaques were 
about half the diameter of wt. UL13-/acZ 
yields were approximately 3.5 times less than 
wt after 72 h on BHK cells.
UL13-/acZ BHK-21 10 UL13-lacZ yields were approximately 4 times 
less than wt after 30 h on BHK cells.
R7350, 7351, 
7354, 7355
143TK, HEp-2, 
Vero, BHK, RSC
- Yielded fewer and smaller plaques than wt 
virus.
UL13' (1) & 
(5)
BHK-21, Hel, 
Neuro 2a
10 Yield of virus 24 h post-infection was 10-fold 
less than wt virus. Mutant plaques consistently 
smaller than wt.
UL13- (1) & 
(5)
Vero 10 Yield of virus 24 h post-infection was 2- to 5- 
fold less than wt virus. Mutant plaques 
smaller than wt.
Table 1.13 Growth characteristics of HSV-1 UL13 mutants on a variety of cell lines.
Derived from Coulter et al. (1993); Purves & Roizman (1992); Overton et al. (1994) and 
Purves et al. (1993). See Table 1.12 for genotypes.
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1.3.3.9 UL13/US3 double mutants
De Wind et al. (1992) constructed a PRV mutant with oligonucleotide inserts in both the 
UL13 and US3 ORFs. Individually, mutations in these ORFs have modest effects on 
virus growth in vitro, but the double mutant yielded a greatly reduced end titre compared 
with wt. In addition, the plaque size of the double mutant was very small. An HSV-1 
UL13-US3 double mutant formed plaques approximately 20-30% the diameter of wt 
plaques (Coulter, 1993). Yields of the HSV-1 UL13-US3 double mutant were shown to 
be 800-fold less than that of wt HSV-1.
Coulter (1993) suggested that the two PKs may have common substrates, and can 
therefore partially substitute for each other. This is unlikely, however, since both have 
very different substrate specificities (Purves et al., 1986; Cunningham et al., 1992). 
Alternatively the two PKs could play overlapping roles in the viral life cycle, while 
targeting different substrates.
1.3.3.10 UL13 phosphorylation assay
Buffer concentration Reference
mM %
Tris-HCl
(pH)
MgCl2 MgAc DTT NaCl NP40
50 (8) - 50 1 1000 or 
1500
0.1 Cunningham etal. (1992)
50 (7.5) 10 - 1 0 to 1500 - Coulter et al. (1993)
50 (8) 25 - 0.5 1000 0.1 Overton etal. (1994)
50 (8) 50 - 1 1500 0.1 Prod’hon etal. (1996)
20 (8) 50 - 1 - 0.1 Ogle etal. (1997)
50 (8) 10 - 1 - - Daikoku et al. (1997)
10(8) 50 - 1 200 0.1 Ng etal. (1998)
50(8) 50 - 1 200 0.1 Kawaguchi etal. (1998)
Table 1.14 Summary of the compositions of UL13 PK phosphorylation buffers.
A variety of buffers have been used to detect activity of the putative UL13 PK in vitro. 
These are summarised in Table 1.14. Extensive purification allowed the optimal buffer 
conditions of HSV-2 UL13 PK to be identified. In contrast to Cunningham et al. (1992) 
and Coulter et al. (1993), who found the HSV-1 UL13 PK to be stimulated by increasing
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salt concentrations, the purified HSV-2 UL13 PK was most active at 0 M NaCl, with 
activity decreasing as NaCl concentration increased (Daikoku et al., 1997).
1.3.4 UL13 homologues
1.3.4.1 HSV-2 UL13
There is 85.9% amino acid sequence homology between the HSV-1 and HSV-2 UL13 
PKs. Daikoku et al. (1997) characterised the activity of purified preparations of HSV-2 
UL13 PK. It demonstrated optimal activity in the absence of salt, with activity inhibited 
by about 70% at 500 mM NaCl. Both CKI and CKII were stimulated by salt 
concentrations up to 200 mM, but at 500 mM NaCl CKI activity was inhibited by 70% 
and CKII activity was undetectable. All three PKs were active over a broad pH range, 
with the optimal pHs of the UL13 PK, CKI and CKII being 9.0, 6.8 and 8.4, respectively. 
As expected, the UL13 PK demonstrated an absolute requirement for divalent cations, 
with an optimal Mg2+ concentration of 10-20 mM.
Percentage of activity
UL13 CKI CKII
Casein 100 100 100
a-Casein 52 43 <3
P-Casein 118 129 68
K-Casein 79 167 37
Histone 86 85 16
Protamine <3 <3 <3
Phosvitin 63 94 30
Table 1.15 Substrate specificity of HSV-2 UL13 PK in comparison with CKI and 
CKII. Derived from Daikoku et al. (1997).
Under optimal conditions, casein was shown to be phosphorylated mainly at serine 
residues by the UL13 PK, with a minor degree of phosphorylation at threonine residues. 
The substrate specificity of the purified UL13 PK was tested (Table 1.15). The UL13 PK 
efficiently phosphorylated all acidic proteins assayed. It did not detectably phosphorylate 
one basic protein, protamine, but did phosphorylate a second, histone. The substrate 
specificities of CKI and CKII were similar to that of UL13 PK. Unlike CKI and CKII, 
the UL13 PK was resistant to inhibition by heparin. The HSV-2 UL13 PK was unable to 
utilise GTP as a phosphate donor, unlike CKI and CKII.
49
Introduction Chapter 1
1.3.4.2 VZV ORF47
Ng et al. (1994) attempted to identify substrates for the ORF47 PK by analysing 
modification of individual viral phosphoproteins. Coimmunoprecipitation coupled with 
in vitro phosphorylation of the immune complex identified the ORF62 protein (the 
homologue of HSV-1 ICP4) as a potential target. However, the ORF62 protein was also 
shown to be phosphorylated by CKII. Both ORF47 and CKII were shown to utilise ATP 
and GTP as phosphate donors, although ATP was the preferred donor in both cases. Both 
the ORF62 and ORF47 proteins were phosphorylated in vitro in the presence of heparin 
concentrations ten times higher than the CKII inhibitory level, thus indicating that 
ORF62 was phosphorylated by the ORF47 PK. In addition, the ORF62 protein was 
phosphorylated mainly on Ser residues with minor phosphorylation on Thr residues.
1.3.4.3 PRV UL13
De Wind et al. (1992) produced two mutants in PRV gene UL13 by inserting 
oligonucleotides containing stop codons. The mutant showed a very small reduction in 
titre and plaque size compared to wt virus. Immunoprecipitation of transiently expressed 
C-terminally tagged PRV UL13 allowed in vitro kinase assays to be performed. These 
demonstrated that the protein had intrinsic Mn2+-dependent PK activity, and was able to 
autophosphorylate and transphosphorylate acidic and basic substrates.
To ensure that phosphorylation of the UL13 protein was due to autophosphorylation and 
not transphosphorylation by a contaminating PK, a full length inactivated UL13 mutant 
was produced. In this mutant, the invariant lysine residue (Lys103) was changed to Met, a 
substitution which has been shown to abolish the activity of other PKs (Chen et al., 1987; 
Saris et al., 1991). When in vitro phosphorylation reactions were performed on 
immunoprecipitated samples, the mutant protein was not phosphorylated, leading De 
Wind et al. (1992) to conclude that the PRV UL13 protein was capable of 
autophosphorylation. Phosphoamino acid analysis of autophosphorylated UL13 protein 
and histone phosphorylated by the UL13 PK revealed the presence of phosphoserine and 
phosphothreonine residues.
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1.3.4.4 HCMV UL97
Research on the HCMV-encoded PK activity was prompted by the need to identify the 
enzyme responsible for phosphorylating ganciclovir in HCMV-infected cells ((Littler et 
al., 1992). To function as an antiviral agent, the nucleoside analogue 9-(l,3-dihydroxy-2- 
propoxymethyl)-guanine, or ganciclovir, must be phosphorylated to the triphosphate. In 
HSV-1, initial phosphorylation of gancyclovir is carried out by thymidine kinasie (tk) and 
is completed by cellular enzymes. However, HCMV does not encode a tk. By analogy 
with phosphorylation of aminoglycoside antibiotics by bacterial kinases, HCMV UL97 
was suggested as the kinase which phosphorylates ganciclovir. In confirmation,, Littler et 
al. (1992) showed that ganciclovir could be phosphorylated by the catalytic domain of 
UL97 cloned into a prokaryotic expression vector.
Using a recombinant baculovirus expressing full-length UL97, He e t al. (1997) 
demonstrated that UL97 was phosphorylated on Ser and Thr residues when incubated 
with [y-32P]ATP. Phosphorylation was optimal at high NaCl concentration and high pH. 
PK activity required either Mg2+ or Mn2+, with a preference for Mn2+, and utilised either 
ATP or GTP as a phosphate donor.
To determine whether HCMV UL97 can substitute for HSV-1 UL13, Ng et al. (1996) 
constructed a HSV-1 recombinant in which UL13 was replaced by UL97 and the tk gene 
deleted. In BHK cells, which restrict the growth of UL13 mutant virus, the recombinant 
grew as well as wt virus. The UL97 protein partially restored phosphorylation of ICP22, 
supposedly targeted by the UL13 protein, and the recombinant virus was sensitive to 
ganciclovir in all but tk negative cell lines.
1.3.4.5 EBV BGLF4
BGLF4 is the only EBV gene encoding a PK. To evaluate the potential PK activity of 
BGLF4, Chen et al. (2000) expressed the protein in a range of prokaryotic and eukaryotic 
systems. BGLF4 expressed by a recombinant vaccinia virus and partially purified by 
immunoprecipitation was found to be phosphorylated. Despite carrying out only partial 
purification, Chen et al. (2000) suggested this could be due to autophosphorylation.
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An antiserum against BGLF4 was required, but to avoid cross reactivity with cellular 
PKs a fusion protein comprising EBNA-1 residues 408-446 and BGLF4 was 
manufactured. The fusion protein, E1/BGLF4, could be specifically immunoprecipitated 
using monoclonal antibodies against the cognate EBNA-1 epitope. Transfected 
E1/BGLF4 was principally detected in the cytoplasm, and the immunoprecipitated fusion 
protein was shown to possess autophosphorylation activity similar to native BGLF4. 
Prior to phosphorylating the anti-EBNA-l-El/BGLF4 immunocomplexes, Chen et al.
(2000) performed washes with high salt buffers in an attempt to eliminate contaminating 
cellular PK activity. These experiments, in conjunction with the observed resistance of 
BGFL4 phosphorylation to heparin or okadaic acid, potent inhibitors of CKII, supported 
autophosphorylation of BGFL4.
PK activities of the authentic BGLF4 protein and E1/BGLF4 fusion protein were 
characterised. PK activity peaked between pH 6.5 and 8.0, required ATP or GTP as 
phosphate donor for autophosphorylation and showed a preference for magnesium, rather 
than manganese ions. Monovalent cations further increased PK activity, with 300 mM 
KC1 or NaCl proving optimal.
Membrane-bound phosphorylated BGLF4 immunoprecipitates were probed with 
antibodies specific for three phosphoamino acids. Only phosphoserine and 
phosphothreonine were detected, in line with the prediction that BGLF4 encodes a 
Ser/Thr PK. BGLF4 was found to phosphorylate casein and histone, and also the EBV 
protein EA-D (Chen et al., 2000; Li et al., 1987).
Chen et al. (2000) introduced a number of site specific mutations into BGLF4. The 
residue predicted to be the catalytic lysine was changed to Met, two mutants with 
invariant residues in subdomains VI and VII changed to Ala were produced, and a fourth 
mutant was made with a residue in a nonconserved region changed to Ala. When 
phosphorylated in vitro all four mutants showed autophosphorylation activity very 
similar to that of wt BGLF4. A series of mutants with deletions around the ATP-binding 
site and the basic amino acids from residues 367-403 or at the N-terminus were 
produced. Deletion of residues 35 to 65, a thirty residue region just N-terminal to
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subdomain I, stimulated autophosphorylation approximately two-fold. However, residues 
1 to 26 were identified as essential for the autophosphorylation of the BGLF4 protein.
1.3.4.6 HHV-8 ORF36
To determine whether ORF36 possesses PK activity, Park et al. (2000) expressed the 
full-length protein as a GST fusion protein in mammalian cells, purified the protein and 
subjected it to in vitro phosphorylation conditions. The purified protein was found to 
autophosphorylate on serine residues alone. In addition, Park et al. (2000) found that 
ORF36 is a late gene, and that the protein localised in the nucleus of transiently 
transfected cells.
Park et al. (2000) generated a ORF36 mutant in which the invariant Lys residue was 
replaced by Gin. This resulted in dramatically reduced phosphorylation of the mutant 
ORF36, and thus supported the view that the ORF36 protein possesses intrinsic PK 
activity and is capable of autophosphorylation. The wt and mutant proteins were 
| phosphorylated on serine residues, the latter to a much lower level.
I
1.3.5 UL13 protein kinase targets
| Several proteins have been identified as potential targets for the HSV-1 UL13 PK (Table
j
| 1.16). This section will concern itself with summarising the published data without
! commenting on their significance. A brief appraisal of their significance is given in the
Discussion.
Target Function References
ICP22 (US1) Viral gene trans-activation Purves & Roizman (1992)
RNA polymerase II mRNA transcription Long et al. (1999)
EF-16 Cellular translation 
regulatory protein
Kawaguchi et al. (1998)
VP22 (UL49) Major tegument protein Coulter et al. (1993), 
Morrison et al. (1998)
gE and gl (US8 & US7) Fc receptor Ng etal. (1998)
ICP0 (RL1) Transactivator Ogle et a l  (1997)
vhs (UL41) Viral host shutoff Overton et al. (1994)
Table 1.16 Summary of the proteins identified to date as targets for the HSV-1 
UL13 PK.
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1.3.5.1 ICP22
Purves & Roizman (1992) used the HSV-1 UL13 mutants shown in Table 1.12 to 
distinguish the activities of the US3 and UL13 PKs. In vitro phosphorylated extracts 
from wMnfected cells showed a series of five phosphoproteins from 70 to 82 kDa, shown 
to be the products of the gene US1 (ICP22), while UL13 mutant-infected cell extracts 
demonstrated increased radiolabelling of the 70 kDa phosphoprotein and reduced 
radiolabelling of the four others. These differences in phosphorylation profile depended 
on the cell type used. Purves & Roizman (1992) concluded that the UL13 protein 
mediates cell type-specific posttranslational processing of ICP22. These observations 
were made using mutants containing a functional US3 gene, and the situation was later 
made more complex when it was found that the US3 PK phosphorylates ICP22 at 
different sites from UL13 PK (Purves et al., 1993).
ICP22 is among the first viral proteins made after infection, and Purves & Roizman 
(1992) suggested that the UL13 protein modifies ICP22 late in infection, thereby altering 
its function. Because ICP22 was implicated in transactivation of late viral proteins (Sears 
et al., 1985), Purves et al. (1993) investigated whether phosphorylation of ICP22 affects 
synthesis of late viral proteins. Purves et al. (1993) detected reduced accumulation of 
ICPO (RL2), ICP22 (US1), ICP35 (UL26) and the US 11 proteins and mRNAs in UL13 
mutant-infected cell extracts.
UL13 is expressed late in infection and it is a component of the virion (Cunningham et 
al., 1992; Overton et al., 1992). Consequently Purves et al. (1993) examined whether 
UL13 in the virion mediates posttranslational processing of newly synthesised ICP22. Wt 
infected cells were incubated for 6 h in the presence of cycloheximide followed by 
actinomycin D to block further RNA synthesis and permit translation of IE mRNA. The 
newly synthesised ICP22 was not modified, and thus not phosphorylated by UL13 
packaged within the infecting virus particle. When in vitro transcribed and translated 
UL13 (pUL13) and a22 (p22) were incubated in phosphorylating conditions several 
phosphoproteins between 68 and 82 kDa were detected (Prod’hon et al., 1996). These 
corresponded to the phosphoproteins identified by Purves & Roizman (1992) as ICP22, 
suggesting that UL13 directly phosphorylates ICP22.
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These data suggest that UL13 encodes a PK expressed late in infection which directly 
phosphorylates ICP22, and that this modification is required for accumulation of a subset 
of late viral mRNAs and proteins. While it seems unlikely that a PK expressed late in 
infection would affect the kinetics of gene expression of other late genes, certain late 
genes can be expressed at low levels early in infection, UL13 might be one of these.
Leopardi et al. (1997b) showed that ICP22 co-localises with ICP4, EBER-associated 
protein (EAP) and RNA polymerase II as transcriptional complexes with viral DNA in 
defined nuclear structures. A truncated, non-phosphorylated form of ICP22 still 
associated with EAP, showing that phosphorylation is not required for ICP22 to interact 
with EAP. However, because ICP22 did not associate with these nuclear structures in 
UL13 mutants it was proposed that UL13 may be required for the localisation of ICP22 
to the nuclear bodies.
These complex studies support the view that ICP22 may have a role in transcription of 
viral genes, apparently enhancing the expression of at least one IE gene (RL2 encoding 
ICPO) and a subset of late genes at both mRNA and protein levels. ICP22 is extensively 
posttranslationally modified, with both the UL13 and US3 PKs contributing. Mutational 
studies suggested that ICP22 may express functions both early and late in infection, 
consistent with the kinetics of expression of UL13 and US3. Finally, modification of 
ICP22 by one or both PKs is required for colocalisation with viral DNA, ICP4, EAP and 
RNA polymerase II in a nuclear compartment at the time of transcription of late genes.
1.3.5.2 ICPO
The HSV-1 gene transactivator ICPO, encoded by RL2, is posttranslationally modified by 
nucleotidylylation and phosphorylation (Ackerman et al., 1984; Blaho et al., 1993, 1994; 
Mitchell et al., 1994). To determine whether the UL13 PK targeted ICPO, Ogle et al. 
(1997) examined the phosphorylation profiles of wt and UL13 mutant cell extracts. In un­
infected RSC cells, three closely migrating bands representing ICPO, were detected. They 
were designated a to c in order of decreasing Mr. Only the a form was detected in un­
infected Vero cells. In extracts of UL13 mutant-infected cells, ICPO was identified 
predominantly in the c form in RSC and in the b form in Vero cells. These data indicated 
both a UL13 and a cell-type dependent modification of ICPO, leading Ogle et a l  (1997)
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to suggest that posttranslational processing of ICPO was a dynamic process, perhaps 
reflecting the availability of cellular factors and the requiremens for ICPO during the 
course of the HSV-1 replication cycle.
The UL13 PK was shown to phosphorylate ICPO directly when immune-complexes of 
UL13 and ICPO were mixed under in vitro phosphorylation conditions. But when UL13 
mutant-infected cells were labelled in vivo, ICPO was phosphorylated, albeit to a lower 
level that in wr-infected cells. This indicates that ICPO is not phosphorylated exclusively 
by the UL13PK.
The relationships between UL13, ICPO and ICP22 appear complex, with their expression 
being interactive and independent. ICP22 is modified by UL13 (Purves & Roizman, 
1992; Purves et al., 1993), and ICP22 regulates the utilisation of splice acceptor sites and 
longevity of ICPO mRNA (Carter & Roizman, 1996). Ogle et al. (1997) showed that 
UL13 is involved in posttranslational modification of ICPO, that it controls the 
abundance of ICP22 and that the posttranslational modification of ICPO does not require 
I ICP22. Both ICPO and ICP22 are proposed targets for the UL13 PK and by other cellular
! or viral PKs.
|
I
| 1.3.5.3 RNA polymerase II
| RNA polymerase II (RNAP II) is a multi-subunit enzyme responsible for mediating
mRNA transcription. The largest subunit, which possesses catalytic activity, is highly 
phosphorylated in its C-terminal domain. As a result, RNAP II exists in two forms, one 
hypophosphorylated and the other heavily phosphorylated. Each form is associated with 
distinct aspects of transcription, the hypophosphorylated form with transcription 
initiation and the highly phosphorylated form with transcription elongation (Payne et al., 
1989). As a result, phosphorylation of RNAP II is required in vivo for efficient 
transcription elongation.
HSV-1 infection has been shown to alter the phosphorylation state of the large subunit of 
RNAP II (Rice et al., 1994), stimulating production of a new species of RNAP II which 
demonstrates intermediate electrophoretic mobility. This mobility change can be 
i  attributed to phosphorylation, as phosphatase treatment of the intermediate species
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converts it to the hypophosphorylated form. Rice et al. (1995) showed that in cells 
infected with an ICP22 mutant the hypophosphorylated form of RNAP II was slightly 
depleted and that very low levels of the intermediate form were detected. This minor 
variation from the wt profile suggested that an additional viral gene product may be 
involved in processing RNAP II. Rice et al. (1995) suggested that two viral gene 
products, UL13 and vhs, may be responsible.
Long et al. (1999) used a UL13 mutant and a vhs mutant to test which gene was involved 
in processing RNAP II. The UL13 mutant failed to stimulate production of the 
intermediate form of RNAP II or to deplete the hypophosphorylated form, while the vhs 
mutant was indistinguishable from wt HSV-1. Long et al. (1999) then showed that 
infection with either UL13 or ICP22 mutants led to significantly reduced amounts of 
viral genome transcription at late times post-infection, suggesting both ICP22 and UL13 
are involved in a common pathway that alters RNAP II phosphorylation and 
consequently promotes viral late transcription.
1.3.5.4 Eukaryotic elongation factor 18
Translation elongation factor (EF-1) is a complex of proteins which mediates the 
elongation of polypeptide chains during translation of mRNA. The complex consists of 
EF-1 a , which transports aminoacyl tRNA for binding to ribosomes concurrent with 
hydrolysis of GTP, and the EF-lpyS complex, which is responsible for the GDP-GTP 
exchange on EF-1 a. EF-18, a component of the EF-lpyS complex, is phosphorylated by 
several cellular PKs, including CKII (Palen et al., 1994), cdc2 kinase (Mulner-Lorillon et 
al., 1994) and PKC (Venema et al., 199la,b). Studies suggest that hyperphosphorylation 
of EF-18 alters translational efficiency (Minella et al., 1994; Mulner-Lorillon et al., 
1994; Richter et al., 1982; Venema et a l, 1991a,b; Wasserman et al., 1982).
Kawaguchi et al. (1998) showed that HSV-1 infection stimulates phosphorylation of EF- 
18 and that hyperphosphorylation of EF-18 occurs in cells infected with wt virus or a 
UL13 revertant (R7358), but not in mock-infected or cells infected with a UL13 mutant 
(R7355 or R7356). Mutating the US3 ORF had no effect on phosphorylation of EF-lS. 
These results indicate that a functional UL13 protein is required for 
hyperphosphorylation of EF-18. Because ICPO associates with EF-18 (Kawaguchi et al.,
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1997), it was necessary to test whether ICPO is a cofactor in the modification of EF-15. It 
was found that EF-18 was hyperphosphorylated in ICPO mutant infected cell extracts, 
thus indicating that ICPO was not involved in modification of EF-18.
Incubating immunoprecipitated UL13 protein and EF-18 together under phosphorylating 
conditions stimulated hyperphosphorylation of EF-18, whereas phosphorylation was not 
detected when immune precipitates from MI and UL13 mutant-infected cells were used. 
These data showed that either UL13 or a protein complexed with UL13 directly 
phosphorylates EF-18.
Further work by Kawaguchi et al. (1999) showed that EF-18 is hyperphosphorylated in 
cells infected with representative members of the A l p h a - ,  Beta- and 
Gammaherpesviruses. Indeed, UL13 homologues can partially compensate for each 
other, with HSV-1 UL13 mutants expressing HCMV UL97 (Table 1.12) phosphorylating 
EF-18 to almost wt levels.
1.3.5.5 Glycoproteins E and I (US8 and US7)
Phosphorylation of viral glycoproteins is a rare post-translational modification occuring 
during virus infections (Grose, 1990). Glycoprotein E (gE), which acts as an Fc receptor 
by itself and more strongly in association with glycoprotein I (gl), was found to be 
phosphorylated and glycosylated in HSV-1, HSV-2, VZV and PRV (Edson, 1993; Edson 
et al., 1987; Montalvo & Grose, 1986; Olson et al., 1997). The VZV homologue of HSV- 
1 gl is also phosphorylated.
Ng et al. (1998) found that antibodies to HSV-1 UL13 formed immune complexes of 
UL13, gE and gl. Incubating these immune-complexes in phosphorylation conditions 
stimulated phosphorylation of all three proteins. Immune-complexes formed by 
monoclonal antibodies to gE but not to gl contained the UL13 protein, indicating that 
UL13 and gE interact (Ng et al., 1998).
Both gE and gl showed reduced phosphorylation in UL13 mutant-infected cells. 
However, UL13 does not account for all the phosphorylation of gE and gl. An acidic 
region in the cytoplasmic domain of gE contains CKII recognition sequences (Litwin et
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al., 1992). Moreover, VZV gE is phosphorylated, in vitro, at its cytoplasmic tail by host 
cell PKs, including CKI and II (Grose et al., 1989; Yao et al., 1993). Ng et al. (1998) 
showed that purified CKII phosphorylated gE in immune complexes where the 
endogenous PK activity has been heat-inactivated, and Miriagou et al. (2000) showed 
that CKII phosphorylates the C-terminus of gE on serines 476 and 477. It is unclear 
whether there is any physiological relevance to multiple PKs targeting gE and gl. Ng et 
al. (1998) suggested that gE and possibly gl perform several functions and that PKs 
direct the functions of the glycoproteins by modifying them at different sites. This has 
yet to be borne out.
While the biological significance of the phosphorylation of gE in HSV-1 infections 
remains elusive it has been suggested that phosphorylated gE could act as an anchor for 
packaging UL13 in the tegument. Whatever the reason, because phosphorylation of gE is 
conserved in HSV-2, VZV and PRV, it is likely to play an important role.
I.3.5.6. vhs (UL41)
As outlined in section 1.2.6, HSV-1 encodes vhs, a virion protein which shuts off host 
cell protein synthesis. Host shutoff can be visualised as reduced actin synthesis in [35S]- 
labelled profiles of wt HSV-1 infected cells when compared to mock-infected cells. 
Using a UL13 mutant (Table 1.12), Overton et al. (1994) found actin levels were similar 
between MI and UL13 mutant-infected cells. Repeating this experiment in the presence 
of actinomycin D, which inhibits viral gene expression and thus allows the effects on 
host protein synthesis to be seen more clearly, showed wt HSV-1 inhibited the synthesis 
of host cell proteins whereas the UL13 mutant did not (Overton et al., 1994).
The product of HSV-1 gene UL41 has been assigned the virion-associated host shut-off 
function (vhs) (Kwong et al., 1988; Fenwick & Everett, 1990). Overton et al. (1994) 
showed that vhs levels were drastically reduced in UL13 mutant-infected cells compared 
to wf-infected cells. Interestingly, while the level of vhs was reduced in UL13 mutant 
extracts, the kinetics of synthesis were the same as in wtf-extracts. Overton et al. (1994) 
attributed the reduced vhs levels to the reduced virus yield in UL13 mutant infections.
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Overton et al. (1994) suggested a variety of interactions between UL13 and vhs. UL13 
might up-regulate expression of vhs, target vhs to the virion tegument or activate vhs by 
phosphorylation. Indeed, Read et al. (1993) detected a hyperphosphorylated form of vhs 
which was preferentially packaged into virions.
1.3.5.7 VP22 (UL49)
Coulter et al. (1993) manufactured an HSV-1 UL13 mutant in which the UL13 ORF was 
disrupted by insertion of the E. coli lacZ gene (Table 1.12), and performed in vitro 
phosphorylation reactions on UL13-/acZ infected CNE or membrane-stripped virions. 
The in vitro phosphosphorylation assays, performed over a range of NaCl concentrations, 
revealed two highly radiolabelled proteins of 38 and 57 kDa. The 57 kDa protein was 
highly radiolabelled at all NaCl concentrations, while radiolabelling of the 38 kDa 
protein increased with increasing NaCl concentration. The phosphorylated 57 kDa 
protein was completely absent from UL13-/<zcZ CNE, and phosphorylation of a variety of 
other proteins, including the 38 kDa protein, was reduced. In UL13-lacZ CNE the 38 
kDa protein was most highly phosphorylated at low NaCl concentrations.
Cunningham et al. (1992) detected a 57 kDa phosphoprotein which possessed PK 
activity and localised in the nucleus of infected cells. It was thought that the 57 kDa 
phosphoprotein was encoded by the HSV-1 gene UL13. The absence of the highly 
phosphorylated 57 kDa protein from UL13-/acZ CNE confirmed this (Coulter et al.,
1993), and reduced phosphorylation of proteins in UL13-/ae*Z CNE was consistent with 
the UL13 gene encoding a PK. The data from Coulter et al. (1993) indicates the 38 kDa 
protein, shown to be encoded by the gene UL49, is a target for phosphorylation by the 
UL13 PK. But, since the 38 kDa protein was phosphorylated in UL13-/<2cZ CNE it must 
by targeted by at least one other PK.
Coulter et al. (1993) suggested that the UL49 protein was phosphorylated at high NaCl 
concentrations by the UL13 PK, and at low NaCl concentrations by an unknown cellular 
PK. However, Coulter et al. (1993) manufactured and used only a single UL13 mutant 
and did not produce a rescuant, and hence the results require confirmation. In addition, 
Daikoku et al. (1997) showed that the purified HSV-2 UL13 PK was inhibited at NaCl
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concentrations above 0 M, in contrast to the HSV-1 UL13 PK. This discrepancy has yet 
to be fully addressed.
It is unclear whether VP22 is phosphorylated in the virions. Szilagyi & Cunningham
(1991) identified an abundant radiolabelled 40 kDa phosphoprotein in virions labelled 
with [32P]orthophosphate. This phosphoprotein correlated in size with VP22. However, 
Elliot et al. (1996) identified two species of VP22, which were shown to represent 
phosphorylated and unphosphorylated forms of the protein. Both forms were present in 
infected cells, the phosphorylated form alone was present in transfected cells and the 
unphosphorylated form alone found in virions.
While investigating tegument dissociation, Morrison et al. (1998) found that major 
structural components of the HSV-1 tegument were phosphorylated upon cell entry. In 
vitro assays showed that phosphorylation mediated dissociation of VP 13/14 and VP22 
from the virion, with CKII specifically promoting VP22 release. However, Morrison et 
al. (1998) maintained that by virtue of its proximity and higher local concentration, 
UL13 PK is the major contributor to VP22 dissociation in vivo. This was supported when 
it was found that UL13 mutant demonstrated severely impaired VP22 release. However, 
addition of CKII compensated for the loss of the UL13 PK.
1.4 Aims
The aims of this thesis were firstly to confirm and extend the work of Coulter et al. 
(1993) in regard to the possible role of VP22 as a target of the HSV-1 UL13 PK. The PK 
activity was then characterised further, and attempts made to map the phosphorylated 
residues within VP22 and the UL13 PK.
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2 MATERIALS 
2.1 Cells and viruses
Wild-type HSV-1 strain 17+ (Brown et al., 1973) and mutants derived therefrom were 
grown in baby hamster kidney clone C l3 (BHK C l3) cells (MacPherson & Stoker, 
1962), MeWo cells (Bean et al., 1975) or rabbit skin cells (RSC).
The HSV-1 mutant with the UL13 gene disrupted by insertion of the Escherichia coli 
lacZ gene was produced by Lesley Coulter (Coulter, 1993; Coulter et al., 1993) and was 
obtained from Mary Murphy. The two further HSV-1 UL13 mutants, UL13D-4bp and 
UL13I-16bp (Table 1.12), were produced by and obtained from Charles Cunningham. 
The HSV-1 UL49 truncation mutant, vUL49del268-301 (Leslie, 1996), was obtained 
from Dr. J. McLauchlan.
2.2 Cell culture growth media
Eagles A:
Eagles B:
salts/plus:
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0.23 g/1 CaCl2.2H20  
0.23 g/1 MgS04.7H20  
0.1 ml/1 conc. HC1
50% (v/v) salts/plus 
40% (v/v) amino acids/plus 
3.2% (v/v) vitamins
10.24 g/1 NaCl
0.64 g/1 KC1
0.24 g/1 NaH2P 04.2H20
7.2 g/1 glucose
0.00016% (v/v) Fe2(N 03)3
0.468 g/1 L-glutamine
0.016% (v/v) penicillin
0.016 g/1 streptomycin
0.00032% (v/v) amphotericin B
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amino acids/plus: 0.84 g/1 arginine mono-HCl
0.48 g/1 cystine
0.384 g/1 histidine mono-HCl
1.048 g/1 isoleucine
1.048 g/1 leucine
1.462 g/1 lycine mono-HCl 
0.66 g/1 phenylalanine 
0.952 g/1 threonine 
0.16 g/1 tryptophan 
0.724 g/1 tyrosine 
0.936 g/1 valine 
0.3 g/1 methionine 
0.07% inositol 
0.03% (v/v) phenol red 
55 g/1 NaHC03
vitamins: 0.05 g/1 choline chloride
0.05 g/1 folic acid 
0.05 g/1 nicotinamide 
0.05 g/1 pantothentic acid, Ca salt 
0.05 g/1 pyridoxal-HCl 
0.05 g/1 thiamine-HCl 
0.005 g/1 riboflavine
70% (v/v) Eagles A 
10% (v/v) Eagles B 
10% (v/v) tryptose phosphate 
10% (v/v) newborn calf serum (NCS)
As above with NCS replaced by foetal calf 
serum (FCS).
85.75% (v/v) Eagles A
ETC 10:
ETF10:
EC2:
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12.25% (v/v) Eagles B 
2% (v/v) NCS
EF2: As above with NCS replaced by FCS
Methylcellulose overlay: 39% (v/v) carboxymethylcellolose
1.56% (v/v) tryptose phosphate
3.9% (v/v) NCS
24.3% (v/v) NaC03 (7.5%)
1.56% (v/v) penicillin/streptomycin (10000 
IU/ml)
0.8% (v/v) L-glutamine (200 mM)
0.08% (v/v) amphotericin B
7% (v/v) 10 x Glasgow’s modified medium
Dulbecco’s medium: 500 ml Dulbecco’s modified Eagles medium
9% (v/v) FCS
1 % (v/v) penicillin/streptomycin
1% (v/v) L-glutamine
1% (v/v) non-essential amino acids
BHK growth medium: 500 ml BHK-21 medium (Glasgow MEM)
9.8% (v/v) tryptose phosphate 
8.2% (v/v) NCS
2.3 Radiochemicals
Radiochemicals were supplied by Amersham International pic:
[y-32P]ATP, lOmCi/ml; 370MBq/ml
2.4 Enzymes
Sequencing grade clostripain (endoproteinase Arg-C), S. aureus V8 pro*tease 
(endoproteinase Glu-C), endoproteinase Lys-C and modified trypsin with storage buffers 
were obtained from Sigma Chemical Co. or Promega.
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Lambda protein phosphatase (^-PPase) was obtained from New England Biolabs Inc.
2.5 Chemicals
All chemicals used were of analytical grade and were supplied by BDH and Sigma 
Chemical Co.
The exceptions were:
Ammonium persulphate (APS) and Coomassie Brilliant Blue R250: Bio-Rad 
Laboratories Ltd.
Sulforhodamine B: Kodak 
Ultrapure NTPs: Pharmacia Biotech
Miscellaneous materials and suppliers
Rainbow™ protein molecular weight marker supplied by Amersham International pic. 
X-Omat-S-film supplied by Kodak Ltd.
2.6 Protein gels
2.6.1 Tris-glycine polyacrylamide gels
8 x Stacking gel buffer: 0.5 M Tris-HCl pH 6.8
4 x Resolving gel buffer: 1.5 M Tris-HCl pH 8.8
Electrophoresis buffer: 50 mM Trizma base 
380 mM glycine 
0.2% (w/v) SDS
Fixing solution: 40% (v/v) methanol 
10% (v/v) acetic acid
Coomassie staining solution: Fixing solution containing 0.1 % (w/v) 
Coomassie brilliant blue R250
Destaining solution: 5% (v/v) methanol 
10% (v/v) acetic acid
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Boiling buffer: 30% (v/v) stacking buffer
24% (v/v) 25% SDS
30% (v/v) glycerol
15% (v/v) 14.3 M 2-mercaptoethanol
1% (w/v) bromophenol blue
2.6.2 Tris-Tricine polyacrylamide gels
Acrylamide solution: 37.5 g acrylamide 
1 g NN* methylenebisacrylamide
to 100 ml in dH20
Gel buffer 3.0 M Tris-HCl pH 8.45 
0.3% (w/v) SDS
Electrophoresis buffer (anodic) 0.2 M Tris-HCl pH 8.9
Electrophoresis buffer (cathodic) 0.1 M Trizma base 
0.1 M Tricine 
0.1% (w/v) SDS 
(approximate pH 8.25)
Boiling buffer: 0.05 M Trizma 
4% (w/v) SDS 
12% (v/v) glycerol 
2% (v/v) mercaptoethanol 
1% (w/v) bromophenol blue
2.7 Protein blotting for mass spectrometric analysis
10 x PVDF buffer: 0.5 M Trizma base
0.5 M glycine
Transfer buffer: 1 x PVDF buffer
Chapter 2
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20% (v/v) methanol 
0.01% (w/v) SDS
Matrix: 10 mg/ml a-cyano-4-hydroxycinnamic acid in 
50% (v/v) acetonitrile plus 0.1% (v/v) 
trifluoroacetic acid
Sulforhodamine stain: 50 mg/1 sulforhodamine 
30% (v/v) methanol 
0.2% (v/v) acetic acid
PVDF Coomassie stain: 0.1 % (w/v) Coomassie Brilliant Blue R250 
1 % (v/v) acetic acid 
40% (v/v) methanol 
59% (v/v) dH20
PVDF membrane destain: 50% (v/v) methanol 
50% (v/v) dH20
Formic acid/ethanol: 1:1 (v/v) formic acid:ethanol
2.8 In vitro phosphorylation assay
Buffer A: 10 mM Hepes pH 8.0
50 mM NaCl
0.5 M sucrose
1 mM EDTA
0.5% (v/v) Triton X-100
1 mM PMSF
7 mM 2-mercaptoethanol
Phosphorylation buffer: 50 mM Tris-HCl pH 7.5 
10 mM MgCl2 
Im M DTT
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2.9 Immune precipitation
Buffer E: 100 mM Tris-HCl pH 8 
100 mM NaCl 
2 mM EDTA 
2 mM EGTA 
1% (v/v) NP40
0.5% (w/v) sodium deoxycholate 
0.5 mM PMSF
Buffer EN: 100 mM Tris-HCl pH 8 
500 mM NaCl 
2 mM EDTA 
2 mM EGTA 
1% (v/v) NP40
0.5% (w/v) sodium deoxycholate 
0.5 mM PMSF
Buffer EB: Buffer E containing 2 mg/ml BSA
2.10 Endoproteinase reaction buffers
Clostripain (endoproteinase Arg-C): 50 mM Tris-HCl pH 7.5
20 mM DTT 
1 mM CaCl2
V8 protease (endoproteinase Glu-C):
For cleavage at Glu 50 mM NH4H C03 pH 7.8
For cleavage at Glu and Asp 50 mM NaH2P 04 pH 7.8
Endoproteinase Lys-C 25 mM Tris-HCl pH 7.7 
1 mM EDTA
Chapter 2
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Trypsin
2.11 Other buffers
Ficoll gradient solution: 
(Eagles AB)
Versene:
Trypsin:
Tris-saline:
Trypsin/versene:
50 mM NH4HC03 pH 7.8
5% (w/v) Ficoll 400 in Eagles A plus 
Eagles B without phenol red 
15% (w/v) Ficoll 400 in Eagles A plus Eagles 
B without phenol red
0.6 mM EDTA 
0.0002% (w/v) phenol red 
in PBS A
0.25% (w/v) trypsin dissolved in Tris-saline
140 mM NaCl 
30 mM KC1 
280 mM N a^P O ,
25 mM Tris-HCl pH 8 
1 mg/ml glucose 
0.1 mg/ml streptomycin 
100 units/ml penicillin 
0.0015% (w/v) phenol red
1:1 (v/v) trypsin:versene
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3 METHODS
3.1 Growth of cells and virus stocks
3.1.1 Cell culture
RSC and MeWo cells were grown in Dulbecco’s medium supplemented with 9% (v/v) 
FCS, and BHK C13 cells were grown in GMEM supplemented with 8% (v/v) NCS. All 
cells were grown at 37°C in a humidified atmosphere comprising 95% (v/v) air and 5% 
(v/v) C 0 2. The cells were harvested from plastic roller bottles by pouring off the medium 
and washing the monolayer with 20 ml versene. They were then washed with 20 ml 
trypsin/versene to remove the monolayer and resuspended in fresh medium at a 
concentration of approximately 107 cells/ml. Aliquots of 107 cells were seeded into roller 
bottles containing 100 ml of the relevant medium.
3.1.2 Virus stocks
Cells were grown in roller bottles containing 100 ml Dulbecco’s medium until 90% 
confluent. The medium was replaced with 40 ml Dulbecco’s medium supplemented with 
2% (v/v) FCS. The appropriate amount of virus (usually 0.01 pfu/cell) was added in 500 
jil Dulbecco’s medium and the roller bottles returned to 37°C. The infected cells were 
incubated until maximal cpe was observed (usually 2-4 days pi). The medium was 
poured off and infected cells pelleted by centrifugation for 15 min at 2500 rpm and 4°C 
using a Sorvall RC-5B refrigerated Superspeed centrifuge. The supernatant was decanted 
and centrifuged at 12,000 rpm for 2 h in a Sorvall RC-5B refrigerated Superspeed 
centrifuge. The pellet was resuspended in approximately 1 ml of Dulbecco’s medium to 
give the cell-released virus stock. Stocks were disrupted in a bath ultrasonicator at 4°C, 
frozen on dry ice and stored at -70°C. Virus stocks were titrated before use.
3.1.3 Titration of virus stocks
Virus stocks were titrated at 37°C on 90% confluent monolayers of RSC, MeWo or BHK 
C l3 cells (depending on the cell type used to grow the stock) on 35 mm 6-well trays in 
Dulbecco’s medium. Serial dilutions of the virus (usually from 10'3 to 10'8) were made 
and 1 ml of each dilution added to drained monolayers. The plates were returned to the 
incubator for 90 min, after which the inoculum was removed and the plates overlaid with
4 ml methyl cellulose. After 2-4 days the overlay was removed and the plates were
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stained with Giemsa stain for 30 min at RT and washed. The plaques were counted under 
a dissecting microscope and the virus titre calculated.
3.1.4 Purification of virions and L-particIes
Virions and L-particles were purified as described by Szilagyi & Cunningham (1991).
(a) Production of gradients
Virions and L-particles were purified using 5-15% Ficoll 400 gradients prepared as 
follows in 35 ml cellulose nitrate centrifuge tubes using a Biocomp Gradient Master. 
Five percent (w/v) and 15% (w/v) solutions of Ficoll were made in EAB. The required 
volume of 5% Ficoll was poured into a fresh centrifuge tube, and underlayed with the 
required volume of 15% Ficoll. The tube was sealed with a rubber cap, ensuring that air 
bubbles were excluded. The platform on the gradient maker was levelled and the tubes 
placed in the magnetic holder. Two settings were used to mix the gradient: 5 min at an 
angle of 50° and a speed of 25, followed by 40 sec at 80° and a speed of 25.
(b) Purification
A virus stock was prepared and pelleted as described in section 3.1.2 and 5%-15% Ficoll 
400 gradients were prepared as described in section 3.1.4(a). The virus pellet was 
resuspended in a minimal volume of Dulbecco’s medium, layered onto the gradient and 
centrifuged for 2 h at 12,000 rpm in a Sorvall AH629 rotor. The virions, which formed a 
well defined lower band, and the L-particles, which formed a more diffuse upper band, 
were withdrawn separately from the gradient using a wide bore needle. Both virions and 
L-particles were diluted to 34 ml in complete PBS and pelleted by centrifugation at
20,000 rpm for 1 h in a Sorvall AH629 rotor. The pellets were resuspended in a 
minimum volume of complete PBS, frozen on dry ice and stored at -70°C.
3.2 Analysis of HSV-1 induced polypeptides
3.2.1 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
(a) Tris-glycine gels
SDS-PAGE was carried out using slab gels cast vertically in a sandwich consisting of 
two glass plates separated by perspex spacers. Two types of gels were used; “mini-gels” 
were run on a Bio-Rad Mini Protean II™ apparatus, large gels were run on a Life 
Technologies, Inc BRL V 15.17 apparatus. A 45 ml gel mix was prepared for the large
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gels and a 5 ml gel mix prepared for “mini-gels” using commercial polyacrylamide (40% 
acrylamide/Bis-acrylamide 37.5:1, Sigma) and a resolving gel buffer containing 375 mM 
Tris-HCl pH 8.8 and 0.1% (w/v) SDS. Polymerisation was initiated by addition of 
0.006% (w/v) ammonium persulphate (APS) and 0.004% (v/v) N,N,N’,N \ 
tetramethylenediamine (TEMED) just prior to pouring. The resolving gel was left to 
polymerise under a thin layer of butan-2-ol. Before the stacking gel was poured the 
butan-2-ol was removed and the surface of the resolving gel rinsed with dH20.
The stacking gel was composed of 5% acrylamide in stacking gel buffer composed of 
125 mM Tris-HCl (pH 6.8) and 0.1% (w/v) SDS. Just before pouring, 0.006% (w/v) APS 
and 0.004% (v/v) TEMED were added to initiate polymerisation. A comb was used to 
form wells. Before electrophoresis protein samples were boiled for 5 min in protein 
boiling mix to denature them and then applied to the gel. Electrophoresis was carried out 
in electrophoretic buffer at 10-15 mA at RT.
(b) Tris-Tricine
Tris-Tricine gel electrophoresis for resolution of smaller proteins and peptides was 
performed as detailed by Schagger & Von Jagow (1987). Acrylamide stock solutions of 
the ratios 48:1.5 and 46.5:3 acrylamide/NN’-methylenebisacrylamide were prepared and 
deionised using Amberlite beads. The resolving gel solution with the desired acrylamide 
concentration, usually 16.5%, and final concentrations of 1 M Tris-HCl pH 8.45 and 
0.1% (w/v) SDS was poured as outlined in the protocol for Tris-glycine gels (section 
3.2.1(a)). Polymerisation of resolving gel was initiated by addition of 0.05% (w/v) APS 
and 0.0005% (v/v) TEMED, and proceeded under a thin layer of butan-2-ol.
The stacking gel comprised 4% acrylamide with a final concentration of 1 M Tris-HCl 
pH 8.45 and 0.1% (w/v) SDS. Polymerisation was initiated by 0.08% (w/v) APS and 
0.0008% (v/v) TEMED. The stacking gel was poured on top of the resolving gel and the 
well-forming comb inserted. Electrophoresis was carried out for 16 h at 105 V at RT.
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3.2.2 Protein visualisation
(a) Coomassie Brilliant Blue
Following electrophoresis, proteins were fixed for 30 min in fixing solution and then 
stained using Coomassie staining solution, followed by destaining in destain solution for 
at least 1 h at 37°C or (usually) overnight at RT.
(b) Autoradiography
Gels were fixed, stained and destained as detailed in section 3.2.3.(a). They were dried 
under vacuum onto Whatman grade 182 filter paper and exposed to Kodak X-Omat XS-1 
film at RT.
Preparative gels for in-gel protease digestion and Tris-Tricine gels were fixed, stained 
and destained as detailed in section 3.2.3(a). The wet gels were carefully sealed in plastic 
bags and exposed in the same manner as dried gels.
3.2.3 Protease digestion and extraction of peptides from gel slices
(a) For analysis by SDS-PAGE
In-gel protease digestions were performed as detailed by Rothmann et al. (1998). 
Coomassie Brilliant Blue-stained bands were excised from SDS-PAGE gels and cut into 
small cubes (approximately 2 mm by 2 mm). Gel pieces were destained four times with 
100 pi of acetonitrile:water (1:1 v/v) and suspended in 50 pi of acetonitrile, resulting in 
shrinkage of the gel cubes. The supernatant was discarded, and 50 pi of 100 mM 
NH4HCO3 was added. After 15 min of swelling, the gel pieces were again shrunk in 50 pi 
of acetonitrile and dried briefly in a Speed-Vac. The dried pieces were then submerged in 
100 pi of protease digestion buffer containing 12.5 pg/ml of protease (see section 2.10). 
After incubation for 30 min on ice, surplus digestion buffer was replaced by buffer 
without protease so that the gel pieces were just covered, and the samples were incubated 
overnight at the required temperature. Peptides were extracted from the gel pieces by 
washing twice with 50 pi of 25 mM NH4HC03, and then three times with 50 pi of 5% 
formic acid (or twice with 70% aqueous trifluoracetic acid and twice with trifluoracetic 
acid-acetonitrile [1:1 (v/v)]), the gel slices were shrunk by a 50 pi acetonitrile wash after 
every step. All extraction steps were carried out with gentle shaking at 30-37°C, and 
volumes were kept as low as possible to reduce the final volume containing the eluted
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peptides. All washes, including the acetonitrile from shrinkage steps, were pooled and 
dried down in a Speed-Vac. For analysis by SDS-PAGE, the peptides were resuspended 
in protein boiling mix and separated on a 16.5% Tris-Tricine gel.
(b) For mass spectrometric analysis
Peptide bands (approximately 8 mm by 2 mm) were excised, cut into very small cubes (1 
mm by 1 mm), washed for 15 min with 40 \i\ of 50% aqueous methanol-10% acetic acid 
and then for 10 min in 40 jul of 10% aqueous methanol-7.5% acetic acid, and shrunk with 
20 jllI of acetonitrile. Washes were discarded, and peptides were extracted by incubating 
the gel pieces for 1 h each in 30 pi of 100 mM NH4HC03, 30 jllI of 25 mM NH4HC03 
and 30 jliI of 25 mM NH4HC03-acetonitrile (1:1 v/v), shrinking with 20 jllI of acetonitrile 
after every step. Extractions were carried out with gentle shaking at 37°C in 500 (il tubes 
with a tiny hole in the bottom so that liquid could be removed into a collection tube by 
brief centrifugation. Pooled extracts were concentrated to 2-5 ]ll1 in a Speed-Vac and 
directly analysed by mass spectrometry.
3.2.4 Blotting polyacylamide gels for mass spectrometric analysis
(a) General blotting protocol
PVDF membrane was cut to size and soaked in methanol for approximately 5-10 
seconds, followed by soaking in water and then PVDF transfer buffer for at least 5 min. 
The electrophoresed gel was cut to size and soaked in PVDF transfer buffer for at least 5 
min. The membrane was applied to the gel, sandwiched between two filter papers and 
electroblotted at 100 V for 1 h at RT. The membrane was removed, washed extensively 
in dH20  and dried in vacuo overnight. The membrane was stained with sulforhodamine 
solution until bands were clearly visible, usually after about 1 min, washed in water and 
air dried.
(b) For the UL49-encoded protein
Blotting was carried out as described in section 3.2.7.(a), except that the PVDF blotting 
buffer contained 0.1% SDS rather than 0.01% SDS.
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(c) Coomassie staining of PVDF blotted samples
The membrane was removed from the blotting assembly and wet for a few seconds with 
methanol. PVDF Coomassie stain was added and gently agitated for 1 min. The stain was 
decanted, destain added and the blot rinsed several times with destain until bands appear. 
The destained blot was rinsed several times with dH20.
3.2.5 Mass spectrometric analysis of proteins
After staining, the membranes were dried in vacuo overnight. The bands to be analysed 
were excised from the membrane and placed into 0.5 ml tubes. 3 jul of endoproteinase 
(usually sequencing grade trypsin) was added at a concentration of 40 pg/ml in 50 mM 
NH4HCO3 containing 1% (w/v) n-octyl (3-D-glucopyranose (Sigma). The tubes were 
incubated overnight at RT, after which 7 jul formic acid:ethanol (1:1 v/v) was added for 1 
h at RT to elute the peptides. Then 0.5 pi of each sample was placed onto a mass 
spectrometer loading strip and air dried, and 0.5 pi of matrix solution containing insulin 
B as a mass marker was added to each sample and air dried before inserting the strip into 
the mass spectrometer (Finnigan MAT Lasermat). The samples were subjected to laser 
desorption mass spectrometric analysis to produce a mass spectrum characteristic of the 
protein analysed.
3.2.6 Immune precipitation
Glass beads were used to remove a confluent monolayer of cells from a roller bottle. The 
cells were transferred to a 50 ml Falcon tube and centrifuged at 2.5 K for 5 min at 4°C 
using aSorval RT6000B centrifuge. The supernatant was removed and 1 ml 0.9% NaCl 
added per 1 g of cells, and left for 5 min at 4°C. Five ml of acetone (pre-chilled to -20°C) 
was added per 1 g of cells and left for 30 min at 4°C, mixing every 5 min. The sample 
was then centrifuged at 2.5 K for 10 min using aSorval RT6000B centrifuge and the 
supernatant removed. The pellet was spread onto Whatman number 1 filter paper and 
allowed to air dry. The dry powder was transferred to an air-tight vial and stored at RT.
Antisera was pre-cleared by mixing 200 pi of the antisera with a small amount of the 
dried acetone powder (approximately 1/10 of the dried volume). The antisera and acetone 
powder was mixed on a rotary mixer for 90 min at 4°C. Following this, the antisera 
acetone powder mix was centrifuged at 12,000 rpm for 7 min using a MSE Mini Centaur.
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The supernatant, which represented the pre-cleared antisera, was removed to a fresh vial. 
The pre-cleared antisera was stored at -20°C.
Fifty jllI of CNE was mixed with 150 pi buffer A and the required pre-cleared antibody at 
4°C for 5 h. Protein A insolubilized on Sepharose CL-4B was mixed 1:1 (v/v) with 
buffer E and washed twice. After mixing for 5 h, 75 pi of the Protein A Sepharose was 
added to each sample and mixed at 4°C for 1 h. After 1 h the samples were centrifuged at
12,000 rpm for 1 min using a MSE Mini Centaur, the supernatant was removed and 
stored. The Protein A Sepharose beads were washed twice with buffer EB, once with 
buffer EN and four times with buffer E. After washing the beads were suspended in 
protein boiling mix and boiled for 5 min and analysed on SDS-PAGE. The gels were 
fixed, stained and destained and exposed if necessary.
3.3 In vitro phosphorylation reactions
Sample preparation and phosphorylation reactions were performed as detailed by Coulter 
(1993).
3.3.1 Preparation of nuclear and cytoplasmic extracts from infected cells
Confluent monolayers of MeWo, RSC or BHK C13 cells in roller bottles were infected 
with HSV-1 at 5-10 pfu/cell and incubated at 37°C for 5 h. The cells were scraped into 
10 ml complete PBS, pelleted by centrifugation at 2000 rpm for 10 min at 4°C using a 
Sorval RT6000B refrigerated centrifuge and resuspended in 10 ml Buffer A. The cells 
were then disrupted on ice using 20 strokes of a Dounce homogeniser and centrifuged at 
3000 rpm for 10 min at 4°C using a Sorval RT6000B centrifuge. The supernatant, 
representing the crude cytoplasmic extract, was removed and frozen on dry ice to be 
stored at -70°C. The nuclear pellet was resuspended in 3 ml Buffer A and subjected to 
ultrasonic disruption followed by centrifugation at 2000 rpm for 3 min at 4°C using a 
Sorval RT6000B centrifuge. The supernatant, representing the crude nuclear extract 
(CNE), was frozen on dry ice and stored at -70°C.
3.3.2 Treatment of virions for in vitro phosphorylation reactions
Permeabilised virions were produced by mixing 30 |Lil of virions with 1.2 pi each of 0.25 
M Tris-HCl pH 7.5, 0.025 M DTT and 1.25% (v/v) NP40. The mixture was incubated on
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ice for 1 h and diluted with an equal volume of 10 mM Tris-HCl pH 7.5, 1 mM MgCl2 
and 1 mM DTT.
Stripped virions were produced by mixing a 90 pi sample of virions with 10 pi of 10% 
(v/v) NP40. This was incubated on ice for 15 min, followed by centrifugation at 12,000 
rpm for 10 min using a MSE Mini Centaur. The supernatant, constituting the virion 
membranes were removed, and an equal volume of 1% (v/v) NP40 added to the pellet. 
The pellet was resuspended by sonication and centrifuged at 12,000 rpm for 10 min using 
an MSE Mini Centaur. The supernatant was discarded, an equal volume of complete PBS 
added and the pellet resuspended by sonication.
3.3.3 In vitro phosphorylation of infected cell extracts and virions
Five pi CNE or stripped or permeabilised virions were mixed with 10 pi NaCl (ranging 
from 0-3 M), 5 pi 4 x phosphorylation buffer and 1 pCi [y-32P]ATP. The mixture was 
incubated at 37°C for 30 min. The products were analysed by SDS-PAGE. The gel 
stained, dried and exposed to X-ray film.
3.3.4 Assay for phosphate cycling
In vitro phosphorylation reactions were performed as described in section 3.3.3. After the 
30 min incubation, half the sample was transferred to a fresh Eppendorf tube, protein 
boiling mix added and the sample placed on ice. To the other half, 1 pi of the relevant 
concentration of unlabelled ATP was added and incubated at 37°C for a further 30 min. 
The products were analysed by SDS-PAGE. The gel was stained, dried and exposed to 
X-ray film.
3.4 Computational analysis
Sequence alignments were produced using the PILEUP and PRETTY programs 
(University of Wisconsin, Genetics Computing Group).
3-D protein structures were obtained from the National Center for Biotechnology 
Information (NCBI) database and viewed using Cn3D version 3.0.
Secondary structure predictions were made using PsiPred, an on-line secondary structure 
prediction programme (wwwrun@insulin.brunel.ac.uk).
Peptide masses were obtained using Massmap software (Finnigan, MAT).
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4 RESULTS
4.1 In vitro phosphorylation of nuclear extracts from infected cells
A previous study by Coulter et al. (1993) employed an in vitro assay to compare the 
phosphorylation profiles of wt HSV-1 and an HSV-1 UL13-/<zcZ mutant. The assay 
involved incubating membrane stripped virions or infected BHK cell CNEs for 30 min at 
37°C in the presence of [y-32P]ATP. Assays were performed at a variety of NaCl 
concentrations ranging from 0 to 1.5 M. Proteins were separated on a 9% polyacrylamide 
gel, and radiolabelled proteins were visualised by autoradiography. In wt CNE, two 
highly radiolabelled phosphoproteins were detected migrating with Mrs of 57 and 38 
kDa. Radiolabelling of the 57 kDa protein was slightly reduced at low NaCl 
concentrations, whereas the 38 kDa protein showed peak radiolabelling at NaCl 
concentrations of 0.5 to 1 M. In UL13-/acZ CNE, the phosphorylated 57 kDa protein was 
absent and the 38 kDa protein was phosphorylated only at low NaCl concentrations. The 
data indicated that the 57 kDa protein, probably encoded by gene UL13, was involved in 
phosphorylation of a variety of CNE proteins, the 38 kDa protein prominent among 
them. Sequence analysis predicted that the UL13 protein is a PK (Fig. 1.13). Therefore, it 
was hypothesised that UL13 PK targeted the 38 kDa protein, shown to be encoded by the 
gene UL49, for phosphorylation. These experiments were carried out using a single 
mutant containing a large insertion in the UL13 gene, and without using a revertant virus 
to ensure that the phenotype was due to the UL13 mutation In order to confirm and 
extend these observations, the assay was repeated using two additional independent 
UL13 mutants containing a small insertion or deletion in gene UL13.
MeWo cells were either mock infected (MI) or infected with wt, UL13I-16 bp, UL13D-4 
bp or UL13-ZacZ HSV-1 (see Table 1.12). Cells were infected at a moi of 10, and 
infection was allowed to proceed for 5 h at 37°C. Nuclear extracts were prepared and 
phosphorylated in vitro following the protocol defined by Coulter et al. (1993). An 
autoradiograph showing the radiolabelled phosphoproteins is shown in Fig. 4.1.1. 
Several phosphorylated proteins detected in wt CNE were absent from MI CNE, 
including strongly phosphorylated proteins migrating at 57 kDa and 38 kDa. The 
phosphorylation profiles of the UL13 mutants were similar to each other, but
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Figure 4.1.1 Autoradiograph showing in vitro phosphorylation profiles of 
wt and UL13 mutant-infected cell CNE.
MeWo cells were mock-infected or infected with wt or UL13' mutants for 5 h 
at 37°C. CNEs were prepared and incubated in the presence of [y-32P]ATP 
over a range of NaCl concentrations. The proteins were separated on a 9% 
polyacrylamide gel and visualised by exposure to X-ray film.
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demonstrated a number of differences compared to wt CNE. Most strikingly, these 
included absence of the 57 kDa phosphoprotein, and substantially reduced 
phosphorylation of a number of proteins, most obviously the 38 kDa protein. In addition, 
the phosphorylation levels of some proteins were dependent on NaCl concentration. In wt 
CNE the 57 and 38 kDa proteins showed reduced phosphorylation at low NaCl 
concentrations. In UL13 mutant CNE the 38 kDa protein was most highly 
phosphorylated at 0 M NaCl.
Fig. 4.1.1 shows that deletion of the UL13 gene stimulates increased radiolabelling of a 
viral protein of approximately 75 kDa and decreased labelling of a 96 kDa 
phosphoprotein. As outlined in section 1.3.5.1, Purves & Roizman (1992) identified 
ICP22 in wt CNE as five phosphoprotein species ranging in Mr from 70 to 82 kDa. 
However, in UL13 mutant CNE the 70 kDa phosphoprotein appeared to be present in 
increased amounts while the higher Mr phosphoproteins were absent. In addition, Ogle et 
al. (1997) showed ICPO to be a substrate for the UL13 PK. While the observations in this 
I study correlate with the previous data, further work would be required to determine
I whether the 75 and 96 kDa phosphoprotein observed in Fig. 4.1.1 are ICP22 and ICPO.
I
!
I These observations confirm those made by Coulter et al. (1993) and prove that the
I observed differences in phosphorylation profile are due to disruption of the UL13 gene.
l
! The presence of the 57 kDa and 38 kDa phosphoproteins in wt CNE but not MI CNE
i
suggests that they are viral proteins. Since the 57 kDa phosphoprotein was totally absent
! from each mutant CNE, it is likely to represent the UL13 gene product. Indeed the
I
predicted mass of the UL13 protein is 57,193 Da (McGeoch et al., 1988). The prediction 
that the UL13 protein is a PK is consistent with reduced phosphorylation of several 
proteins in UL13 mutant CNEs, the most prominent being the 38 kDa protein. These 
proteins could act as direct or indirect targets for the putative UL13 PK. However, 
phosphorylation of the 38 kDa protein in mutant CNE, albeit greatly reduced, indicates 
the activity of additional PKs.
The in vitro phosphorylation assay shown in Fig. 4.1.1 followed the protocol defined by 
j Coulter et al. (1993), in which CNE samples are incubated for 30 min at 37°C in the
presence of [y-32P]ATP. To ensure maximal phosphorylation was achieved in vitro,
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Figure 4.1.2 Autoradiograph showing the effects of varying in vitro 
phosphorylation incubation times.
Aliquots of wt HSV-1 infected MeWo cell CNE were incubated at 
37°C and 1.5 M NaCl in the presence of [y-32P]ATP for the times 
indicated. Reactions were stopped by immediate addition of protein 
boiling mix (PBM) and boiling the samples. Proteins were separated on 
a 9% polyacrylamide gel and visualised by exposure to X-ray film.
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phosphorylation assays were carried out for a range of times from 5 to 45 min. The 
resulting autoradiograph is shown in Fig. 4.1.2. The level of phosphorylation of all 
proteins, including the 57 and 38 kDa proteins, increased between 5 and 10 min, and was 
followed by a gradual increase up to 25 min. From 30 min onwards, radiolabelling did 
not increase. Because there is no obvious increase in the phosphorylation levels beyond 
30 min incubation, this would appear to be the optimal incubation time. Despite 
increased radiolabelling, the phosphorylation profile remained unchanged at all time 
points, indicating that an incubation time of less than 30 min could be used if necessary.
The phosphorylation protocol defined by Coulter et al. (1993) required incubating 
infected cell CNE in a buffer comprising 10 mM MgCl2, 50 mM Tris-HCl pH 7.5 and 1 
mM DTT, in addition to [y-32P]ATP and a range of NaCl concentrations. A variety of 
phosphorylation buffers have been used in other studies. A study on the PRV UL13 PK 
by De Wind et al. (1992) showed that replacing MgCl2 with MnCl2 in the 
phosphorylation buffer stimulated PK activity. A separate study on HSV-2 UL13 found 
that PK activity increased with increasing pH, peaking when buffered by Tris-HCl pH 
8.8-9.2 (Daikoku et al., 1997). To examine the effects of buffer conditions on the HSV-1 
UL13 PK, a series of in vitro phosphorylation reactions were performed on CNE samples 
using different buffer compositions and concentrations. Fig. 4.1.3 shows the 
phosphorylation profiles of aliquots of wt and UL13-/acZ CNE incubated in a buffer 
comprising either 10 mM MgCl2 or MnCl2, either 50 mM Tris-HCl pH 7.5 or 9.2 and 1 
mM DTT. The samples were incubated at 37°C for 30 min in the presence of [y-32P]ATP.
The most highly radiolabelled phosphoprotein in wt CNE was the 57 kDa UL13 protein, 
which was absent from \JL\3-lacZ  CNE. Phosphorylation of the UL13 protein was 
greater in wt CNE incubated at pH 7.5, and MnCl2 stimulated phosphorylation in 
comparison with MgCl2 at both pHs. These data are in agreement with De Wind et al.
(1992), who showed that MnCl2 stimulated phosphorylation of the PRV UL13 protein. 
However, they are at variance with Daikoku et al. (1997), who found that 
phosphorylation of the HSV-2 UL13 protein was greater at pH 9.2 than at pH 7.5. It 
should be noted, however, that HSV-2 UL13 also differs from HSV-1 UL13 in its NaCl 
sensitivity. HSV-2 UL13 is inhibited at NaCl concentrations above 0.5 M, compared to
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Figure 4.1.3 Autoradiograph showing the in vitro phosphorylation 
profiles of wt and UL13-lacZ CNE under a variety of buffer 
conditions.
Aliquots of wt and UL13-/acZ infected MeWo cell CNE were 
incubated at 37°C in the presence of [y-32P] ATP and the indicated 
phosphorylation reaction buffer. All assays were performed at 1.5 M 
NaCl. The proteins were separated on a 9% polyacrylamide gel and the 
radiolabelled proteins visualised by exposure to X-ray film.
Results Chapter 4.1
the well documented stimulation of HSV-1 UL13 at higher NaCl concentrations 
(Cunningham et al., 1992; Coulter etal., 1993).
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4.2 Multiple phosphorylation of the 57 kDa protein
The data so far confirm that a large number of proteins in wt CNE are phosphorylated 
when incubated in vitro with [y-32P]ATP. The two most highly phosphorylated migrate 
with apparent Mrs of 57 and 38 kDa. The phosphorylated 57 kDa protein was absent 
from each of the three independent UL13 mutant CNEs, indicating that it was encoded 
by the UL13 gene. Disruption of the UL13 gene also resulted in reduced phosphorylation 
of a variety of proteins, including a 38 kDa protein encoded by the gene UL49 (Coulter 
et al., 1993). The hypothesis that the UL13 protein possesses PK activity, 
phosphorylating a variety of proteins including the 38 kDa protein was investigated 
further by attempting to map phosphorylated amino acid residues within the 57 and 38 
kDa proteins. Initially, however, it was important to determine basal phosphorylation 
levels of these proteins in CNE. Since CNE proteins can be radiolabelled in vitro using 
[y-32P]ATP, if these proteins are phosphorylated prior to radiolabelling they must be able 
to cycle phosphate. An in vitro assay was devised to test for phosphate cycling.
Aliquots of in vitro radiolabelled wt and UL13-lacZ CNE (unchased) were incubated 
with excess unlabelled ATP (chased). The details and results of the assay are shown in 
Fig. 4.2.1. Two highly phosphorylated proteins migrating at 57 and 38 kDa were present 
in radiolabelled, unchased wt CNE. Both were absent from unchased UL13-/acZ CNE. In 
chased wt CNE, radiolabelling of both the 57 and 38 kDa phosphoproteins was reduced. 
In addition, a novel, highly phosphorylated protein migrating with a Mr of approximately 
62 kDa was present. No phosphoproteins of 38, 57 or 62 kDa were present in chased 
UL13-/acZ CNE.
Analysis of the UL13D-4 bp and UL13I-16 bp mutants produced similar results. In Fig.
4.2.2 the two major radiolabelled phosphoproteins in the unchased wt CNE migrated as 
before with Mrs of 57 and 38 kDa. In all unchased UL13 mutant CNEs the 57 kDa 
phosphoprotein was completely absent and the 38 kDa protein demonstrated a marked 
reduction in phosphorylation. Chased wt CNE exhibited reduced phosphorylation of the 
57 and 38 kDa proteins and appearance of the 62 kDa phosphoprotein. All of these 
radiolabelled phosphoproteins were absent from the chased UL13 mutant CNEs.
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Figure 4.2.1 Autoradiograph showing an in vitro assay for 
phosphate cycling.
Aliquots of wt or \JL\3-lacZ infected MeWo cell CNE were incubated 
at 37°C and 1.5 M NaCl in the presence of [y-32P]ATP. After 30 min 
incubation, half of each sample was added to PBM and boiled. The 
remaining half was incubated for a further 30 min in the presence of 5 
mM unlabelled ATP. Proteins were separated on a 9% polyacrylamide 
gel, and radiolabelled proteins visualised by exposing the dried gel to 
X-ray film.
Figure 4.2.2 Autoradiographs showing an in vitro assay for 
phosphate cycling.
Aliquots of MeWo cell CNE infected with either wt or UL13' mutants 
were incubated at 37°C and 1.5 M NaCl in the presence of [y-32P]ATP. 
After 30 min incubation, half of each sample was added to PBM and 
boiled. The remaining half was incubated for a further 30 min in the 
presence of 5 mM unlabelled ATP. Protein were separated on a 9% 
polyacrylamide gel and radiolabelled proteins visualised by exposing 
the dried gel to X-ray film.
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Chase assays involve incubating CNE with excess ATP for 30 min beyond the normal 
phosphorylation incubation time. Fig. 4.2.3 details a series of phosphorylation assays 
designed to determine whether the chased CNE phosphorylation profile resulted from 
excess ATP or increased incubation time. Comparing lanes 1 and 2 shows no change in 
the phosphorylation profile. In lane 3, radiolabelling was greatly reduced when 
unlabelled ATP was added at the start of the assay. Under these conditions, two faintly 
radiolabelled phosphoproteins were detected in wt CNE with Mrs of approximately 97 
and 62 kDa. Both proteins were absent from UL13-/acZ CNE. In lane 4 the unlabelled 
ATP chase was added after radiolabelling for 30 min and phosphoproteins with Mrs of 
57 and 62 kDa were clearly detected. No radiolabelled phosphoproteins with these Mrs 
were seen in UL13-lacZ CNE treated under the same conditions. These data prove that 
excess ATP and not extended incubation time stimulated phosphorylation of the 62 kDa 
protein. As expected, unlabelled ATP added at the start of the incubation resulted in a 
very low level of radiolabelling, with the 62 kDa phosphoprotein being one of the 
products.
To determine conclusively whether phosphorylation of the 62 kDa protein is stimulated 
by excess ATP independent of incubation time, a series of assays was performed as 
detailed in Fig. 4.2.4. Aliquots of wt CNE were phosphorylated in vitro with [y-32P]ATP, 
followed by an unlabelled ATP chase ranging from 5 to 45 min. The radiolabelled 57 and 
62 kDa phosphoproteins were detected in all samples, confirming that production of the 
62 kDa phosphoprotein is stimulated in the presence of excess ATP regardless of 
incubation time. It is unclear why the 10 min and 35 min samples demonstrate reduced 
radiolabelling. On the basis of these data it was hypothesised that the 62 kDa protein is a 
hyperphosphorylated protein. Phosphorylation interferes with SDS binding causing the 
protein to migrate more slowly, as such a hyperphosphorylated protein would migrate 
with an artificially high Mr. The best candidate for the precursor of the 62 kDa protein 
was the highly radiolabelled 57 kDa protein. To test this hypothesis, 
immunoprecipitations were performed on aliquots of in vitro radiolabelled CNE samples 
using polyclonal antisera raised against amino acid residues 149 to 207 of the UL13 
protein (Cunningham et al, 1992).
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Figure 4.2.3 Autoradiograph showing an in vitro assay to 
determine the effect of varied incubation and chase times on 
phosphorylation profiles.
Aliquots of wt and UL13-/acZ infected MeWo cell CNE were 
incubated at 37°C and 1.5 M NaCl in the presence of [y-32P]ATP. 
Samples 1 and 5 were incubated unchased for 30 min and samples 2 
and 6 incubated unchased for 1 h. Samples 3 and 7 were 
simultaneously radiolabelled and chased for 1 h. Samples 4 and 8 
were radiolabelled for 1 h, chased with 5 mM unlabelled ATP for the 
final 30 min. Proteins were separated on a 9% polyacrylamide gel and 
radiolabelled proteins visualised by exposing the dried gel to X-ray 
film.
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Figure 4.2.4 Autoradiograph showing an in vitro assay to determine 
the effect of varied chase times on phosphorylation profiles.
Aliquots of wt infected MeWo cell CNE were incubated at 37°C and
1.5 M NaCl in the presence of [y-32P]ATP. After 30 min 5 mM 
unlabelled ATP was added and the samples were incubated at 37°C for 
the indicated time. Reactions were stopped by adding PBM and 
boiling. Proteins were separated on a 9% polyacrylamide gel, and 
radiolabelled proteins were visualised by exposing the dried gel to X- 
ray film.
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Fig. 4.2.5 shows the immunoprecipitates derived from MI, UL13-/acZ and wt CNE. No 
radiolabelled phosphoproteins were immunoprecipitated from MI and UL13-/acZ CNE. 
A single radiolabelled protein with a Mr of approximately 57 kDa was precipitated from 
wt CNE. The yield of this protein was greater from CNE derived from cells infected for 
20 h than for 5 h. This result confirms that the 57 kDa protein is the UL13 protein. To 
determine whether the 57 and 62 kDa proteins are related, the immunoprecipitation was 
repeated using unchased and chased wt CNE. The results are shown in Fig. 4.2.6.
The 57 kDa phosphoprotein was precipitated in small amounts from unchased 5 h wt 
CNE and in greater amounts from unchased 20 h wt CNE. The 57 and 62 kDa 
phosphoproteins were immunoprecipitated from chased samples, again more obviously 
in 20 h wt CNE. It is not possible to rule out that the 57 kDa and 62 kDa protein co- 
immunoprecipitate. However, these data, coupled with the fact that the 62 kDa protein 
must be a chased form of a previously highly labelled phosphoprotein, show that the 62 
kDa phosphoprotein is a hyperphosphorylated form of the UL13-encoded 57 kDa 
phosphoprotein. Thus, the putative UL13 PK possesses multiple phosphorylation sites.
The majority of PKs utilise only ATP as a phosphate donor, but a few, including the 
putative UL13 PK, utilise both ATP and GTP. The nucleotide specificity of 
phosphorylation of the 62 kDa protein was tested by performing chase assays using 
unlabelled GTP, CTP or UTP. The results are shown in Fig. 4.2.7.
Aliquots of wt CNE were incubated at 37°C for 30 min in the presence of [y-32P] ATP and 
chased with 5 mM (reaction concentration) unlabelled GTP, CTP or UTP. Chasing with 
GTP resulted in reduced phosphorylation of the 57 and 38 kDa proteins and production 
of the 62 kDa phosphoprotein. Neither CTP nor UTP stimulated reduced radiolabelling 
of the 57 or 38 kDa protein or production of the 62 kDa phosphoprotein. Therefore, 
phosphate cycling of the 38 kDa protein and production of the 62 kDa phosphoprotein 
specifically utilises GTP or ATP. These data further confirm that the 62 kDa protein is a 
hyperphosphorylated protein and show that the PK responsible is able to utilise both ATP 
and GTP.
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Figure 4.2.5 Autoradiograph showing immunoprecipitation of in 
vitro phosphorylated CNE by a UL13 antiserum.
MeWo cells were mock-infected (lanes 1 and 5) or infected with 
UL13-lacZ (lanes 2 and 6) or wt for 5 h (lanes 3 and 7) or 20 h (lanes 
4 and 8). CNE were prepared and incubated at 37°C and 1.5 M NaCl 
in the presence of [y-32P]ATP. The phosphorylated CNE samples
were then incubated with polyclonal antiserum raised against amino 
acid residues 149 to 207 of the UL13 protein. The precipitated 
antibody-antigen complexes were separated on a 9% polyacylamide 
gel and visualised by exposing the dried gel to X-ray film.
Lanes 1-4 represent immunoprecipitated samples and lanes 5-8 
represent 20% of the supernatant.
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Figure 4.2.6 Autoradiograph showing immunoprecipitation of in 
vitro phosphorylated unchased and chased wt CNE by a UL13 
antiserum.
MeWo cells were infected with wt virus for 5 h (lanes 1, 2, 5 and 6) or 
20 h (lanes 3, 4, 7 and 8). CNE were prepared and incubated at 37°C 
and 1.5 M NaCl in the presence of [y-32P]ATP. After 30 min, 1 pi 
unlabelled ATP was added to samples 2 and 4 to a reaction 
concentration of 5 mM and incubated for a further 30 min. The 
phosphorylated CNE samples were incubated with polyclonal 
antiserum raised against amino acid residues 149 to 207 of the UL13 
protein. The precipitated antibody-antigen complexes were separated 
on a 9% polyacrylamide gel and visualised by exposing the dried gel 
to X-ray film.
Lanes 1-4 represent the immunoprecipitated samples and samples 5-8 
represent 20% of the supernatant.
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Results Chapter 4.2
On the basis of the previous finding, chase assays were performed with various 
concentrations of unlabelled ATP or GTP to determine the relative efficiency of each as 
phosphate donor. The results are given in Figs. 4.2.8 and 4.2.9. Aliquots of wt CNE were 
incubated for 30 min at 37°C in the presence of [y-32P]ATP, followed by an unlabelled 
ATP or GTP chase of the indicated concentration. Fig. 4.2.8 shows the effect of 
decreasing the ATP concentration. Chasing with 5 mM unlabelled ATP resulted in 
reduced labelling of the 57 and 38 kDa proteins and phosphorylation of the 62 kDa 
protein. This phosphorylation profile was maintained as the ATP concentration in the 
chase was reduced to 5 pM. At 500 nM, labelling of the 57 and 38 kDa proteins was only 
slightly reduced compared to unchased wt CNE. Under these conditions, the 62 kDa 
phosphoprotein was absent, and instead a novel phosphoprotein of approximately 60 kDa 
was produced. The phosphorylation profile produced in the presence of 50 nM ATP is 
indistinguishable from that of an unchased sample, and remains unchanged at lower ATP 
concentrations. Fig. 4.2.9 shows the effect of unlabelled GTP chase concentration on the 
phosphorylation profile. Chasing with 500 pM GTP stimulated only a partial reduction in 
the level of radiolabelling of the 38 and 57 kDa phosphoproteins. It stimulated 
phosphorylation of a 60 kDa protein, but not the 62 kDa protein. At 50 pM GTP the 
phosphorylation profile was identical to unchased wt CNE and remained unchanged at 
lower GTP concentrations.
There appear to be three distinct phosphorylation profiles depending upon ATP or GTP 
concentration. At higher concentrations, an unlabelled ATP or GTP chase stimulated 
reduced radiolabelling of the 57 and 38 kDa phosphoproteins and phosphorylation of a 
62 kDa protein. At low ATP or GTP chase concentrations the phosphorylation profiles 
were indistinguishable from those of unchased CNE. At intermediate chase 
concentrations, radiolabelling of the 57 and 38 kDa phosphoproteins was partially 
reduced. In addition, the 62 kDa phosphoprotein was not detected, but a novel 60 kDa 
phosphoprotein was detected instead. Production of the 60 kDa phosphoprotein was 
stimulated by a 500 nM ATP or 500 pM GTP chase. The novel 60 kDa phosphoprotein 
probably represents an additional level of phosphorylation between the 
hypophosphorylated 57 kDa and hyperphosphorylated 62 kDa UL13 proteins.
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Figure 4.2.8 Autoradiograph showing an in vitro assay for 
phosphate cycling with decreasing unlabelled ATP chase 
concentrations.
Aliquots of wt infected MeWo cell CNE were incubated at 37°C aid
1.5 M NaCl in the presence of [y-32P]ATP. After 30 min incubation, 
1 jul of unlabelled ATP was added to give the indicated reaction 
concentration and the samples were incubated for 30 min. The protehs 
were separated on a 9% polyacylamide gel and visualised by exposing 
the dried gel to X-ray film.
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Figure 4.2.9 Autoradiograph showing an in vitro assay for 
phosphate cycling with decreasing unlabelled GTP chase 
concentrations.
Aliquots of wt infected MeWo cell cell CNE were incubated at 37°C 
and 1.5 M NaCl in the presence of [y-32P]ATP. After 30 min 
incubation, 1 pi of unlabelled GTP was added to give the indicated 
reaction concentration and the samples were incubated for 30 min. 
The proteins were separated on a 9% polyacrylamide gel and 
visualised by exposing the gel to X-ray film.
Panel 2 shows a lower exposure of the 57 to 60 kDa region.
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All the chase-stimulated phosphorylation profiles discussed to this point were visualised 
by separating the proteins on small (55 x 95 mm) polyacrylamide gels. Fig. 4.1.1 shows 
radiolabelled, unchased wt CNE separated on a large (120 x 175 mm) polyacrylamide 
gel. On this autoradiograph a phosphoprotein migrating slightly more slowly than the 57 
kDa phosphoprotein can be clearly seen. The migration of this phosphoprotein in relation 
to the chase-stimulated 62 kDa phosphoprotein was unknown. To clarify the situation, 
radiolabelled, chased CNE samples were separated on a large polyacrylamide gel. The 
results are shown in Fig. 4.2.10.
A highly phosphorylated protein was detected in unchased wt CNE migrating with a Mr 
of 57 kDa. It is clearly visible at 0 M and 1.5 M NaCl, with increased phosphorylation at 
the higher NaCl concentration. A second phosphoprotein migrated at 59 kDa, and 
phosphorylation of this protein appears to be similar at both NaCl concentrations. As 
expected, radiolabelling of the 57 kDa phosphoprotein was greatly reduced in chased wt 
CNE. The 59 kDa protein also showed reduced radiolabelling in chased wt CNE. 
Chasing with unlabelled ATP stimulated phosphorylation of the 62 kDa protein at 0 M 
and 1.5 M NaCl, moreso at 1.5 M NaCl. These results show that a 59 kDa 
phosphoprotein is present in unchased and chased wt CNE, and it is only possible to 
differentiate the 57 and 59 kDa phosphoproteins when they are visualised on “large” 
gels, as they co-migrate on mini gels. It is unclear whether the 59 kDa phosphoprotein in 
unchased samples and the chase stimulated 60 kDa proteins are the same. However, the 
60 kDa phosphoprotein is only detected in CNE incubated with a 500 nM ATP or 500 
pM GTP chase. The concentration of [y-32P]ATP in unchased CNE was only 80 pM, far 
too low to stimulate phosphorylation of the 60 kDa phosphoprotein. However, further 
work, such as western blot analysis, would be required to confirm this.
Because phosphorylation of the 57 and 62 kDa proteins depends on NaCl concentration, 
ATP chase assays were performed over a range of NaCl concentrations. The results are 
shown in Fig. 4.2.11. As in previous experiments, two highly phosphorylated proteins 
migrating at 57 and 38 kDa were produced by unchased wt CNE. The 38 and 57 kDa 
phosphoproteins were marginally more highly phosphorylated at 1.0 M NaCl. The 57 
kDa protein was absent from phosphorylated UL13-/acZ CNE under all conditions, and 
radiolabelling of the 38 kDa decreased dramatically as NaCl concentration increased.
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Figure 4.2.10 Autoradiograph showing the relative migration of 
the 57, 59 and 62 kDa phosphoproteins.
Aliquots of xvt and UL 13-/acZ infected MeWo cell CNE were 
incubated at 37°C in the presence of 0 M or 1.5 M NaCl and [y- 
32P]ATP. After 30 min incubation, half the sample was added to 
PBM and boiled. The remaining half was incubated for a further 30 
min in the presence of 5 mM unlabelled ATP. Proteins were 
separated on a 9% polyacrylamide gel and visualised by exposing 
the dried gel to X-ray film.
Figure 4.2.11 Autoradiograph showing an in vitro assay for 
phosphate cycling over a range of NaCl concentrations.
Aliquots of wt and UL13-/acZ infected MeWo cell CNE were 
incubated at 37°C at the indicated NaCl concentration in the presence 
of [y-32P]ATP. After 30 min incubation, 1 jil of unlabelled ATP was 
added to a final concentration of 5 mM and the samples were incubated 
for 30 min. Proteins were separated on 55 x 95 mm 9% polyacrylamide 
gels and visualised by exposing the dried gels to X-ray film. Panel 1 
represents wt CNE and panel 2 represents UL13-lacZ CNE
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The effects produced by the unlabelled ATP chase depended upon NaCl concentration. 
In chased wt CNE, radiolabelling of the 38 and 57 kDa phosphoproteins decreased as 
NaCl concentration increased, whereas radiolabelling of the 62 kDa phosphoprotein 
increased between 0 and 0.5 M NaCl concentrations. In chased UL13-/acZ CNE the 57 
and 62 kDa phosphoproteins were totally absent and the 38 kDa phosphoprotein was 
only detected at 0 M NaCl.
It can be concluded from the data presented in this chapter that the 57 kDa and the 62 
kDa phosphoprotein represent two differently phosphorylated forms of the UL13 protein. 
Hyperphosphorylation of the UL13 protein was stimulated by increased ATP or GTP 
concentration, and was independent of incubation time. It is noteworthy that both ATP 
and GTP were utilised in hyperphosphorylating the UL13 protein. Utilisation of both 
ATP and GTP as phosphate donors is relatively uncommon; CKI, CKII and the UL13 PK 
(Cunningham et al., 1992) are examples of PKs that can use either nucleotide.
The data presented here shows that the UL13 protein possesses multiple phosphorylation 
sites, but the exact number is difficult to determine. The 57 and 62 kDa species imply at 
least two sites of phosphorylation. The third 60 kDa species, only found at intermediate 
ATP or GTP concentrations, implies a third site. As outlined earlier, because the 
minimum chase concentration required to phosphorylate the 60 kDa protein is far above 
the [y-32P]ATP concentration, it is unlikely that the 60 kDa and the 59 kDa 
phosphoproteins are the same. Interestingly, although it is known that multiple PKs 
target the UL49 protein, presumably at different sites, there was no evidence that the 
UL49 protein was capable of being hyperphosphorylated under any of the conditions 
tested.
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4.3 Post-translational modification of the UL49 protein
The data presented in Chapter 4.2 showed that the UL13 protein was 
hyperphosphorylated in CNE incubated with excess ATP or GTP. However, the UL49 
protein was found to cycle phosphate, and there was no evidence that the UL49 protein 
was hyperphosphorylated beyond a basal level. Because buffer composition affects 
phosphorylation (Fig. 4.1.3), the phosphorylation potential of UL49 was examined under 
different conditions. Fig. 4.3.1 shows the effects of a variety of buffer conditions on 
migration of the UL49 protein. The assay was performed using membrane stripped 
virions. As the UL49 protein is a highly abundant protein it could be clearly visualised 
by Coomassie staining as well as by radiolabelling.
An abundant 38 kDa protein, identified previously as the UL49 gene product (Coulter et 
al., 1993), was seen migrating as a sharply defined, heavily staining band in 
unphosphorylated wt virions. Phosphorylating wt virions at 0 M NaCl in 10 mM MgCl2 
and 10 mM Tris-HCl stimulated the 38 kDa protein to migrate as a slightly broader, more 
diffuse band. The 38 kDa protein migrated as an equally diffuse band when the Tris-HCl 
concentration was increased to 50 mM. At 50 mM MgCl2 and 10 mM Tris-HCl, the 38 
kDa protein migrated as a more diffuse band. Incubating wt virions in 50 mM Tris-HCl 
and 50 mM MgCl2 resulted in a diffuse 38 kDa band coupled with the appearance of a 
novel band migrating slightly more slowly than the 38 kDa protein, with an Mr of 
approximately 40 kDa. In all wt virions phosphorylated at 1.5 M NaCl, the 38 kDa 
protein migrated as a sharp, heavily stained band regardless of buffer composition.
Altering the composition of the phosphorylation buffer clearly stimulated changes in the 
migration of the 38 kDa protein. Individually, the effect of increasing MgCl2 
concentration was greater than increasing Tris-HCl concentration, and increasing both 
stimulated the appearance of a novel protein, migrating with an Mr of approximately 40 
kDa. This 40 kDa protein is very likely to be a species of the 38 kDa protein 
demonstrating aberrant migration due to phosphorylation. To determine if the appearance 
of the 40 kDa protein is dependent upon ATP, a series of in vitro phosphorylation assays 
was performed as detailed in Fig. 4.3.2.
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Figure 4.3.1 Coomassie stained gel of wt virions phosphorylated in 
vitro at different buffer concentrations.
Wt virions were purified, treated with NP40 and incubated in the 
indicated phosphorylation buffer at either 0 M or 1.5 M NaCl in the 
presence of 5 mM ATP. The proteins were separated on a 10% 
polyacrylamide gel and visualised by staining with Coomassie Brilliant 
Blue.
Figure 4.3.2 Coomassie stained gels of wt virions phosphorylated in 
vitro at a range of ATP concentrations.
Wt virions were purified, treated with NP40 and incubated in 
phosphorylation buffer (50 mM MgCl2, 50 mM Tris-HCl pH 7.5, 1 mM 
DTT) at either 0 or 1.5 M NaCl in the presence of the indicated 
reaction concentration of ATP. The proteins were separated on a 10% 
polyacrylamide gel and visualised by staining with Coomassie Brilliant 
Blue. Panel 1 shows the virion proteins after phosphorylation at 0 M 
NaCl, panel 2 shows the virion proteins after phosphorylation at 1.5 M 
NaCl.
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Phosphorylating wt virions in a buffer comprising 50 mM MgCl2 and 50 mM Tris-HCl 
pH 7.5 at 0 M NaCl in the presence of 5 mM or 500 pM ATP stimulated the appearance 
of the 40 kDa protein. Incubating wt virions in the presence of 50 pM ATP caused the 38 
kDa protein to migrate as a diffuse band. Migration of the 38 kDa protein in wt virions 
phosphorylated at ATP concentrations of 5 pM or less was indistinguishable from 
unphosphorylated samples. Migration of the 38 kDa protein was unaffected if 
phosphorylated at 1.5 M NaCl, regardless of the ATP concentration.
These data show that altered migration of the 38 kDa protein is dependent upon ATP 
concentration, thus indicating that the effect may be due to phosphorylation. In addition, 
Figs. 4.3.1 and 4.3.2 clearly show that NaCl concentration affected processing of the 38 
kDa protein. To obtain a more detailed picture, a series of in vitro phosphorylation assays 
was performed over a range of NaCl concentrations. The results are shown in Fig. 4.3.3.
The 38 kDa protein migrated aberrantly when incubated at 0 or 0.1 M NaCl in the 
presence of 50 mM MgCl2 and 10 or 50 mM Tris-HCl. In both buffers, NaCl 
concentrations of 0.5 M and above failed to stimulate a change in migration. Thus, it 
appears that altered migration of the 38 kDa protein is highly sensitive to NaCl 
concentration. If phosphorylation caused the aberrant migration, the PK targeting the 38 
kDa protein was inhibited at NaCl concentrations above 0.1 M.
To ensure that the abundant 38 kDa protein under examination was the product of the 
HSV-1 UL49 gene, the assay was repeated using a mutant virus (vUL49del268-301) 
(Leslie, 1996). The mutant encodes a truncated UL49 protein which is missing the C- 
terminal 34 amino acids. The truncated version is under the control of the HCMV IE 
promoter which leads to overexpression of the truncated form. This is preferentially 
packaged into virions at the expense of the wt form (Leslie, 1996). The details and results 
are shown in Fig. 4.3.4.
The strongly staining 38 kDa protein is clearly visible in unphosphorylated wt virions. As 
expected, the 38 kDa protein was completely absent from the unphosphorylated 
vUL49del268-301 profile, and a novel protein of approximately 36 kDa was detected. A 
novel 40 kDa protein was clearly detected in phosphorylated wt virions. The 40 kDa
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Figure 4.3.3 Coomassie stained gels of wt virions phosphorylated in 
vitro at different buffer and NaCl concentrations.
Wt virions were purified, treated with NP40 and incubated in the 
indicated phosphorylation buffer and salt concentration in the presence 
of ATP. The proteins were separated on a 10% polyacrylamide gel and 
visualised by staining with Coomassie Brilliant Blue.
Panel 1 shows the virion proteins after phosphorylation at 50mM 
MgCh, 50mM Tris-HCl pH 7.5 and ImM DTT. Panel 2 shows the 
virion proteins after phosphorylation at 50mM MgCl2 lOmM Tris-HCl 
pH 7.5 and ImM DTT. In all cases a 5 mM ATP reaction concentration 
was used.
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Figure 4.3.4 Coomassie stained gel of showing the migration of the 
UL49 protein in wt and vUL49ep virions.
Wt virions and vUL49de!268-301 were purified, treated with NP40 and 
incubated in phosphorylation buffer (50 mM Tris-HCl pH 7.5, 50 mM 
MgCh and 1 mM DTT) at 0 M NaCl in the presence of a 5 mM ATP 
reaction concentration. The proteins were separated on a 10% 
polyacrylamide gel and visualised by staining with Coomassie Brilliant 
Blue.
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protein, or any novel, slowly migrating proteins, are absent from the phosphorylated 
vUL49del268-301 virions, although the 36 kDa protein does appear to migrate as a 
slightly broader band.
Comparing the wt and vUL49del268-301 profiles, it is clear that the 38 kDa protein is 
encoded by gene UL49. Phosphorylated wt virions showed the expected protein profile, 
with a novel 40 kDa protein migrating slightly slower than the 38 kDa protein. Previous 
data (Figs. 4.3.1, 4.3.2 and 4.3.3) indicate that this protein may be a hyperphosphorylated 
form of the UL49 protein. Since a more slowly migrating form of the UL49 protein was 
not apparent in phosphorylated vUL49del268-301 virions, it is possible that the UL49 
protein is phosphorylated in the C-terminal 34 amino acids. If hyperphosphorylation of 
the UL49 protein is indeed occurring it is unclear whether a cellular or viral PK is 
responsible, although a requirement for low NaCl concentrations implies that a cellular 
PK is more likely. To elucidate this, additional characterisation of the putative PK 
activity was necessary. Fig. 4.3.5 shows the effect of incubating wt virions in the 
presence of ATP, GTP, UTP or CTP.
Unexpectedly, all four NTPs stimulated the UL49 protein to migrate as a smeared band, 
ATP and CTP more noticeably than GTP or UTP. This result is unexpected because, 
although some PKs are known to utilise ATP or GTP as phosphate donor, utilisation of 
UTP and CTP is unusual.
Thus far, the data show that under certain conditions the 38 kDa protein, encoded by 
gene UL49, could be stimulated to migrate with a higher apparent Mr. Because this 
occurred under phosphorylating conditions and was ATP-dependent, it was attributed at 
first to hyperphosphorylation. However, aberrant migration of the UL49 protein was 
stimulated by all four NTPs, a feature not previously reported for a PK. An NTP- 
dependent candidate processing event other than phosphorylation, nucleotidylylation, has 
been reported for the UL49 protein (Blaho et al., 1994). However, phosphorylation 
cannot be ruled out, since reports have demonstrated PKs which utilise TTP as a 
phosphate donor (Nghiem et al., 2000).
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Figure 4.3.5 Coomassie stained gel showing the effect of a variety of 
dNTPs on migration of the UL49 protein derived from wt virions.
Wt virions were purified, treated with NP40 and incubated in 
phosphorylation buffer (50 mM MgC12, 50 mM Tris-HCl pH 7.5, 1 mM 
DTT) at 0 M NaCl in the presence of 5 mM ATP, GTP, UTP or CTP. The 
proteins were separated on a 10% polyacrylamide gel and visualised by 
staining with Coomassie Brilliant Blue.
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Figure 4.3.6 Autoradiograph showing the in vitro phosphorylation 
profile of the UL49 protein upon incubation in 50 mM MgCl2 and 50 
mM Tris-HCl phosphorylation buffer.
Aliquots of detergent stripped wt virions were incubated at 37°C and the 
indicated NaCl concentration in the presence of [y-32P]ATP. After 30 
min incubation, half the sample was added to PBM and boiled. The 
remaining half was incubated for a further 30 min in the presence of 5 
mM unlabelled ATP. Proteins were separated on a 9% polyacrylamide 
gel, and the radiolabelled proteins visualised by exposure to X-ray film.
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Figure 4.3.7 Coomassie stained gel showing the effect of X-protein 
phosphatase and heparin on migration of the UL49 protein.
Aliquots of detergent stripped wt virions were incubated at 37°C in 50 
mM MgCl2, 50 mM Tris-HCl pH 7.5 and 5 mM ATP. In addition 
sample 4 was incubated with 50 pg/ml heparin. After 30 min incubation 
PBM was added to samples 1, 2 and 4, and 1 |il (400 units) ?i-PPase was 
added to sample 2 and the sample incubated for 30 min at 30°C. Proteins 
were separated on a 10% polyacrylamide gel, and the proteins visualised 
by staining with Coomassie Brilliant Blue.
Results Chapter 4.3
When wt virions were radiolabelled and chased with unlabelled ATP at 50 mM MgCl2 
and 50 mM Tris-HCl pH 7.5 radiolabelled proteins were detected as shown in Fig. 4.3.6. 
In both unchased and chased samples, phosphorylation of the 38 kDa protein diminished 
as NaCl concentration increased. In the chased samples, the 38 kDa protein migrated as a 
diffuse band at 0 M NaCl, as seen in Fig. 4.3.1. The migration of the 38 kDa protein was 
reduced at 0.5 and 1.5 M NaCl, and a novel band appeared with an approximate Mr of 44 
kDa. Clearly, the abberant migration of the UL49 protein is stimulated at high NaCl 
concentrations. To determine which post-translational event was responsible for the 
aberrant migration of the UL49 protein, membrane-stripped wt virions were incubated at 
50 mM MgCl2 and 50 mM Tris-HCl pH 7.5 and were then treated with X-protein 
phosphatase (X-PPase). An additional sample was incubated in 50 mM MgCl2 and 50 
mM Tris-HCl in the presence of 50 |ig/ml heparin which inhibits CK II activity (Mitchell 
et al., 1994). The results are shown in Fig. 4.3.7.
In Fig. 4.3.7 the UL49 protein clearly migrated aberrantly when incubated with ATP, a 
phenomenon attributed to either nucleotidylylation or phosphorylation. However, 
migration of the UL49 protein in the sample incubated with X-PPase is almost 
indistinguishable from the unphosphorylated UL49 protein. In the sample incubated with 
ATP and heparin, the UL49 protein migrated as a band which was slightly less diffuse 
than in the absence of heparin.
These data clearly indicate that the UL49 protein is hyperphosphorylated when incubated 
with ATP in a buffer comprising 50 mM MgCl2 and 50 mM Tris-HCl, and that 
hyperphosphorylation is the major cause of aberrant migration. However, 
nucleotidylylation cannot be entirely excluded. Mitchell et al. (1994) showed that CKII 
was capable of nucleotidylylating proteins. The buffer used by Mitchell et al. (1994) was 
similar to the phosphorylation buffer used in this study, and nucleotidylylation was 
observed to occur in the absence of NaCl, with the nucleotidylylating activity inhibited 
by heparin. Phosphorylation of the UL49 protein to this level has not been previously 
reported, but it is known to be nucleotidylylated. As such the aberrant migration 
stimulated under these conditions could be a result of both types of post-translational 
modification.
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4.4 Dependence of phosphorylation of the UL13 protein on cell type
The highly phosphorylated 57 kDa protein present in wt CNE is encoded by UL13, a 
gene which had previously been predicted to encode a PK (Section 1.3.3.1). The 38 kDa 
phosphoprotein, encoded by gene UL49, demonstrated a considerable reduction in 
phosphorylation in UL13 mutant CNE (Fig. 4.1.1). This protein was therefore considered 
a target for phosphorylation by the putative UL13 PK. Nevertheless, the 38 kDa protein 
is still phosphorylated in UL13 mutant CNE, indicating that it is targeted by a second 
PK, most probably of cellular origin.
Hyperphosphorylation of the UL13 protein occurred in wt CNE phosphorylated in the 
presence of 5 |iM ATP or 5 mM GTP (Figs. 4.2.7 and 4.2.8), but not in virions incubated 
under the same conditions (Fig. 4.4.3). It was hypothesised that hyperphosphorylation 
could be orchestrated by a second PK, possibly of cellular origin. Thus far all assays had 
been performed on CNE prepared from infected MeWo cells. If cellular PKs target the 
UL13 or UL49 proteins, it is possible that phosphorylation profiles may differ between 
cell lines. To test this hypothesis, a line of rabbit skin cells (RSCs) was infected with wt 
or UL13-/acZ virus and aliquots of CNE were phosphorylated in vitro.
Fig. 4.4.1 shows the phosphorylation profiles of wt and UL13-/acZ RSC CNE 
phosphorylated at a variety of NaCl concentrations, with each sample phosphorylated in 
duplicate. A highly radiolabelled 57 kDa phosphoprotein was clearly detected in wt 
CNE, demonstrating a small increase in phosphorylation as NaCl concentration 
increased. A 38 kDa phosphoprotein was poorly phosphorylated at 0 M NaCl, with 
phosphorylation increasing slightly at higher NaCl concentration. In UL13-ZacZ CNE a 
phosphoprotein of approximately 57 kDa was detected. However, phosphorylation of this 
protein was greatly reduced compared to wt CNE. Radiolabelling of the 38 kDa 
phosphoprotein was also reduced in the UL13-/acZ CNE.
Clearly there are differences between the phosphorylation profiles of wt and UL13-lacZ 
CNE prepared from RSC and MeWo cells (Fig. 4.1.1). Phosphorylation of the 38 kDa 
protein was reduced in UL13-/acZ CNE from both cell lines. However, unlike MeWo 
CNE, UL13-/acZ RSC CNE contained a 57 kDa phosphoprotein, albeit with greatly
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Figure 4.4.1 Autoradiographs showing in vitro phosphorylation 
profiles of wt and UL13-infected RSC CNE.
Rabbit skin cells (RSC) were infected with wt or UL13-/<zcZ mutant 
virus for 5 h at 37°C. CNEs were prepared and incubated in duplicate in 
the presence of [y-32P]ATP over a range of NaCl concentrations. The 
proteins were separated on 9% polyacrylamide gels and visualised by 
exposure to X-ray film. Panel 1 shows wt CNE and panel 2 shows 
UL13-/acZ CNE.
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reduced radiolabelling compared to wt CNE. Mass spectrometric analysis showed that 
this protein is probably vimentin, an abundant cytoskeletal phosphoprotein (data not 
shown).
Figure 4.4.2 shows the results of chasing radiolabelled wt RSC CNE with unlabelled 
ATP at a variety of NaCl concentrations. In unchased wt CNE, the 57 and 38 kDa 
phosphoproteins were detected at all NaCl concentrations assayed, with the 57 kDa 
protein much more highly phosphorylated. However, in chased wt CNE the 57 and 38 
kDa proteins exhibited reduced radiolabelling, with the greatest reduction at 1.5 M NaCl. 
The ATP chase also stimulated phosphorylation of the 62 kDa protein at all NaCl 
concentrations, most noticeably at 1.5 M NaCl concentrations. The 62 kDa 
phosphoprotein in RSC CNE was not as highly radiolabelled as in MeWo CNE (see Fig. 
4.2.1).
These observations are summarised in Fig. 4.4.3, in which the unchased and chased 
phosphorylation profiles of infected MeWo CNE, RSC CNE and virions are compared. 
Both infected MeWo CNE and RSC CNE demonstrated a 62 kDa phosphoprotein in 
chased samples, but this phosphoprotein was much more highly radiolabelled in the 
former. In addition, radiolabelling increased with NaCl concentration in MeWo CNE, 
while it remained reasonably constant in chased RSC CNE. Neither the 57 nor 62 kDa 
phosphoproteins was visible in chased wt virions.
Production of the 57 and 62 kDa phosphoproteins differed in wMnfected MeWo and 
RSC CNEs under chased and unchased conditions. Assuming that the 62 kDa in RSC 
CNE represents the hyperphosphorylated UL13 protein, its production may have been 
less efficient in RSC CNE. To test this, a series of chase assays were performed using 
varying concentrations of unlabelled ATP chase. The results are shown in figure 4.4.4.
Fig. 4.4.4 demonstrates that a highly radiolabelled 57 kDa phosphoprotein was present at 
all ATP chase concentrations tested. A radiolabelled 62 kDa phosphoprotein is seen at 
ATP chase concentrations of 500 |iM  and higher, while a third radiolabelled 
phosphoprotein, migrating between the 57 and 62 kDa phosphoproteins was visible when
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Figure 4.4.2 Autoradiograph showing the effect of an unlabelled 
ATP chase on radiolabelled ntf-infected RSC CNE at a variety of 
NaCl concentrations.
Aliquots of wt infected RSC CNE were incubated at 37°C at the 
indicated NaCl concentration in the presence of [y-32P] ATP. After 30 
min incubation half of each sample was added to PBM and boiled. The 
remaining half was incubated for a further 30 min in the presence of 5 
mM unlabelled ATP. Proteins were separated on a 9% polyacrylamide 
gel and visualised by exposure to X-ray film.
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Figure 4.4.3 Autoradiograph comparing the effects of an unlabelled 
ATP chase on radiolabelled wt -infected MeWo CNE, RSC CNE and 
wt virions.
Aliquots of wt infected MeWo and RSC infected CNE and detergent 
stripped wt virions were incubated at 37°C and 1.5 M NaCl in the 
presence of [y-32P]ATP. After 30 min incubation, half of each sample 
was added to PBM and boiled. The remaining half was incubated for a 
further 30 min in the presence of 5 mM unlabelled ATP. Proteins were 
separated on a 9% polyacrylamide gel and visualised by exposure to X- 
ray film.
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Figure 4.4.4 Autoradiograph showing the effect of various 
unlabelled ATP chase concentrations on radiolabelled wf-infected 
RSC CNE.
Aliquots of wt infected RSC CNE were incubated at 37°C and 1.5 M 
NaCl in the presence of [y-32P] ATP. After 30 min incubation 1 pi of 
unlabelled ATP was added to give the indicated reaction concentration. 
Proteins were separated on a 9% polyacrylamide gel and visualised by 
exposure to X-ray film.
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a 50 jliM  chase was added. CNE samples incubated with ATP chase concentratios of 5 
jiM  and below are indistinguishable from unchased samples.
These data prove that phosphorylation of the 62 kDa protein in RSC CNE is dependent 
upon ATP concentration, similar to MeWo CNE. In MeWo CNE the 62 kDa protein was 
shown to be a hyperphosphorylated form of the UL13 protein, and this is likely also to be 
the case for the 62 kDa phosphoprotein in RSC CNE. The minimum ATP chase 
concentration required to stimulate hyperphosphorylation of the UL13 protein in MeWo 
CNE was 5 JiM and 500 |iM  in RSC CNE. The 100-fold difference could reflect 
differences in cellular PKs. Cellular PKs are more sensitive to heparin inhibition than 
viral PKs, and, to test whether cellular PKs target the UL13 PK, a series of in vitro 
phosphorylation assays were performed on wt MeWo CNE in the presence of 100 (Xg/ml 
heparin as detailed in Fig. 4.4.5.
As expected, both the 57 and 38 kDa phosphoproteins appeared in wt CNE, whereas the 
57 kDa phosphoprotein is totally absent from UL13-lacZ CNE and radiolabelling of the 
38 kDa phosphoprotein was greatly reduced. Heparin appeared only to inhibit protein 
phosphorylation at 0 M NaCl, with a slight reduction in phosphorylation of the 38 kDa 
protein in wt CNE and almost total abolition of phosphorylation of the 38 kDa protein in 
UL13-/acZ CNE. Phosphorylation of the 57 kDa protein appeared unaffected by heparin. 
These data show that the 38 kDa protein is targeted by a heparin-sensitive PK, most 
probably of cellular origin. Production of the 57 kDa phosphoprotein was unaffected by 
heparin, consistent with autophosphorylation.
The heparin inhibition assay was repeated using unchased and chased RSC CNE as 
detailed in Fig. 4.4.6. Chase assays were performed on wt CNE samples at 0 and 1.5 M 
NaCl in the presence of various concentrations of heparin. While there was a general 
reduction in labelling as heparin concentration increased, neither phosphorylation nor 
hyperphosphorylation of the UL13 protein appeared to be specifically affected.
While heparin inhibits many cellular PKs, there are a number of potent inhibitors to 
specific PKs. CKII has been implicated in the phosphorylation of several viral proteins, 
and has also been shown to phosphorylate proteins thought to be targeted by UL13. 5,6-
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Figure 4.4.5 Autoradiograph showing an in vitro assay for heparin 
sensitivity of phosphorylation of the UL13 and UL49 proteins.
Aliquots of wt or UL13-lacZ infected MeWo cell CNE were incubated 
at 37°C and the indicated NaCl concentration in the presence of [y-
32P]ATP. Where indicated 100 pg/ml heparin (reaction concentration) 
was included in the reaction. Proteins were separated on a 9% 
polyacrylamide gel and visualised by exposure to X-ray film.
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Figure 4.4.6 Autoradiograph showing an in vitro assay for heparin 
sensitivity of the unlabelled ATP chase.
Aliquots of wt infected RSC CNE were incubated at 37°C and the 
indicated NaCl concentration in the presence of [y-32P]ATP. The 
indicated reaction concentration of heparin was included where 
incubated. After 30 min incubation, half of each sample was added to 
PBM and boiled. The remaining half was incubated for a further 30 min 
in the presence of 5 mM unlabelled ATP. Proteins were separated on a 
9% polyacrylamide gel and visualised by exposure to X-ray film. Panel 
1 shows samples incubated at 0 M NaCl, panel 2 shows samples 
incubated at 1.5 M NaCl.
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Figure 4.4.7 Autoradiograph showing an in vitro assay to determine 
the effect of 5, 6-dichloro-l-(3-D-ribofuranosylbenzimidazole (DRB) 
on the phosphorylation profile of MeWo CNE.
Aliquots of wt infected MeWo cell CNE were incubated at 37°C and 0 
M NaCl in the presence of [y-32P]ATP. Where indicated 100 mM DRB 
(reaction concentration) was included. After a 30 min incubation, half 
of each sample was added to PBM and boiled. The remaining half was 
incubated for a further 30 min in the presence of 5 mM unlabelled 
ATP. Proteins were separated on a 9% polyacrylamide gel and 
visualised by exposure to X-ray film.
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dichloro-l-p-D-ribofuranosylbenzimidazole (DRB) is a known inhibitor of CKII activity 
(Zandomeni et al., 1986; Zandomeni, 1989). Fig. 4.4.7. shows the effect of DRB on 
hyperphosphorylation of the UL13 protein in wt MeWo CNE at 0 M NaCl. Earlier data 
showed that incubation in 50 mM MgCl2, 50 mM Tris-HCl caused retardation of the 
UL49 protein on SDS-PAGE which was attributed to hyperphosphorylation. The 
experiment was performed under these conditions to examine the effect of DRB on 
migration of the UL13 and UL49 proteins.
DRB slightly inhibited phosphorylation of the 38 kDa protein in unchased wt CNE, and 
phosphorylation of the 57 kDa protein was largely unaffected. In the chased samples, 
DRB caused a slight reduction in phosphorylation of the 38 kDa protein, but completely 
inhibited production of the 62 kDa protein. These results indicate that at low NaCl 
concentrations the UL13 protein is phosphorylated by cellular CKII. Although it affected 
the level of phosphorylation slightly, DRB did not alter the migration of the UL49 
protein. If the UL49 protein is phosphorylated by CKII there may be other cellular PKs 
also targeting the protein. This would agree with the identification of both CKII and PKC 
consensus motifs in the N-terminal portion of the UL49 protein (Elliott et al., 1996).
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4.5 Mapping sites of phosphorylation
The initial intention of this research project was to identify the sites of phosphorylation 
within the UL13 PK and its target protein UL49. A variety of techniques were employed, 
but a number of problems arose which will be discussed.
Previous data (Fig. 4.1.1) showed the UL13 and UL49 proteins were the most highly 
radiolabelled proteins in in vitro phosphorylated wt infected MeWo cell CNE. The 
phosphorylated peptides produced by proteolytic cleavage of either protein should be 
highly radiolabelled, and thus easily detected in a gross digest of phosphorylated MeWo 
CNE samples. Fig. 4.5.1 shows a gross proteolytic digest of phosphorylated wt and 
UL13-/<acZ infected MeWo CNE. The CNE samples were phosphorylated at 1.5 M NaCl 
as detailed in section 4.1, and boiled for 5 minutes to denature the proteins prior to 
adding the endoproteinase. Three endoproteinases were used, Glu-C (S. aureus V8  
protease), Lys-C and Arg-C (clostripain), which cleave at the carboxylic side of glutamic 
acid, lysine and arginine respectively.
Arg-C stimulated little change in the phosphorylation profiles of either wt or UL13-/acZ 
CNE, whereas incubating wt CNE with Glu-C produced two weakly radiolabelled 
peptides of 21.5 and 6.5 kDa. The 21.5 kDa phosphopeptide was also detected in Glu-C 
digested UL13-/acZ CNE, albeit with reduced radiolabelling, but the 6.5 kDa peptide was 
absent. Three highly radiolabelled peptides of approximately 24, 15 and 12.5 kDa were 
detected in Lys-C digested wt CNE, but only a weakly phosphorylated 24 kDa peptide 
was detected in Lys-C digested UL13-lacZ CNE.
This preliminary digest showed that Arg-C and Glu-C failed to digest the protein samples 
completely, in contrast to Lys-C. The 12.5 and 15 kDa Lys-C peptides were probably 
derived from either UL13 or UL49, and the 24 kDa Lys-C peptide could represent a 
UL49 peptide phosphorylated by a PK other than UL13. Despite repeated attempts, 
neither Glu-C nor Arg-C digested the input CNE efficiently. However, the experiment 
was repeated using Lys-C with a broader sample range. Fig. 4.5.2 shows the 
phosphopeptide profiles derived from Lys-C digestions of wt and UL13-/acZ CNE
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Figure 4.5.1 Autoradiograph showing the phosphopeptide profiles of 
in vitro phosphorylated wt and UL13-/acZ CNE.
MeWo cells were infected with wt or UL13-/acZ mutant virus for 5 h at 
37°C. Nuclear extracts were prepared and incubated with [y-32P]ATP at
1.5 M NaCl. After 30 min incubation the samples were boiled for 5 min 
to denature the proteins and 1 p i of the indicated protease (10 pg/ml) 
was added to each sample and incubated for a further 30 min. The 
proteins were separated on an 18% polyacrylamide gel and visualised by 
exposure to X-ray film.
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phosphorylated at two different NaCl concentrations with or without an unlabelled ATP 
chase.
A highly radiolabelled 12 kDa phosphopeptide was detected in all wt CNE samples, 
regardless of the NaCl concentration or use of an ATP chase. A 15 kDa phosphopeptide 
was detected only in unchased wt CNE phosphorylated at 1.5 M NaCl. A 18.5 kDa 
phosphopeptide was detected in chased wt CNE phosphorylated at both NaCl 
concentrations, and a 21 kDa phosphopeptide was detected only in chased wt CNE 
phosphorylated at 1.5M NaCl. All of these peptides were absent from UL13-/acZ CNE.
Interpretation of these results is difficult, not least because phosphorylated peptides 
migrate with an artificially high Mr. However, some of the phosphorylated peptides can 
be tentatively identified. The UL13 protein was shown to be hyperphosphorylated in the 
presence of excess ATP or GTP (see Fig. 4.2.1). It seems reasonable to suggest that the
18.5 kDa phosphopeptide, seen only in chased wt CNE, represents the 
hyperphosphorylated UL13 peptide. The 12 kDa phosphopeptide was highly 
phosphorylated at both NaCl concentrations, with a slight reduction in phosphorylation in 
chased wt CNE, suggesting that it is derived from the hypophosphorylated UL13 protein. 
Even if these peptides are correctly identified, it is not known whether the 18.5 kDa 
peptide is a hyperphosphorylated form of the 12 kDa peptide or a separate peptide from a 
different region of the UL13 protein. The 15 kDa phosphopeptide may be derived from 
the UL49 protein phosphorylated at 1.5 M NaCl since it is present in UL13-/acZ CNE. 
The 21 kDa phosphopeptide is unlikely to be derived from the UL49 protein, since the 
UL49 protein was not hyperphosphorylated under these buffer conditions, and thus may 
be an additional UL13 peptide.
4.5.1 Phosphorylation of the UL49 protein
Gross digestion of labelled CNE provided a limited approach to identifying the 
phosphorylated peptides within UL13 and UL49. A more useful approach would require 
the isolation of each protein followed by individual digestion. To this end, an in-gel 
proteolytic digestion system was adopted. This involves isolating individual proteins by 
SDS-PAGE, excising each in a gel slice, and infusing the gel slice with the selected 
proteolytic enzyme in the relevant buffer. The gel slice was incubated overnight, and
97
wt MeWo CNE UL13-lacZ CNE
220 kDa 
66 kDa
U L 1 3 -  
46 kDa
U L 4 9 -
30 kDa
23 kDa — 
21 kD a— 
18.5 kDa — 
15 kDa — 
14.3 kDa
12 kD a—
6.5 kDa
3.4 kDa 
2.35 kDa
[NaCl] 0 1.5 0 1.5 0 1.5 0 1.5 0 1.5 0 1.5 0 15 0 1.5 M
Unlabelled - - +  +  - - +  +  +
ATP chase
Lys-C - - -  - +  +  +  + -  _ . _ + +  +  +
Figure 4.5.2 Autoradiograph showing the phosphopeptide profiles 
of chased and unchased wt and UL13-/acZ CNE phosphorylated at 
a variety of NaCl concentrations.
MeWo cells were infected with wt or UL13-/acZ mutant virus for 5 h at 
37°C. Nuclear extracts were prepared and incubated with [y-32P]ATP at 
0 M or 1.5 M NaCl. After 30 min half the sample was removed and the 
reaction stopped by boiling in PBM. The remaining half was incubated 
for a further 30 min in the presence of 5 mM unlabelled ATP. After the 
labelling and chase reactions, 1 pi of Lys-C (10 pg/ml) was added to 
each sample and incubated for a further 30 min. The proteins were 
separated on an 18% polyacrylamide gel and visualised by exposure to 
X-ray film.
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peptides were eluted from the gel slice by sequential washes with 25 mM NH4H C03, 5% 
formic acid and acetonitrile. The eluted peptides were dried in vacuo, resuspended in 
protein loading buffer and analysed by electrophoresis on 16.5% Tris-Tricine 
polyacrylamide gels. To maximise peptide resolution, the dye front was electrophoresed 
off the bottom of the gel. To examine the efficiency of this technique, UL49 protein 
isolated from in vitro phosphorylated wt virions was digested with various concentrations 
of Arg-C, Glu-C, Lys-C or trypsin, the latter cleaving after most Lys and Arg residues. 
The results are shown in Fig. 4.5.3.
Trypsin produced the same phosphopeptide profile when used at 12.5 |ig/ml or 1.25 
|ig/ml, whereas 125 ng/ml gave partial digests, and 12.5 ng/ml did not yield detectable 
peptide fragments. Glu-C treatment appeared to produce only partially digested peptides, 
even at 12.5 (ig/ml. A highly radiolabelled peptide was detected when Arg-C was used at 
125 ng/ml, but higher or lower concentrations of the enzyme resulted in reduced yields. 
Lys-C produced a weakly labelled phosphopeptide profile at all dilutions except at 12.5 
ng/ml, where no peptides were detected.
This experiment identified trypsin as potentially the most useful enzyme for in-gel 
digestion, while Glu-C appeared to be the least effective. On the basis of these data, 12.5 
|ig/ml trypsin was used to examine the phosphopeptide profile of the UL49 protein 
derived from wt virions phosphorylated over a range of NaCl concentrations. The results 
are shown in Fig. 4.5.4.
UL49 repeatedly yielded a single labelled tryptic band regardless of the NaCl 
concentration at which the protein was phosphorylated. The phosphopeptide migrated 
with an approximate Mr of 2 kDa, but it is difficult to determine its actual size because 
phosphorylated peptides migrate aberrantly on SDS-PAGE. As with native UL49 protein 
(Fig. 4.1.1) radiolabelling of the peptide peaked at 0.5 M NaCl, but was reduced at 1.5 M 
NaCl. This could indicate that phosphorylation of the UL49 protein is restricted to 
residues within the 2 kDa phosphopeptide. However, this is unlikely since the UL49 
protein was still highly phosphorylated at 1.5 M NaCl, whereas the 1.5 M NaCl peptide 
was poorly phosphorylated. Although a single labelled band was detected, this could 
contain more than one peptide, and other phosphorylation sites may be located on
98
46 kDa 
30 kDa
21.5 kDa 
14.3 kDa
6.5 kDa
3.4 kDa
2.5 kDa m '  0m
Glu-CArg-C Lys-C
~V" 
Trypsin
Figure 4.5.3 Autoradiograph showing phosphopeptide profiles of 
the UL49 protein digested with various concentrations of selected 
proteolytic enzymes.
Wt virions were purified, treated with NP40 and incubated at 0 M NaCl 
in the presence of [y-32P]ATP. The proteins were separated on a 9% 
polyacrylamide gel and visualised by staining with Coomassie brilliant 
blue and exposure to X-ray film. UL49 was excised and digested in-gel 
using the following concentrations of each enzyme: 1, 12.5 pg/ml; 2, 
1.25 jLig/ml; 3, 125 ng/ml; 4, 12.5 ng/ml. The peptides were separated 
on a 16.5% Tris-Tricine polyacrylamide gel and visualised by exposure 
to a phosphorimaging plate.
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Figure 4.5.4 Autoradiograph showing the tryptic 
phosphopeptide profile of the UL49 protein from in vitro 
phosphorylated wt virions.
Wt virions were purified, treated with NP40 and incubated at 
the indicated salt concentration in the presence of [y -32P]ATP. 
The protein were separated on a 9% polyacylamide gel and 
visualised by staining with Coomassie brilliant blue and 
exposure to X-ray film. UL49 was excised and digested in-gel 
using 12.5 |ig/ml trypsin. The peptides were separated on a 
16.5% Tris-Tricine polyacrylamide gel, which was 
electrophoresed until the dye front was off the bottom of the 
gel. Phosphopeptides were visualised by exposure to X-ray 
film.
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peptides too small to be resolved using a gel-based method. A similar experiment was 
performed using UL49 protein isolated from phosphorylated wt HSV-1 infected RSC 
CNE rather than virions. The protein was digested with 12.5 p,g/ml trypsin, Arg-C and 
Lys-C, and the results are shown in Fig. 4.5.5.
Both Arg-C and Lys-C produced what appeared to be a series of partial digests, with the 
smallest Arg-C phosphopeptide demonstrating an Mr of approximately 2 kDa and the 
smallest Lys-C phosphopeptide approximately 3 kDa. The tryptic phosphopeptide 
migrated with an Mr of approximately 2 kDa. While the tryptic phosphopeptide from 
RSC CNE corresponded in size with the phosphopeptide derived from wt virions, the 
assay would need to be repeated using a variety of NaCl concentrations to confirm 
whether UL49 is phosphorylated on the same residues in virions and infected RSC CNE. 
Arg-C and Lys-C probably gave partial digests, as such the phosphorylation profiles are 
difficult to interpret. However, it is noteworthy that the smallest Arg-C peptide was the 
same size as the tryptic peptide. This would indicate that the peptide is flanked at its N- 
and C-termini by Arg residues. This is not unexpected, however, since the UL49 protein 
is richer in Arg residues than in Lys residues.
Liao et al. (1994) described an alternative approach for locating phosphorylation sites 
which used matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry 
(MALDI-TOF-MS). The protocol involves degradation of the phosphoprotein into 
peptides by specific enzymatic or chemical reactions, followed by identification of the 
phosphopeptides by 80 (or multiple of 80)-Da mass shifts in certain peptides after 
phosphorylation or dephosphorylation.
Both wt HSV-1 virions and the HSV-1 mutant which produced a truncated form of the 
UL49 protein (vUL49del268-301) were analysed using this method. Purified wt HSV-1 
and vUL49del268-301 virions were dephosphorylated or phosphorylated at 0 or 1.5 M 
NaCl. The proteins were separated by SDS-PAGE, blotted onto PVDF membrane and 
visualised by staining with sulforhodamine. The UL49 bands were excised (see Fig. 
4.5.6) and subjected to proteolytic digestion using trypsin. The resulting peptides were 
identified using MALDI-TOF-MS. An example of the spectra obtained are shown in 
Figs. 4.5.7 to 4.5.13.
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Figure 4.5.5 Autoradiograph showing the phosphopeptide 
profiles of the UL49 protein from in vitro phosphorylated 
wt RSC CNE.
Wt RSC cell CNE were prepared and incubated with [y- 
32P]ATP at 1.5 M NaCl. Radiolabelled UL49 protein was 
isolated on a 9% polyacylamide gel and excised. In-gel 
proteolytic digestion was performed using 12.5 pg/ml trypsin, 
Arg-C or Lys-C and the peptides separated on 16.5% Tris- 
Tricine SDS-PAGE, the phosphorylated fragments were 
visualised by exposure to X-ray film
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Figure 4.5.6 Coomassie stained gel showing the phosphorylation 
induced alteration in migration of the UL49 protein
Membrane stripped virions were phosphorylated in vitro in either 0 M or
1.5 M NaCl in the presence of 5 mM ATP. The proteins were separated 
on a 10% polyacrylamide gel, excised, digested using trypsin and 
subjected to mass spectrometric analysis. The marked proteins were 
analysed. UL49 UB refers to the slowly migrating “upper band,” UL49 
LB refers to the faster migrating “lower band.” The mutant UL49 protein
lacking the C-terminal 28 amino acids is shown as UL49ep.
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Figure 4.5.7 Mass spectrometric analysis of the UL49 protein from 
phosphatase treated wt virions
A mass spectrum generated from analysis of dephosphorylated UL49 
protein . All the masses represent the protonated forms. The 3496.9 peak 
is the insulin B chain marker used to calibrate the spectrum.
39.0
1423.3
38.0-
37.0-
36.5-
36.0-
35.5-
35.0-
2037.1
2099.934.5- 1705.1
801.61
1556.534.0-
3496.966.I
33.5- 3094.4
9.61
i 1031.
3287.41942,
33.0-
3817.8
31.5-
31.0-
3400 3800 4200 460030001000 1200 1400 1600 1800 2200 2600800
(mfe)
Figure 4.5.8 Mass spectrometric analysis of the UL49 protein from wt 
virions phosphorylated at 0 M NaCl
A mass spectrum generated from analysis of UL49 LB (see Fig. 4.5.6). 
All the masses represent the protonated forms. The 3496.9 peak is the 
insulin B chain marker used to calibrate the spectrum.
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Figure 4.5.9 Mass spectrometric analysis of the UL49 protein from wt 
virions phosphorylated at 0 M NaCl
A mass spectrum generated from analysis of UL49 UB (see Fig. 4.5.6). 
All the masses represent the protonated forms. The 3496.9 peak is the 
insulin B chain marker used to calibrate the spectrum.
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Figure 4.5.10 Mass spectrometric analysis of the UL49 protein from 
wt virions phosphorylated at 1.5 M NaCl
A mass spectrum generated from analysis of UL49 protein. All the 
masses represent the protonated forms. The 3496.9 peak is the insulin B 
chain marker used to calibrate the spectrum.
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Figure 4.5.11 Mass spectrometric analysis of the UL49ep protein 
from phosphatase treated vUL49ep virions
A mass spectrum generated from analysis of dephosphorylated UL49ep. 
All the masses represent the protonated forms. The 3496.9 peak is the 
insulin B chain marker used to calibrate the spectrum.
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Figure 4.5.12 Mass spectrometric analysis of the UL49ep protein
from vUL49ep virions phosphorylated at 0 M NaCl
A mass spectrum generated from analysis of UL49ep protein (see Fig. 
4.5.6). All the masses represent the protonated forms. The 3496.9 peak is 
the insulin B chain marker used to calibrate the spectrum.
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Figure 4.5.13 Mass spectrometric analysis of the UL49ep protein
from vUL49ep virions phosphorylated at 1.5 M NaCl
A mass spectrum generated from analysis of UL49ep protein. All the 
masses represent the protonated forms. The 3496.9 peak is the insulin B 
chain marker used to calibrate the spectrum.
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Only one peptide reproducibly demonstrated an 80-Da mass shift. The 1786.6 Da 
peptide, possibly corresponding to a phosphorylated form of the 1705.6 Da peptide, was 
detected in wt UL49 phosphorylated at 1.5 M (Fig. 4.5.10) but was absent from all other 
samples. Although this peptide corresponds roughly in size with the radiolabelled 
phosphopeptide detected in Figs. 4.5.4 and 4.5.5, the 1786.6 Da peptide was detected in 
the UL49 protein phosphorylated at 1.5 M NaCl, while Fig. 4.5.4 shows radiolabelling of 
the phosphopeptide is reduced at 1.5 M NaCl.
34 amino
1424.2 2098.0
Figure 4.5.14 A schematic representation of the 301 residue UL49 protein showing 
the position of the peptides detected in mass spec tra  generated  from  
dephosphorylated UL49.
The N- and C-termini are marked, as are the C-terminal 34 amino acids. The peptides 
detected are shown in blue, and their unphosphorylated masses marked.
The mutant vUL49del268-301 produced a truncated form of the UL49 protein lacking the 
C-terminal 34 amino acids. Indeed, the 1231.5 Da peptide (residues 277-287), situated 
within the C-terminal 34 amino acids (see Fig. 4.5.14), was absent from Figs. 4.5.11 to 
4.5.13. The 1705.6 Da peptide (228-242) is not situated in the C-terminal 34 amino acids 
(see Fig. 4.5.14), and was detected in all UL49del268-301 samples. However, no 
phosphorylated 1705.6 Da peptide was detected in the UL49del268-301 protein at any of 
the NaCl concentrations tested (Figs. 4.5.11 to 4.5.13).
Interpretation of these data is complicated, not least because only a subset of peptides are 
ionised in the mass spectrometer. However, when wt virions or wMnfected RSC CNE 
were phosphorylated in vitro at NaCl concentrations between 0 and 1.0 M, the UL49 
protein was phosphorylated on a tryptic peptide with a Mr of approximately 2 kDa. When 
the UL49 protein was phosphorylated at 1.5 M NaCl, phosphorylation of the 2 kDa 
peptide was reduced and a phosphorylated 1705.6 Da tryptic peptide was detected. This
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interpretation agrees with the established hypothesis that two PKs target the UL49 
protein, one cellular and the other viral (Coulter et al., 1993). It is likely that the UL13 
PK phosphorylates residues within the 1705.6 Da UL49 peptide at 1.5 M NaCl.
4.5.2 Phosphorylation of the UL13 protein
Previous data (Figs. 4.5.1 and 4.5.2) indicated that hypophosphorylated UL13 protein 
was phosphorylated on a 12 kDa Lys-C peptide, and hyperphosphorylated UL13 was 
phosphorylated on both the 12 kDa and an 18.5 kDa peptide. However, these data were 
derived from gross digests of phosphorylated CNE. To confirm these observations, UL13 
phosphopeptides were examined using in-gel digestion. Fig. 4.5.15 shows the 
phosphopeptide profiles obtained from digesting phosphorylated UL13 protein from wf- 
infected RSC CNE with Arg-C and Glu-C.
Digesting the UL13 phosphoprotein with Glu-C produced a single major phosphopeptide 
with an approximate Mr of 11 kDa. Two additional peptides were faintly visible at 14.5 
and 22 kDa, and may represent partial digestion products. The Arg-C digest yielded no 
detectable phosphopeptides, and it is not known whether this was due to failure to digest 
or to the peptides being too small to be detected on the gel. The digestion protocol was 
repeated on UL13 from wMnfected RSC CNE using Glu-C and Lys-C, individually and 
in combination. The results are shown in Fig. 4.5.16.
Digesting the UL13 protein with Glu-C give an 11 kDa peptide, which corresponds in 
size to the Glu-C phosphopeptide in Fig. 4.5.15. Digestion with Lys-C produced four 
strongly phosphorylated peptides with Mrs of approximately 15, 12, 11 and 4.8 kDa. The 
phosphopeptide profile of the Lys-C/Glu-C double digest resembles that of Lys-C, with 
the addition of an 8 . 6  kDa peptide. The two most highly radiolabelled peptides detected 
after digesting hyperphosphorylated UL13 with Lys-C/Glu-C migrated with approximate 
Mrs of 15 and 18.5 kDa.
The phosphopeptide profiles shown in Fig. 4.5.16 were derived from wt HSV-1 infected 
RSC CNE. The Lys-C digests were repeated using wt virions and wt HSV-1 infected 
MeWo cells, phosphorylated at 0 or 1.5 M NaCl (Fig. 4.5.17). Lys-C treatment of UL13 
from phosphorylated wt virions yielded a single phosphopeptide of 12 kDa, regardless of
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Figure 4.5.15 Autoradiograph showing the phosphopeptide profile 
of the UL13 protein from in vitro phosphorylated wt RSC CNE.
Wt RSC CNE were phosphorylated in vitro at 1.5 M NaCl. 
Radiolabelled UL13 protein was isolated on a 9% polyacrylamide gel 
and excised. In-gel proteolytic digestion was performed using 12.5 
pg/ml Arg-C or Glu-C and the fragments separated on a 18% 
polyacrylamide gel. Phosphopeptides were visualised by exposure of 
the wet gel to X-ray film.
21.5 kDa —
18.5 kD a—►
15 kDa —
14.3 kDa —
12 kDa —►
11 kD a—►
10 kDa —
8.6 kD a—►
6.5 kDa
4.8 kD a—► 
3.4 kDa —
Unlabelled +
ATP chase
Figure 4.5.16 Autoradiograph showing the phosphopeptide 
profiles of the UL13 protein from in vitro phosphorylated wt RSC 
CNE.
Wt RSC cell CNE was phosphorylated in vitro at 1.5 M NaCl with or 
without an unlabelled ATP chase. Radiolabelled UL13 protein was 
isolated on a 9% polyacrylamide gel and excised. In-gel proteolytic 
digestion was performed using 12.5 pg/ml Lys-C, Glu-C or a 
combination of both and the fragments were separated on a 16.5% 
Tris-Tricine polyacrylamide gel. Phosphopeptides were visualised by 
exposure of the wet gel to X-ray film.
wt wt
virions MeWo CNE
46 kDa —  
30 kDa —
2 1  kDa —
14.3 kDa —  
1 0  kDa —
6.5 kDa “
[NaCl] 0 1.5 0 1.5 M
Figure 4.5.17 Autoradiograph showing the phosphopeptide 
profile of the UL13 protein from in vitro phosphorylated wt 
virions and wt MeWo CNE.
Wt virion and infected MeWo cell CNE were phosphorylated in 
vitro at either 0 or 1.5 M NaCl. Radiolabelled UL13 protein was 
isolated on a 9% polyacrylamide gel and excised. In-gel 
proteolytic digestion was performed using 12.5 (ig/ml Lys-C and 
the fragments separated on a 16.5% Tris-Tricine polyacrylamide 
gel, the phosphorylated fragments were visualised by exposure to 
X-ray film.
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NaCl concentration. However, in MeWo CNE phosphorylated at 0 M NaCl, Lys-C 
treatment of the UL13 protein yielded four phosphopeptides with Mrs of approximately 
15, 12, 9 and 5 kDa. When the experiment was performed on UL13 phosphorylated at 1.5 
M NaCl, the peptide recovery was reduced, and the strongest radiolabelled 
phosphopeptides migrated with Mrs of 17 and 12 kDa.
Because of the low abundance of the UL13 protein in CNE and virions and because it co­
migrated with an abundant cellular protein, vimentin, it was not possible to generate 
useful mass spectrometric data. An attempt to identify UL13 Lys-C phosphopeptides 
using mass spectrometry and N-terminal amino acid sequencing succeeding only in 
identifying vimentin (data not shown).
Clearly, the 12 kDa Lys-C phosphopeptide, detected in Figs. 4.5.1, 4.5.16 and 4.5.17 is 
derived from the UL13 protein. The 12 kDa Lys-C peptide was the only phosphopeptide 
detected in both cell lines and virions. This could mean that the 12 kDa Lys-C peptide 
contains the residue or residues which form the autophosphorylation domain of the UL13 
PK. A 5 kDa Lys-C phosphopeptide was detected in Figs. 4.5.16 and 4.5.17, but not in 
the gross digests (Figs. 4.5.1 and 4.5.2). In fact, the 5 kDa phosphopeptide was only 
detected when Tris-Tricine gels were used (Fig. 4.5.16 and 4.5.17), reflecting their 
improved resolution compared to Tris-Glycine gels (Fig. 4.5.1) It was concluded that the
18.5 kDa phosphopeptide probably represents the hyperphosphorylated UL13 protein 
(Fig. 4.5.2). This was confirmed in Fig. 4.5.15, where a 18.5 kDa phosphopeptide was 
detected in chased wt RSC CNE but not in unchased samples. Because phosphorylation 
interferes with SDS binding, causing phosphorylated peptides to migrate with aberrantly 
high Mrs peptide identification is difficult. However, it is possible tentatively to identify 
the phosphorylated peptides, and an assessment of peptide identification is given in the 
Discussion.
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5 DISCUSSION
5.1 UL13
5.1.1 UL13 sequence analysis
When Smith & Smith (1989) and Chee et a l (1989) aligned known PKs with UL13 and 
its homologues, they identified a number of conserved PK subdomain motifs. However, 
neither identified all the PK motifs defined by Hanks et al. (1988). The availability of 
UL13 sequence data from additional herpesviruses allows an updated alignment to be 
analysed. Fig. 5.1 shows an alignment of several the sequenced alphaherpesviruses, with 
the PK subdomain motifs marked according to Hanks et a l  (1988).
Motifs I, II, III, VI, IX and XI are well conserved, with all the expected invariant residues 
present. Motif VII retains the invariant Asp but not the Gly, usually considered invariant. 
Motif VIII also diverges from the established pattern, with three of the sequences lacking 
the invariant Glu. Only ILTV displays the prototypical APE sequence, and a further three 
have PPE motifs. Motifs IV, V and X are less well defined (see Table 1.1), and are thus 
harder to identify. The highly conserved Leu/Ala fits the defined consensus sequence of 
motif X. Motif IV shown in Fig. 5.1 was identified by Chee et a l  (1989), but because 
there are no conserved residues within these motifs there are a variety of residues which 
could equally represent motifs IV and V.
As expected, updated alignments of 8  betaherpesvirus and 8  gammaherpesvirus UL13 
homologues (data not shown) show lower conservation of motifs compared to the 
alphaherpesviruses. Importantly, the highly conserved APE motif is barely identifiable in 
the betaherpesvirus alignment and very poorly conserved in the gammaherpesviruses, 
with the invariant Glu missing from all. Although the difficulties in identifying PKs using 
sequence motifs has been highlighted in section 1.3.3.1, there is sufficient conservation of 
PK motifs to support the earlier conclusion by Chee et a l  (1989) and Smith & Smith 
(1989) that UL13 and its homologues encode active PKs. However, because there are 
significant variations in the conservation and position of functionally important amino 
acids residues, the herpesviral PKs represent a significant departure from known PKs.
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Figure 5.1. A multiple sequence alignment of 10 alphaherpesvirus 
UL13 homologues.
Numerals indicate the positions of the sequence motifs indicative of the 
11 PK subdomains (Hanks et aL, 1988). A consensus sequence (con) 
showing fully conserved residues is shown for the catalytic domain.
HSV1 MDESRRQRPAGHVAANLSPQGAR
HSV2 HDE SGRQR PAS HVAADIS PQGAH
EHV1 MARSRRRSSVDEMDVGGSATSEYENCGGPSFSPLNLSRPKKSTRGRSLRSAQAWGGKQLHPERSTPLARNDCGPSSKPRRRHEVGRSNKGLGASLDRTDE 
EHV4 MARSRGRSSVDEMDVGGSTTSEYENCDGPSFSPLNMSCAKKSTKKRSLRSSRIWGGKSSDSEHTPLLTRNSCGPTGNTRRKH.AGISNHKRGASLNHENG 
MDV1 MDTESKNKKTTNGGENS
MDV2 MDLDLKARKPGRGREND
VZV MDAD
BHV1
PRV
ILTV
HSV1 QRSFKDWLASYVHSNPHGASGRPSGPSLQDAAVSRSSHGSRHRSGLRERLRAGLSRWRMSRSSHRRASPETPGTAAKLNRPPLRRSQAALTAPPSSPSHI 
HSV2 RRSFKAWLASYIHSLSRRASGRPSGPSPRDGAVSGARPGSRRRSSFRERLRAGLSRWRVSRSSRRRSSPEAPGPAAKLRRPPLRRSETAMTSPPSPPSHI
EHV1 DTS QCPRIRASAIRCGASTRKIVRITGECDAQQGDSRPGRSEMAGWHSPPKRRRTPSRHGNSDNERSHLPRLSSHGWRVGGRPLTQTPLQKTII
EHV4 DKSFQSGHNCPRIRASAVRCGAATRKIVRITEEGASRQDNIWPGQSGMAGWHSPPKRRRTPSRHGDSNHERSHLSGQPSQSWRVGGRLLTQTPLRKTII 
MDV1 NCSHSTRTPDKSIEERFYNWERRSRTTNRFGTTVNSRSYNMYFQGTHNTSRRHTYGNIHHRRRFSDNIRRCLRQLCMKRKTPAKKRSDKLVSRPSLPEHV
MDV2 ECPHVKWLSDISDQEDFSGPKGYSSTTDD............ LQGTFSAPRRDSCRKKDHKQHISVNIRRCLKQFYRRRKHISRKTSDILLSRPSLPDHI
VZV DTPPNLQISPTAGPLRSHHNTDGHEPNATAADQQERESTNPTHGCVNHPWANPSTATCMESPERSQQTSLFLLKHGLTRDPIHQRERVDVFPQFNKPPWV 
BHV1 MQARRQRRRARLGLPLLSGRDGRPTAPPDPRAGSSAPPLRRARGRRPPRGGCGAAALAASGRRIRATPRADPPREPPAARSRAHIL
PRV MAAGGGGGGVSRAALAHRGTSAPGGAIAAAGGDGDGDEASRLLGRAQP
ILTV MATRKRKSSDATAITTCTKSRQSRELAKNSTDSQSNFSRRRMPSRPPIRRILSNDDGIDLEHIAPVSEDLTKESR
I II III IV? V?
HSV1 LTLTRIRKLCSPVFAINPALHYTTLEIPGARSFGGSGGYGDVQLIREHKLAVKTIKEKEWFAVELIATLLVGECVLRAGRTHNIRGFIAPLGFSLQQRQI 
HSV2 LSLARIHKLCIPVFAVNPALRYTTLEIPGARSFGGSGGYGEVQLIREHKLAVKTIREKEWFAVELVATLLVGECALRGGRTHDIRGFITPLGFSLQQRQI 
EHV1 LQPKLVRKVFMPTFTVNPEHHYRRVALGEIPKFGGAGSYGEVQIFKQTGLAIKTASSRSCFEHELAVSLLTGECSLRAQASLGIGGIICLMAFSLPSKQM 
EHV4 LQPKLVRKVFMPTFTVNPGMHYRRVSLGETPKFGGAGSYGEVQIFKQNGLAIKTSSSRSCFEHELAVSLLTGECSLRAQSTLGIGGIICLMAFSLPSKQM 
MDV1 FTLARIKNVTTFIFNVTSELHYSHIDLKEMPIYAGSGSYGWKIFKKTDIAVKKVL..ECFKTELLMTLIAGECALQAKSTLRINNIIPLLAFSIPSKEL 
MDV2 FTLSRIKNITSLIFDISPGLHYSTIDLQETPIYAGSGSYGEVKVFKGANVAVKKVF..ECFKTELLMTLIAGECACRARSTLALNSVISLLAFSIPSREL 
VZV FRISKLSRLIVPIFTLNEQLCFSKLQIRDRPRFAGRGTYGRVHIYPSSKIAVKTMDSR.VFNRELINAILASEGSIRAGERLGISSIVCLLGFSLQTKQL 
BHV1 RLAAVERPGCPVFVADASLRIRSAAELAGPAQLRGAGGYGSVWHEAAGVAVKTFASAADFEHELLVTLLAGECSLRALRHARADAIIRPCGFSLRRRQL
PRV REAPYLIPRPDGDLAVPDDLQYATLDLTGDPVAVGAGSYGSVLVY . . GSVAVKTL. . RAGFGHEAVMTLLAAE EARSAGVRGWRLMGLSAPLRQL
ILTV QLAIYIMPKPNKICLKVNPKMSYRWFNLEGSTVIGNGGYGSVQYAPKYHMAVKIFESDGHFRWELAMSLILSNAARRPELSDIAKHFLQIYAFSKIERAF 
con G-G-YG-V------- A-K------- F— E---------------------------- S-----
VI VII
HSV1 VFPAYDMDLGKYIGQLASLRTTNPSVSTALHQCFTELARAWFLNTTCGISHLDIKCANILVMLRSDA. VSLRRAVLADFSLVTLNSNSTIARGQFCLQE 
HSV2 VFPAYDMDLGKYIGQLASLRATTPSVATALHHCFTDLARAWFLNTRCGISHLDIKCANVLVMLRSDA. VSLRPAVLADFSLVTLNSNSTISRGQFCLQE 
EHV1 VFPAYDADLNAYGYRLSRSGPPSVLVTESIERAFIGLGRALVYLNTSCGLTHLDVKGGNIFVN. . . HSHFVISDCVIGDLSLMTLNTNSMAMRAEFEIDT 
EHV4 VFPAYDADLNAYGYRLSRNGPPSVLVTESIERAFIGLGRALVYLNTSCGLTHLDVKGGNIFVN. . .HSHFVISDCVIGDLSLMTLNTNSMAMRAEFEIDT 
MDV1 VFPAYHMDMDSYYHRLARI. DKTVQHWKAIEKTFMDLGKAWFLNVSCGLTHLDIKCGNIFVNVTEGPNPILVDAVIGDFSLALLNTNSTILKSRFDVNI 
MDV2 VFPAYDMDMDSYCHRLRKM. DKTARHWRAIEKAFMGLGRAWYLNVSCGLTHLDIKCGNIFVNVREGSNPIIVEAVIGDFSLALLNTNSTITKARFDITV 
VZV LFPAYDMDMDEYIVRLSRRLTIPDHIDRKIAHVFLDLAQALTFLNRTCGLTHLDVKCGNIFLNVDNFASLEITTAVIGDYSLVTLNTYSLCTRAIFEVGN 
BHV1 ALPAYDADLVAYA. EAAGRAVLSPAALAAIERAFVGLGRAWFLNASCGLAHLDIKGGNIFVNT. . . AGALITRAVLGDFSLMTLTAQSALADAEFLVST 
PRV MFPAYEMDMDAYRRSLTAR. . . PGHWHALGRVFTELGRALVFLNGR. GLSHLDVKGGNIFVRTCGN. . .MWTAVIGDFSLMALNSRSALADPRFRL. . 
ILTV VMEPLSHDLKTYAKRYKDNF.. TMETLNTLTSEFKGLAKALAFLNIDCGLVHMDVKSNNILVKC..DANGKLSRLVLADFSLTGPNTNSILNQSM. .MVC 
con ------ D-- Y--------------------- F— L— A-- LN-G— H-D-K— N---------------- V— D-SL------S----------
VIII IX
HSV1 PDLKSPRM......... FGMPTALTTANFHTLVGHGYNQPPELLVKYLNNERAEFTNHRLKHDVGLAVDLYALGQTLLELWSVYVAPSLGVPVTRFPG
HSV2 PDLESPRG......... FGMPAALTTANFHTLVGHGYNQPPELSVKYLNNERAEFNNRPLKHDVGLAVDLYALGQTLLELLVSVYVAPSLGVPVTRVPG
EHV1 GE . EEIKT......... LRLPRSASQMTFSFVIGHGLNQPISVIADFINNSGLAKSTGPIKHDVGLTIDLYALGQALLELLLVGCISPCLSVPILRTAT
EHV4 GE. EEIKT......... LRLPKSASQMTFSFWGHGHNQPLSVIADFINNSGLAKNTGPIKHDVGLAVDLYALGQALLDLLLVGCISPCLSVPILRTAT
MDV1 SS . DKIQS......... LKVCRGNIKPVFDLVLGHGQTQPCELMIKALNGVGFERRSTPLTSDEGVSIDMYALGQSLMEVILAAGMNFTHRFGISSNPL
MDV2 DS . DRVYS.........VKVSRANIRPVFDLVLGHGQTQPCELLVKALNGTGLERGSSQLSSDEGVAIDMYALGQSLMEVLLAAGMNFTRDFAIPGNPV
VZV PS . HPEHV......... LRVPRDASQMSFRLVLSHGTNQPPEILLDYINGTGLTKYTGTLPQRVGLAIDLYALGQALLEVILLGRLPGQLPISVHRTPH
BHV1 DDGNSDGASDAVAGGRLRLRLPPDARMPDPEIVMGHCATRPSEMLLDFLNRHGLRGRPEPLPADLGLAIDLYALGHALLELVLTGARETPEVQCARRQGA
PRV ............ARRKALKITSLARSPPTGVLLGHARDRPTRVLMDFIN. . GRPPPPGPLPYEVGLAIDLCALGHVLLDVAL. . GLRPQRGQALTR . . .
ILTV PSRGWEGLKIIDSTTVKNHIPSD.....SFIIYNGHCRAPEVIINYCN..GKRYRDQPMDALETLGLDLFSLGQWQEILFEGILCRSREFSFKPKPN
con ------------------------------------------------ N------------------ D LG------------------------
X
HSV1 YQYFNNQLSPDFALALLAYRCVLHPALFVNSAETNTHGLAYDVPEGIRRHLRNPKIRRAFTDRCINY.QHTHKAILSSVALPPELKPLLVLVSRLCHTNP 
HSV2 YQYFNNQLSPDFAVALLAYRCVLHPALFVNSAETNTHGLAYDVPEGIRRHLRNPKIRRAFTEQCINY.QRTHKAVLSSVSLPPELRPLLVLVSRLCHANP 
EHV1 YYYYSNKLSVDYALDLLAYRCSLYPALFPTTPLTTIYGIPWDQVEGVFESIAGAHHREAFRAHLERY.RLTHRRLFASIRIPSAFTGVLELVSLLCHANE 
EHV4 YYYYSNRLSVDYALDLLAYRCSLYPAIFPTTPLTTIYGIPWDQVEGVFESIAGAHHREAFRAHLDRY.RLTHRRLFASIRIPSAFTSVLELVSLLCHSNE 
MDV1 HFYYHRLMRADYLLDILAYRCMLYQHLFPMTPLTSKNGIPWERAEKIRLQLHSSRHRAEFDKYLEAY.DITHRKLFDSLNIFPYLNNLLELAALYCHANP 
MDV2 HFYYHKMMPADYLLDMLAYRCMLYQYLFPATPLTAKIGIPWERAEKIRSQLHGSHHRVAFEKYLEGY.EVTHRKLFDSLRVPPYLSNLFELVALYCHSNS 
VZV YHYYGHKLSPDLALDTLAYRCVLAPYILPSDIPGDLNYNPFIHAGELNTRISRNSLRRIFQCHAVRY.GVTHSKLFEGIRIPASLYPATWTSLLCHDNS 
BHV1 LHMSARRVTCGLVIGILAHRCALLPLVFPATPRTAACGVPWDEPAAVRAAIGNVAIRAAFDRTTEAH. RARYTERVREALAAAPVRRALELAALFCHPNP
PRV .........EYAVEVLARRCVLFAALLPPGSGPSAEALAGDILEE........ELAAGFREGVASS . RPGNQP...... PRTVAPLLELVARFCGEDG
ILTV ..TIHEKLSHDYMMRVLAYRIVLSDNLISRGCDLSFTGPLSGTVESVNASLFRELDRILFQSHVEHYERIDLREKLLNVIIPPETRGLCTLAGLLCHWDA
XI
HSV1 CARHALS 
HSV2 AARHSLS 
EHV1 KARLSIPLLWTPRP 
EHV4 KARLSIPLLWTPHP 
MDV1 VARTADLLLWN 
MDV2 EARAATRLLWK 
VZV EIRSDHPLLWHDRDWIGST 
BHV1 RARRAALVLWS 
PRV GARFAELAA 
ILTV DLRRSAVTFF 
con — R---
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In addition to PK motif identification, these alignments also highlight the heterogeneity 
in sequence length of the N-terminal domain of UL13 and its homologues. A convincing 
alignment cannot be produced for the alphaherpesviruses (Fig. 5.1), and lengths range 
from 86-233 amino acid residues. There is a Pro-x-x-x-x-x-Cys motif conserved in beta- 
and gammaherpesviruses, 20 and 10 residues before motif I, but not in 
alphaherpesviruses, and lengths vary from 185-400 amino acid residues in the 
betaherpesviruses and from 80-90 amino acid residues in the gammaherpesviruses. The 
extended N-terminal domain acts as a regulatory subunit in some PKs, but it is not known 
whether it plays such a role in the herpesvirus UL13 PKs.
While identification of conserved PK motifs is a strong indicator that a protein is a PK, 
their structural arrangement must be appropriate. Fig. 5.2 shows the catalytic domains of 
cAPK, HSV-1 US3 and HSV-1 UL13 aligned according to their conserved PK motifs, 
with the known secondary structure of cAPK indicated along with the predicted 
secondary structure of the two HSV-1 proteins. The secondary structures of US3 and 
UL13 were predicted using PsiPred.
As described in Chapter 1, PKs consist of two lobes. The dominant feature of the small 
lobe (motifs I to IV) is an antiparallel p-sheet comprising five strands (p i-5). In contrast, 
the large lobe is dominated by a-helices with a small p-sheet near the cleft. Fig. 5.2 
shows that in all three PKs the N-terminal region is dominated by p-strands, whereas the 
C-terminal region consists almost entirely of a-helices. However, closer analysis reveals 
areas of apparently poor structural correlation. In Fig. 5.2 the small lobe of US3 contains 
four p-strands, whereas UL13 only contains three. In cAPK, the glycine-rich motif (motif 
I) is situated between P-sheets 1 and 2 (pi and 2) and motif II is situated within p3. Fig.
5.2 shows that both UL13 and US3 have the same structural arrangement. In cAPK, motif 
III is situated within a-helix C (aC). In UL13 and US3 motif III is positioned within a 
predicted a-helix, but aB is missing from both herpesviral PKs. Also, both herpesviral 
PKs lack p5, bringing motifs IV and V closer together. Motif V is positioned within the 
region linking the two lobes. In cAPK motif V is positioned just before aD, whereas in 
both herpesviral PKs motif V is positioned at the start of P5.
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^  31 32 33 aB  aC
c A P K  4 3  f d r i k t L G T G  S F G R V m l v k h  k e s g n h y A M K  i l d k q k w k l  k q i e h t l N E K
U S 3  1 9 1  f t i h g a L T P G  S E G C V f d s s h  p d y p q r v I V K -a --------------------- g w y t s t s H E A
U L 1 3  1 5 1  p g a r s f G QSG GYGDVgl i r -  ehkl^AVT^ t i k e ------------- - - k e w f ayEL,
1 34 35 2 ^  3 ocD m
c A P K  9 2  r i l q a v n f p f  L v k l e f s f k d  n s n l y m v n ^ y  v a g G ^ m f s h l  r r i g r -------------
U S 3  2 3 2  r l l r r l d h p a  I l p l l d l h w --- - - s G V t c l v l  p k y q a d l y t y
U L 1 3  1 8 9  i A t l l v g - e c  Y j L r a g r t h - - -n i r C ^ F i a p l g  f s l q q r q i v f
IV V aE  (36
c A P K  1 3 8    f s e p h a r  f y a a q i v l t f  e y l h s l d L I Y
U S 3  2 7 0  l s r r l n p    l g r p q i a  a v s r q l l s a v  d y i h r q g l l H
U L 1 3  2 2 6  p a y d m d l g k y  i g q l a s l r t t  n p s v s t a l h q  c f t e l a r a w  f l n t t c g l S H
37 38 39
c A P K  1 6 5  R DL KPE NLL I  d q q ------------ g  y i q V T D F G f a  k r v k g r t M r - -------------------------
U S 3  3 0 4  R D I K T E N I F I  n t p ------------ e  d i c L G D F G a a  c f v q g s r s s p  f p y g i a g  
U L 1 3  2 7 6  L D I K C A N I L V  m l r s d a v s l r  r a v L A D F S 1 v  t l n s n s t i a r  g q f c l q e p d l  
VI VII
aF
c A P K  1 9 8   t l  c g t p e y l A P E  i i l s k  -----------------------
U S 3  3 4 5 ----------------------- -------------------------- ---- 1 i d L n A P E  v l a g d p  -----------------------
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Figure 5.2 Amino acid sequence alignment of the catalytic cores of cAPK and the 
HSV-1 PKs encoded by US3 and UL13.
Residues shown in green represent P-stands, residues in blue represent a-helices and 
residues shown in bold are residues indicative of PK subdomains. Arrows 1 and 2 
represent the boundaries of the small lobe, between arrows 2 and 3 represents the linker 
region and the area between arrows 3 and 4 constitutes the large lobe.
The large lobe of all three PKs begins with a long a-helix followed by motif VI. Both 
motif VI and VII are situated between two short P-strands. The conservation and position 
of motif VI between the two P-strands (p6 and 7) is significant, with the conserved 
residues between P6 and p7 forming a loop which, in cAPK, contacts the
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autophosphorylation site. There is a slightly larger gap between motifs VI and VII in 
UL13, and in all three cases the APE motif (motif VIII) lies at the start of a short a-helix, 
and motif IX is situated within a long a-helix (aG). Despite the extended region between 
motifs X and XI, the remaining motifs are reasonably well conserved, and are situated 
within predicted a-helices.
There appears to be strong structural similarity between cAPK and the herpesviral PKs 
across the region of the small lobe containing the first two motifs, followed by a region of 
poor similarity. Generally there is greater similarity between cAPK and the herpesviral 
PKs in the large lobe, with the large lobe of all three PKs composed mainly of a-helices. 
Conservation of the structural elements around the catalytic loop ((36 and 7) is a good 
indicator of PK activity. While this analysis highlights the structural similarities and 
differences between cAPK and the herpesviral PKs, supporting the view that both are 
active PKs, the precise structure and exact nature of the amino acid interactions within 
both UL13 and US3 would require the solution of their crystal structures.
5.1.2 Phosphorylation of the UL13 protein
The first aim of this research was to confirm and extend the work of Coulter et al. (1993), 
who showed that disrupting HSV-1 gene UL13 resulted in reduced in vitro 
phosphorylation of certain proteins, most obviously the 38 kDa UL49 protein. Because 
Coulter et al. (1993) used a single ULl3-lacZ mutant and did not test a revertant, it was 
necessary to analyse additional UL13 mutants in order to ensure that the observed effects 
were due solely to disruption of the UL13 gene. Two additional mutants were used 
(Table 1.12, Fig. 5.3) one with a small deletion and one with a small insertion in different 
regions of the UL13 gene.
i i i  v  v i  v i i i  i x  5 1 8i in in i ■
16bp lacZ 4bp
insertion insertion deletion
Fig. 5.3 Schematic representation of the positions of the lesions within the three 
UL13 mutants employed in this study.
The mutated sites are shown as thick, vertical black lines. The positions of six of the 
eleven PK subdomains are shown as blue boxes.
106
Discussion Chapter 5
Fig. 4.1.1 showed that these two mutants produced phosphorylation profiles 
indistinguishable from the \JL\3-lacZ  mutant which carried a sizeable insertion in the 
UL13 gene. Importantly, reduced phosphorylation of the 38 kDa UL49 protein was 
detected in the phosphorylation profiles of all three mutants.
Some PKs are known to phosphorylate themselves as a form of auto-regulation. 
Consequently, autophosphorylation is a common feature used in PK identification. The 
data presented in this thesis confirm that the putative UL13 PK is highly phosphorylated 
in vitro in infected CNE samples (Fig. 4.1.1) and in virions (Fig. 4.4.3). Phosphorylation 
of the HSV-1 UL13 PK was shown to be stimulated by Mn2+ in comparison with Mg2+, 
thus agreeing with the study performed on PRV UL13 by De Wind et al. (1992). 
However, HSV-1 UL13 PK activity was reduced at pH 9.2, a pH which promoted 
optimal activity of the HSV-2 UL13 PK (Daikoku et al. 1997). Phosphorylation of the 
HSV-1 UL13 PK was sensitive to NaCl concentration, with phosphorylation of the UL13 
PK in MeWo cells and virions increasing as NaCl concentration increased (Fig. 4.4.3). 
This observation is in agreement with Cunningham et al. (1992) and Coulter et al. 
(1993). However, Daikoku et al. (1997) found that activity of the purified HSV-2 UL13 
PK suffered a 70% reduction in activity at 0.5 M NaCl.
Since the amino acid sequence of the HSV-1 and HSV-2 UL13 proteins are 8 6 % identical 
(Fig. 5.1) it is unclear why the two PKs appear to demonstrate such different 
characteristics. However, it is interesting to note the HSV-2 UL13 PK activity purified by 
Daikoku et al. (1997) demonstrated many characteristics similar to CKI (Table 1.15). 
Attempts to purify the HSV-1 UL13 PK have resulted in loss of activity, and it is possible 
that Daikoku et al. (1997) purified an inactive UL13 PK, and that the observed PK 
activity was due to trace amounts of a contaminating cellular PK, perhaps CKI. However, 
the PK activity detected by Daikoku et al. (1997) was highly resistant to heparin, as 
would be expected for the HSV-2 PK. Thus, the disparity in NaCl sensitivity and 
optimum pH between the HSV-1 and HSV-2 UL13 PKs remains unresolved.
5.1.3 Hyperphosphorylation of the UL13 protein
The UL13 protein was shown to be hyperphosphorylated in CNE samples incubated with 
excess ATP or GTP (Fig. 4.2.1). Hyperphosphorylation of the UL13 protein
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demonstrated cell type dependence, and did not occur in virions (Fig. 4.4.3). 
Hyperphosphorylation of the UL13 PK was not inhibited by heparin (Fig. 4.4.6), but was 
inhibited by DRB, a potent CKH inhibitor (Fig. 4.4.7).
While hyperphosphorylation is a relatively common phenomenon, it has not before been 
observed to occur with the HSV-1 UL13 protein, and might be of physiological 
significance. For example, the hypo- and hyperphosphorylated forms of RNA polymerase 
II are associated with distinct aspects of transcription. CKII has been reported to 
phosphorylate viral proteins such as the papillomavirus E7 protein (Barbosa et al., 1990), 
the adenovirus E1A protein (Carroll et al., 1988) and simian virus 40 large T antigen 
(Grasser et al., 1988). It is also relatively common for PKs to function in cascade 
systems, with their activity upregulated by additional PKs. However, it must be borne in 
mind that hyperphosphorylation of the UL13 PK was achieved in an in vitro assay. PKs 
are very active enzymes, often phosphorylating proteins in vitro with recognisable target 
sequences but which are not necessarily of physiological significance.
There are a number of residues throughout the PK catalytic domain which when mutated 
inactivate PK activity. For example charge-to-Ala mutations at Lys72, Glu91, Asp166 and 
Lys168 within cAPK abolish activity (Taylor et al., 1993). Mutation of the invariant Lys in 
HHV- 8  (Lys108) (Park et al., 2000) and in HCMV (Lys355) (He et al., 1997) dramatically 
reduced the PK activity of the proteins. Mutating the invariant Lys (Lys180) in the HSV-1 
UL13 PK would help determine whether hyperphosphorylation of the UL13 PK was an 
extreme form of autophosphorylation or a result of a second PK targeting the UL13 PK.
5.1.4 Mapping sites of phosphorylation in the UL13 PK
At the start of this project, it was not known where or on how many residues the UL13 
PK was phosphorylated. However, detection of three different phosphorylated forms of 
the UL13 PK with Mrs of approximately 57, 60 and 62 kDa suggests that the protein is 
phosphorylated at a minimum of three sites. Attempts were made to locate the sites by 
phosphopeptide mapping.
The UL13 protein derived from virions and MeWo and RSC CNEs was shown to be 
phosphorylated on a 12 kDa Lys-C peptide. Indeed, the 12 kDa Lys-C phosphopeptide
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was the only phosphopeptide detected in UL13 from phosphorylated virions. In addition, 
an 11 kDa phosphopeptide was detected in UL13 protein from RSC CNE digested with 
Glu-C. One interpretation of this is that the 12 kDa Lys-C phosphopeptide contains the 
autophosphorylation domain of the UL13 PK. The major autophosphorylation domain is 
usually situated between PK motifs VII and IX, near motif VTH. The predicted Lys-C and 
Glu-C peptides containing motif VIII are shown, along with their predicted Mws, in Fig. 
5.3.
3626.2 Da
I I
L ys-C  327 SPRMFGMPTALTTANFHTLVGHGYNQ|PPE|LLVK 359
Glu-C 322 PDLKSPRMFGMPTALTTANFHTLVGHGYNQ|PPE| 355
I_____________________________________________ I
3626.1 Da
Figure 5.4 Amino acid sequences of the predicted Lys-C and Glu-C peptides 
containing UL13 PK motif VIII.
The Ser (S) and Thr (T) residues are shown in blue and PK motif VIII is boxed. Non- 
phosphorylated peptide masses are indicated.
Because phosphorylated proteins and peptides can migrate with aberrantly high Mrs, it is 
possible that these two peptides are the 12 kDa Lys-C and 11 kDa Glu-C peptides 
detected in Figs. 4.5.16 and 4.5.15. However, there are problems with this interpretation. 
The Mws of the two peptides differ by only 0.1 Da, but the Lys-C phosphopeptide 
migrated with an Mr 1 kDa greater than the Glu-C peptide. Since the Lys-C peptide 
contains no additional sites for phosphorylation, this difference cannot be attributed to 
phosphorylation. Also, whereas only one peptide was detected from Glu-C digests of 
CNE, a 5 kDa peptide was derived from the Lys-C digest in addition to the 12 kDa 
peptide (Figs. 4.5.15 and 4.5.16). It is possible that the phosphorylated residue within the 
5 kDa Lys-C peptide was situated within a Glu-C peptide too small to be visualised by 
SDS-PAGE. This is unlikely because the smallest predicted Glu-C peptide containing a 
Ser or Thr residue is 1166.4 Da. The data presented here do therefore not readily support 
phosphorylation of the UL13 PK within the accepted autophosphorylation domain. 
However, phosphorylation of residues within the Ser rich N-terminal 100 residues are 
predicted to produce the phosphopeptide patterns shown in Figs. 4.5.15 to 4.5.17. Fig. 5.4 
shows the predicted Lys-C and Glu-C peptides derived from this region.
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As shown in Fig. 5.4, digesting the N-terminal 100 residues with Lys-C is predicted to 
yield two peptides of 3151.5 and 7829.6 Da, whereas Glu-C treatment would yield 
fragments of 393.4, 7326.0 and 2653.0 Da. The 7829.6 Da Lys-C peptide and 7326.0 Da 
Glu-C peptide overlap by 43 residues, 10 of which are Ser residues. The predicted Lys-C 
peptide is approximately 0.5 kDa larger than the Glu-C peptide, which corresponds well 
with the 1 kDa difference in Mr between the Lys-C phosphopeptide and Glu-C 
phosphopeptide in Fig. 4.5.16. Also, if the 7326.0 Da Glu-C peptide is phosphorylated on 
any of its three N-terminal Ser residues, these would appear on the 3151.5 Da Lys-C 
peptide, which would correspond well with the 5 kDa Lys-C phosphopeptide seen in 
Figs. 4.5.16 and 4.5.17. It is unlikely that the 7829.6 Da Lys-C is phosphorylated on the 
C-terminal five Ser residues, as this would result in a second, smaller Glu-C 
phosphopeptide in addition to the 11 kDa phosphopeptide detected in Fig. 4.5.15.
3151.5 Da
I-------------------------------------------------- 1---------------------------------------
L ys-C  1 MDESRRQRPAGHVAANLSPQGARQR§FKDWLASYVHSNPHGASGRPSGP|] 50
g i u - c  i  m d e s r r q r p a g h v a a n l s p q g a r q r | | f k d w l a s y v h s n p h g a s g r p s g p | |  50
393.4 Da 7326.0 Da
7829.6 Da
I
51 LQDAAVSRSSHGSRHRSGLRERLRAGLSRWRMSRSSHRRASPETPGTAAK 100 
51 LQDAAVSRSSHGSRHRSGLRERLRAGLSRWRMSRSSHRRASPETPGTAAK 100
2653.0 Da
Figure 5.5. Sequences of the Lys-C and Glu-C peptides derived from the N-terminal 
100 amino acid residues of the UL13 PK.
Ser (S) and Thr (T) residues are shown in blue, the boxed residues lying within CKII 
consensus sequences. Non-phosphorylated peptide masses are indicated in Da.
Of the two possibilities, that phosphorylation occurs in the autophosphorylation domain 
or in the Ser-rich N-terminal domain, the latter is better supported by the data. This 
region is not within the conserved catalytic core of the PK, and the alignments in Fig. 5.1 
highlights the lack of conservation and heterogeneity in length of the N-terminal domain 
of UL13 and its homologues. However, it should be noted that mutational analysis of 
BGLF4, the UL13 counterpart in EBV, identified the N-terminal 26 residues as essential
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for autophosphorylation (Chen et a l, 2000). The N-terminal 26 residues of UL13 all lie 
within the 3151.6 Da Lys-C fragment, supporting the hypothesis that the HSV-1 UL13 
PK is phosphorylated on residues at its N-terminal region. Further mapping experiments 
are needed to elucidate the situation further.
No success at mapping phosphorylated residues within HSV-1 UL13 or its homologues 
has been reported. Using phosphoamino acid analysis, the PRV UL13 (De Wind et al., 
1992), HCMV UL97 (He et a l, 1997) and HHV- 8  ORF36 PKs (Park et al., 2000) were 
shown to be phosphorylated on Ser and Thr residues. In the PRV UL13 PK there is a 
greater preference for phosphorylation on Ser residues and the HHV- 8  ORF36 PK 
autophosphorylated solely on Ser residues. The 7829.6 Da N-terminal Lys-C peptide 
shown in Fig. 5.4 is very Ser-rich. Indeed, the best supported interpretation of the data 
presented here implies that the HSV-1 UL13 PK is phosphorylated solely on Ser residues. 
During the course of this work, phosphoamino acid analysis of radiolabelled HSV-1 
UL13 PK was attempted, but the results were inconclusive. This would be an important 
avenue for future investigation. Identification of the phosphorylated residues could be 
achieved by protein sequencing. However, this approach is unlikely to yield results easily 
because the UL13 protein is a very minor component of the virion, and is present in low 
levels in infected cells. Identification of phosphorylated residues would require 
phosphopeptide mapping at a very detailed level, supported by mutation of the potential 
target residues.
5.2 Targets for phosphorylation
5.2.1 Phosphorylation of the UL49 protein
Using three independent UL13 mutants, it was confirmed that phosphorylation of a 38 
kDa viral protein was dependent upon a functional UL13 protein. Coulter et a l  (1993) 
used HSV-l/HSV-2 intertypic recombinants to identify the 38 kDa protein as the UL49 
gene product. Data in this thesis obtained using a UL49 truncation mutant (UL49del268- 
301) and mass spectrometry confirmed this identification. Importantly, the UL49 protein 
was still phosphorylated in UL13 mutant CNE samples, albeit to a greatly reduced level. 
This indicated that a second PK targets the UL49 protein. On the basis of NaCl 
sensitivity, Coulter et a l  (1993) suggested that the second PK was of cellular origin. The 
work presented here confirmed that the PK targeting the UL49 protein in UL13 mutant
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CNE was inhibited at high NaCl concentrations (Fig. 4.1.1.) and that it was sensitive to 
heparin (Fig. 4.4.5) but not DRB, a potent CKII inhibitor (Fig. 4.4.7). Elliott et al. (1996) 
identified a number of CKII and PKC sites in the N-terminal 120 residues of the UL49 
protein, which they suggested are targeted for phosphorylation. On the basis of the data 
presented here, it seems likely that the heparin-sensitive but DRB-insensitive PKC 
phosphorylates the UL49 protein in addition to the UL13 PK.
5.2.2 Hyperphosphorylation of the UL49 protein
Initially, the UL49 protein was not detectably hyperphosphorylated when incubated in the 
presence of excess ATP or GTP (Fig. 4.2.1). This seemed unusual, especially since it was 
apparent that multiple PKs may target the UL49 protein. However, under different buffer 
conditions, the UL49 protein demonstrated an altered mobility indicative of 
hyperphosphorylation (Fig. 4.4.1). This novel mobility shift was abolished by 
phosphatase treatment (Fig. 4.4.7), showing that it was due to phosphorylation. However, 
there was an additional post-translational modification which was stimulated by 
incubation with each of the four dNTPs (Fig. 4.4.5). The UL49 protein is known to be 
both nucleotidylylated and mono-(ADP)-ribosylated (Blaho et al., 1994), however the 
identity of the second post-translational modification remains elusive. Neither 
hyperphosphorylation nor the second post-translational modification were detected when 
a mutant producing UL49 protein lacking the C-terminal 34 amino acids (UL49del268- 
301) was analysed.
Using the vUL49del268-301 mutant to map phosphorylated residues in the UL49 protein, 
Elliott et a l (1996) found no indication of phosphorylation within the C-terminal 34 
residues. Indeed, the truncated form of the UL49 protein was radiolabelled when 
phosphorylated in vitro (data not shown). However, the data indicates that 
hyperphosphorylation, undetected by Elliott et al. (1996) requires the C-terminal 34 
residues.
5.2.3 Phosphorylation mapping of the UL49 protein
Tryptic digests of the UL49 protein, phosphorylated at NaCl concentrations between 0 
and 1.0 M, produced a radiolabelled tryptic phosphopeptide of approximately 2 kDa (Fig. 
4.5.4). When the UL49 protein was phosphorylated at 1.5 M NaCl, a tryptic peptide of
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1703.91 Da was found to be phosphorylated. This phosphorylated peptide was not 
detected in UL49 phosphorylated at 0 M NaCl. These data confirm that the UL49 protein 
is phosphorylated at multiple sites, probably by multiple PKs. It seems likely that one of 
the PKs is a NaCl- and heparin-sensitive cellular PK (Figs. 4.1.1 and 4.4.5) and that the 
second is the HSV-1 UL13 PK. It is likely that the herpesviral PK targets the 1703.91 Da 
peptide. The 1703.91 Da peptide constitutes residues 228 to 242 of the UL49 protein and 
the sequence is shown in Fig. 5.5. It was not determined which of the three Thr residues 
was phosphorylated.
228 TDEDLNELLGITTIR 242
Fig. 5.6 The sequence of the 1703.91 Da tryptic peptide representing residues 228 to 
242 of the UL49 protein.
Potentially phosphorylated residues are shown in blue.
Elliott et al. (1996) identified a number of residues in the N-terminal 120 residues of the 
UL49 protein which they believed were targeted by CKII or PKC. Four Ser residues were 
identified on a 13 kDa Lys-C peptide which was located in the established CKII 
consensus motif. The predicted peptides resulting from complete tryptic digestion would 
place one of these Ser residues on a 2.7 kDa peptide and the other three on a 3.1 kDa 
peptide. Unfortunately neither corresponds in size to the 2 kDa tryptic phosphopeptide 
derived from the UL49 protein (Figs. 4.5.4 and 4.5.5). Further work by Elliott et al. 
(1999) identified a cluster of three N-terminal serines present at residues 71, 72 and 73 
(Ser71,72, 73) as a substrate for CKII. In addition, Elliott et al. (1999) identified two C- 
terminal Ser residues (Ser292, 294) which acted as a substrate for another, as yet 
unidentified, cellular kinase. These C-terminal residues identified by Elliott et al. (1999) 
do not lie within the 1703.91 Da fragment identified in this study. Elliott et al. (1996) 
stated that they believed VP22 was modified solely on Ser residues located in the N- 
terminal 120 residues of the protein. Within 3 years they had identified two further 
phosphorylated residues in the C-terminus, it is possible that further phosphorylated 
residues remain undetected by them.
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5.2.3 Critical appraisal of identified UL13 PK targets
A number of proteins have been identified as targets for phosphorylation by the HSV-1 
UL13 PK (Table 1.16). However, critically appraising the validity of these target proteins 
is difficult, not least because all the target proteins were identified using in vitro assays 
which poorly reproduce the in vivo situation.
All the studies outlined in Section 1.5 used UL13 mutants to identify targets for the UL13 
PK. however only ICP22 (US1), ICPO (RL1), EF-15, gE (US8) and gl (US7) were 
proposed to be directly phosphorylated by the UL13 PK, as demonstrated by incubating 
immune complexes of putative target proteins with immune-precipitated UL13 under 
phosphorylating conditions. The major flaw in this technique, as outlined in section 1.3.1, 
in that the likelihood of co-precipitating contaminating PKs, such as CKI and CKII, 
cannot be excluded. Prod’hon et al. (1996) used in vitro transcribed and translated UL13 
protein and ICP22 to show that the UL13 PK can directly phosphorylate ICP22. 
However, even though the UL13 PK is capable of phosphorylating proteins in the assays 
used, it is far from clear whether phosphorylation of these proteins is physiologically 
relevant and whether they are actually targeted in vivo.
One means of determining whether a protein is a true target for phosphorylation by the 
UL13 PK is to show that phosphorylation is required for an aspect of target protein 
function. The observation that the phenotypes of UL13 and US1 mutants are similar 
indicates that UL13 phosphorylation maybe important for an aspect of ICP22 function. 
Hyperphosphorylation of RNA polymerase II and EF-15 has been shown to be of 
physiological importance, and the UL13 PK has been implicated in hyperphosphorylation 
of both proteins. While a hyperphosphorylated form of vhs is preferentially packaged into 
virions this has not been related to host-shutoff function. Phosphorylation of the UL49 
protein has been implicated in tegument dissociation, but only in vitro, and although gE, 
gl and ICPO are known to be phosphorylated in HSV-1 no functional importance of this 
modification has been identified.
The claim that ICP22 is a true target of the UL13 PK is perhaps the strongest of those 
available, but it is not yet proved. Conservation of the UL13 protein across the 
herpesvirus subfamilies implies that the true target is a conserved herpesviral protein or a
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cellular protein. However, the HSV-1 US1 gene encoding ICP22 has counterparts only in 
the alphaherpesviruses, and the VZV UL13 homologue, ORF47, has been shown not to 
phosphorylate the VZV ICP22 homologue, ORF63 (Heineman et al., 1995). Indeed, the 
only protein identified as a potential target for VZV ORF47 is the ORF32 protein, which 
lacks counterparts in other herpesviruses (Reddy et al., 1998). Despite the large number 
of studies concerning the UL13 PK and its targets no one has produced compelling 
evidence that argues for one target over the rest. The function of the UL13 PK seems no 
closer to being elucidated, and it will take much more research to determine the true 
targets from the artifactual evidence.
5.3 Future work
Many of the experiments required to produce a more complete picture have been outlined 
in the results sections. More accurate mapping of the UL49 protein would be possible 
following the protocols outlined in this thesis followed by protein sequencing studies. 
The UL13 protein, however, would require a different approach. Because the UL13 
protein is produced in minor amounts it is not feasible to map phosphorylated residues by 
isolation of the protein from purified virus or infected cell CNE followed by mass 
spectrometric analysis or protein sequencing. While further mapping experiments would 
identify the phosphopeptide with greater accuracy, mutational analysis would be required 
to identify the individual phosphorylated residues. Any interpretation would have to 
accommodate multiple residues targeted by more than one PK.
By its nature, research on PKs tends to be slow and fraught with potential pitfalls. It is 
perhaps not surprising that herpesviral PKs are no exception. Little work has been 
performed on the herpesviral PKs beyond characterisation of their enzymatic activities. 
Purification of the active HSV-1 UL13 PK would represent an important step and would 
allow structural information to be obtained for a divergent member of the PK 
superfamily. In addition, purification of the HSV-1 UL13 PK would allow new 
approaches to be adopted in the search for significant target proteins.
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